Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
43055554	cb-be	mmol/l (mmol/l)	18342	62591	0.00%
43055554	cb-be	— (—)	13610	37838	100.00%	Distribution not available
43055554	cb-be	mmol/l____ (mmol/l)	449	862	0.00%
43055554	cb-be	mmol/L (mmol/l)	117	342	0.00%
43055554	cb-be	MMOL/L (mmol/l)	51	100	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Type 1 diabetes

1570

5630

3.02

321.76

5.3

4.1

1.29

1.57

mmol/l

1.84

1126

4128

Type 1 diabetes, wide definition, subgroup 1

1346

4439

3.32

321.63

5.1

4.1

1.32

1.60

mmol/l

1.75

970

3263

Presence of other functional implants

3239

10704

2.18

316.72

4.2

3.2

1.90

1.95

mmol/l

0.26

2371

8019

Poisoning by medicine

1293

4239

3.32

311.90

3.5

3.4

1.31

1.59

mmol/l

1.63

961

3088

Caries of dentine

1501

5174

3.05

308.67

6.7

3.6

1.51

1.75

mmol/l

1.43

1121

3795

Cough

2201

8769

2.48

308.50

4.3

3.9

1.57

1.55

mmol/l

0.12

1677

6293

Renal failure

5567

10930

5.25

307.65

6.9

3.0

0.98

2.11

mmol/l

55.41

3792

8269

Non-invasive ventilation

1708

2404

6.82

307.65

9.4

3.4

3.26

1.43

mmol/l

49.04

1477

1724

Heart failure and coronary heart disease

3124

8521

2.83

307.65

5.4

3.5

2.29

1.86

mmol/l

6.15

2339

6350

Atrial fibrillation and flutter with reimbursement

1332

2261

4.00

307.65

4.2

2.4

2.34

1.58

mmol/l

8.34

1008

1747

Glomerular disorders in diseases classified elsewhere

1340

2738

6.28

307.65

8.2

3.3

0.61

1.82

mmol/l

21.05

939

2007

Erysipelas, including avohilmo

4118

12969

2.49

307.65

4.6

2.7

1.99

1.73

mmol/l

3.58

3153

9385

Asthma-related infections

3659

16455

2.30

307.65

4.8

3.9

2.13

1.62

mmol/l

14.25

2798

11923

Diarrhoea and gastroenteritis of presumed infectious origin

4096

17541

2.19

307.65

5.9

3.4

1.44

1.70

mmol/l

4.22

2984

12745

Atrial fibrillation and flutter

1548

2772

3.85

307.65

4.2

2.3

2.23

1.55

mmol/l

8.58

1174

2127

Bacterial infection, other or unspecified, including avohilmo

4973

12090

3.77

307.65

5.7

3.2

1.85

1.72

mmol/l

1.36

3808

8778

Nephropathy related operations

1474

3129

6.16

307.65

12.9

3.9

0.41

1.77

mmol/l

29.70

1022

2311

Other diseases of the respiratory system

2117

5636

4.50

307.65

8.1

3.7

3.67

1.58

mmol/l

87.51

1860

4027

Acute renal failure

2433

5478

5.42

307.65

7.2

2.9

1.16

2.12

mmol/l

17.27

1726

4121

Hypertension, essential

3871

8621

2.67

307.65

3.8

2.7

1.64

1.72

mmol/l

0.58

2809

6417

Secondary hypertension

1018

1161

11.44

307.65

10.3

3.2

0.25

1.42

mmol/l

14.13

736

868

Unspecified kidney failure

1020

2414

5.08

307.65

7.7

2.9

0.88

2.25

mmol/l

15.76

709

1783

Heart failure, strict

4602

10730

3.32

307.65

5.5

3.1

2.51

1.54

mmol/l

38.45

3529

7863

Codeine

4480

11032

2.29

307.65

3.4

3.0

1.70

1.63

mmol/l

0.49

3270

7898

Asthma

3855

6885

3.04

307.65

3.8

2.5

1.97

1.09

mmol/l

33.61

2893

4701

Hypo-osmolality and hyponatraemia

1366

4138

3.70

307.65

5.4

3.3

2.20

2.04

mmol/l

0.70

1036

3123

All influenza

1821

5964

3.36

307.65

6.7

3.2

1.98

1.34

mmol/l

10.84

1410

4231

Abnormal findings on diagnostic imaging of lung

3291

12937

2.61

307.65

5.0

3.4

2.05

1.79

mmol/l

3.53

2664

9411

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

5762

16176

2.37

307.65

6.0

3.1

1.52

1.69

mmol/l

2.43

4198

11813

Obesity due to excess calories

3520

10689

3.64

307.65

3.6

3.4

1.73

1.58

mmol/l

1.58

2631

7739

COPD, hospital admissions

3470

10676

3.04

307.65

5.1

3.3

2.72

1.61

mmol/l

47.22

2789

7699

Tramadol

4308

10531

2.59

307.65

4.0

3.0

1.72

1.68

mmol/l

0.27

3201

7604

Parasetamol

3350

7317

2.40

307.65

3.7

3.2

1.56

1.51

mmol/l

0.27

2422

5274

Implicit Sepsis, including avohilmo

6393

14223

3.53

307.65

5.8

2.8

2.02

1.58

mmol/l

12.16

4829

10272

Heart failure, not strict

5969

11259

3.99

307.65

5.9

2.8

2.10

1.51

mmol/l

20.87

4544

8242

Asthma-related pneumonia or sepsis

2520

10464

2.60

307.65

5.7

3.9

2.41

1.75

mmol/l

15.61

1987

7629

Mental and behavioural disorders due to psychoactive substance use

3399

14757

2.23

307.65

4.0

3.4

1.81

1.60

mmol/l

2.22

2548

10677

Diabetes mellitus

5797

14527

2.43

307.65

3.7

3.4

1.62

1.70

mmol/l

0.72

4173

10720

Other and unspecified iron deficiency

2279

9345

2.64

307.65

5.4

3.6

1.79

1.81

mmol/l

0.04

1713

6836

COPD

3567

9797

3.30

307.65

5.1

3.3

2.67

1.59

mmol/l

43.97

2854

7040

Covid-19 confirmed case

3011

10385

3.23

307.65

5.7

3.6

2.26

1.69

mmol/l

14.11

2286

7518

Glomerular diseases

1830

4616

4.80

307.65

8.8

3.8

0.74

1.78

mmol/l

22.64

1289

3402

Abnormalities of breathing

5873

11607

3.10

307.65

4.1

3.6

1.83

1.48

mmol/l

8.42

4355

8267

Dialysis

613

881

10.73

307.65

16.2

4.6

0.30

1.83

mmol/l

16.36

435

664

Obesity and other hyperalimentation

4283

14224

3.07

307.65

3.7

3.4

1.87

1.61

mmol/l

4.20

3230

10327

General examination and investigation of persons without complaint and reported diagnosis

3530

6958

2.78

307.65

4.6

3.0

1.46

2.02

mmol/l

13.15

2596

5026

Chronic kidney disease

4104

8183

6.08

307.65

7.6

3.1

0.78

2.15

mmol/l

65.75

2734

6167

Hypertensive diseases

3964

9271

2.53

307.65

4.9

3.0

1.61

1.65

mmol/l

0.21

2894

6889

Concussion

2583

6739

3.14

307.65

3.8

4.6

1.67

1.56

mmol/l

0.69

1886

4776

Type 2 diabetes, definitions combined

4946

12982

2.32

307.65

3.4

3.0

1.75

1.80

mmol/l

0.37

3575

9607

Neurological diseases

4425

8544

2.73

307.65

4.0

4.7

1.48

1.60

mmol/l

1.15

3223

6004

COPD related to multimorbidity

3109

9460

3.10

307.65

5.3

3.3

2.74

1.62

mmol/l

41.62

2492

6800

COPD/asthma related infections

5261

11178

2.47

307.65

4.2

2.6

2.06

1.37

mmol/l

28.23

3987

7815

Oxycodone

3101

8078

3.65

307.65

4.8

3.2

2.28

1.78

mmol/l

8.31

2444

5903

General symptoms and signs

5721

12457

2.41

307.65

4.0

3.1

1.67

1.64

mmol/l

0.22

4205

8961

L04AD Calcineurin inhibitors

1084

2719

4.88

307.65

14.6

4.2

0.59

1.56

mmol/l

13.68

751

2033

Hypothyroidism and >3 levothyroxin purchases

1016

1181

5.07

307.65

3.9

2.9

1.28

1.00

mmol/l

1.47

732

838

Any gastric operation

3986

7355

2.85

307.65

4.9

2.6

1.53

1.73

mmol/l

2.37

2907

5126

Hypertension

3961

9253

2.54

307.65

4.9

3.0

1.61

1.65

mmol/l

0.25

2890

6877

Continuous positive airway pressure

2787

2331

13.42

307.65

4.7

4.6

1.32

1.23

mmol/l

0.56

2212

1693

Endocrine, nutritional and metabolic diseases

3957

7931

2.63

307.65

4.5

3.6

1.50

1.51

mmol/l

0.04

2839

5781

Substance abuse, excluding more controls

3309

11441

2.57

307.65

3.9

3.4

1.82

1.60

mmol/l

2.10

2484

8277

Other (not insulin) diabetes medications

5094

14330

2.18

307.65

3.5

3.2

1.73

1.81

mmol/l

0.66

3715

10582

Nausea and vomiting

1996

6896

3.09

307.65

7.1

4.0

1.55

1.79

mmol/l

1.89

1506

5048

Other anaemias

2948

12041

2.48

307.65

5.4

3.6

1.68

1.89

mmol/l

1.90

2133

8913

Cerebrovascular diseases (FINNGEN)

1536

3080

3.73

307.65

4.6

2.5

1.69

1.47

mmol/l

1.32

1134

2319

Other nutritional deficiencies

4502

14882

2.99

307.65

3.8

3.5

1.84

1.61

mmol/l

3.48

3382

10810

Poisoning by drugs, medicaments and biological substances

1427

4777

3.25

307.65

3.6

3.4

1.33

1.59

mmol/l

1.58

1072

3467

Diabetes, varying definitions

5753

14557

2.41

307.65

3.7

3.4

1.63

1.70

mmol/l

0.66

4137

10747

COPD (mode)

2708

4087

5.98

307.65

5.3

2.5

2.80

1.15

mmol/l

65.98

2195

2813

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3545

11610

2.58

307.65

4.5

3.4

1.55

1.92

mmol/l

5.54

2538

8725

Type 2 diabetes

5464

13303

2.51

307.65

3.6

3.0

1.68

1.77

mmol/l

0.83

3955

9833

Other respiratory disorders and diseases

2117

5636

4.50

307.65

8.1

3.7

3.67

1.58

mmol/l

87.51

1860

4027

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5439

13940

2.44

307.65

3.8

3.4

1.66

1.75

mmol/l

0.79

3911

10342

COPD differential diagnosis

3696

7000

2.77

307.65

3.8

2.5

1.92

1.09

mmol/l

29.46

2756

4787

6149

11178

3.48

307.65

5.2

2.6

2.19

1.37

mmol/l

41.45

4753

7815

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1445

4467

3.42

307.65

3.3

3.1

1.39

1.50

mmol/l

0.45

1088

3165

Diabetes medication

5762

15777

2.24

307.65

3.8

3.5

1.66

1.72

mmol/l

0.54

4182

11620

Symptoms and signs involving the circulatory and respiratory systems

4949

11626

2.22

307.65

3.9

3.6

1.59

1.48

mmol/l

1.16

3604

8281

Aplastic and other anaemias

3301

12602

2.60

307.65

6.0

3.6

1.56

1.88

mmol/l

4.04

2386

9332

Any death

4003

11561

2.62

307.65

5.7

3.0

2.37

1.60

mmol/l

21.59

3087

8567

Dialysis, with operation codes

1570

2864

7.25

307.65

12.5

3.5

0.24

1.89

mmol/l

43.97

1086

2159

Syncope and collapse

2548

8902

2.53

307.65

3.7

3.2

1.65

1.75

mmol/l

0.60

1877

6459

Other chronic obstructive pulmonary disease

3451

9506

3.32

307.65

5.1

3.3

2.71

1.58

mmol/l

45.95

2773

6818

COPD, hospital admission 2, with asthma infections

2652

7723

3.33

307.65

5.7

3.3

2.89

1.61

mmol/l

47.50

2162

5511

Headache

3081

11208

2.21

307.65

3.7

3.0

1.54

1.63

mmol/l

0.66

2230

8056

COPD, hospital admissions 1, only main diagnosis

2708

8424

3.09

307.65

5.5

3.3

2.89

1.64

mmol/l

46.01

2215

6040

Pain in throat and chest

4154

11222

2.28

307.65

3.5

3.3

1.65

1.51

mmol/l

1.51

3031

8013

COPD, hospital admissions 3, with asthma pneumonia sepsis

2272

6517

3.38

307.65

6.0

3.3

2.99

1.63

mmol/l

45.08

1855

4610

Acute tubulo-interstitial nephritis

4076

12774

2.90

307.65

5.6

3.0

1.67

1.94

mmol/l

3.83

2989

9490

All chronic kidney diseases

5613

10784

4.82

307.65

6.7

3.0

1.01

1.98

mmol/l

47.62

3867

8089

Acute bronchitis

2615

11525

2.38

307.65

6.0

3.7

2.12

1.68

mmol/l

7.50

2030

8330

Viral pneumonia

1087

2629

4.78

307.65

6.8

3.5

2.36

1.31

mmol/l

15.90

873

1863

Malaise and fatigue

3539

9696

3.10

307.65

4.2

3.3

1.87

1.72

mmol/l

1.30

2669

7002

All kidney diseases

7272

15585

3.40

307.65

5.8

2.9

1.38

1.84

mmol/l

15.40

5184

11538

Codeine or tramadol medication

5477

16305

1.89

307.65

3.4

3.3

1.73

1.71

mmol/l

0.09

4020

11842

Other disorders of fluid, electrolyte and acid-base balance

2792

7587

3.95

307.65

5.7

3.3

2.13

1.92

mmol/l

1.57

2109

5676

Opioids

4645

11258

2.21

307.65

3.4

3.0

1.63

1.62

mmol/l

0.02

3377

8047

Anaemias

1519

1437

7.48

307.65

7.4

4.2

1.25

0.89

mmol/l

2.49

1101

1005

All pneumoniae

7142

16012

3.13

307.65

5.6

3.1

2.15

1.32

mmol/l

54.16

5513

11317

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

6194

14297

3.16

307.65

5.5

2.9

1.97

1.51

mmol/l

13.08

4636

10310

Non-ischemic cardiomyopathy

2285

6001

3.36

307.65

5.4

3.2

2.85

1.56

mmol/l

34.25

1774

4436

Neurological diseases, wide definition

1498

1787

4.46

307.65

4.5

5.6

1.28

1.38

mmol/l

0.41

1100

1251

Other diseases of pleura

3936

11171

3.47

307.65

6.4

3.4

3.05

1.49

mmol/l

98.55

3259

8013

Polyarthropathies

3638

11090

2.21

307.65

4.7

3.5

1.70

1.71

mmol/l

0.05

2621

8089

Condition for Implicit Sepsis (Organ dysfunction codes)

6308

14225

3.35

307.65

5.7

2.8

2.03

1.55

mmol/l

13.90

4769

10272

Bacterial Sepsis

4449

9804

4.29

307.65

6.8

2.9

2.07

1.68

mmol/l

6.47

3422

7104

Bronchitis

5848

18343

1.99

307.65

4.4

3.2

1.89

1.65

mmol/l

4.99

4434

13190

Explicit Sepsis

3875

10134

3.93

307.65

6.6

3.0

1.78

1.62

mmol/l

1.38

2928

7308

Extracorporeal dialysis

899

1452

9.24

307.65

12.7

3.7

0.15

1.99

mmol/l

29.83

641

1064

Other acute lower respiratory infections

3349

14965

2.26

307.65

5.7

3.7

2.07

1.60

mmol/l

10.78

2577

10775

Certain infectious and parasitic diseases

4832

11334

2.22

307.65

4.6

2.8

1.72

1.61

mmol/l

1.04

3568

8090

Nutritional anaemias

3220

13628

2.41

307.65

5.2

3.6

1.75

1.83

mmol/l

0.52

2388

9999

Other bacterial diseases, including avohilmo

6804

15786

2.89

307.65

5.5

3.1

1.82

1.59

mmol/l

4.45

5149

11314

Complications of surgical and medical care, not elsewhere classified

5303

18636

1.98

307.65

4.7

3.3

1.78

1.71

mmol/l

0.59

3947

13583

Extreme obesity with alveolar hypoventilation

501

765

9.00

307.65

6.8

3.4

4.43

1.71

mmol/l

27.99

442

578

Obesity

4266

14177

3.07

307.65

3.7

3.4

1.87

1.60

mmol/l

4.19

3216

10293

Other medical care

3213

10633

2.74

307.65

4.9

3.1

2.42

1.73

mmol/l

14.99

2453

7826

Heart failure and bmi 25plus

2764

6949

2.97

307.65

5.9

2.9

2.53

1.40

mmol/l

33.50

2194

5147

Substance abuse

3309

14555

2.23

307.65

3.9

3.4

1.82

1.60

mmol/l

2.26

2484

10535

Erysipelas

3311

11694

2.60

307.65

4.9

2.8

2.09

1.77

mmol/l

4.12

2549

8500

Renal tubulo-interstitial diseases

7153

15311

3.79

307.65

6.1

2.9

1.35

1.88

mmol/l

19.22

5043

11388

Pneumonias (Asthma/COPD co-morbidities)

7128

15983

3.15

307.65

5.6

3.0

2.16

1.32

mmol/l

54.07

5505

11307

Episodal and paroxysmal disorders

6562

12541

2.81

307.65

3.4

4.5

1.51

1.73

mmol/l

4.30

4848

8954

Other special examinations and investigations of persons without complaint or reported diagnosis

3139

6977

2.37

307.65

4.0

3.0

1.58

2.02

mmol/l

7.53

2245

5037

Other heart diseases

2513

5222

3.33

307.65

5.6

3.3

1.94

1.25

mmol/l

15.07

1896

3804

Implicit viral Sepsis

1912

4808

4.62

307.65

8.1

3.0

2.05

1.67

mmol/l

3.27

1468

3452

Other antidepressants

5071

13781

1.95

307.65

3.4

3.5

1.76

1.66

mmol/l

1.08

3798

9873

Cardiac arrhythmias

2677

6459

2.78

307.65

4.2

3.0

1.91

1.46

mmol/l

7.53

2002

4744

Septicaemia

3789

10120

3.87

307.65

6.7

3.3

1.79

1.73

mmol/l

0.39

2871

7335

Metabolic disorders

5410

14821

2.31

307.65

4.8

3.3

1.69

1.70

mmol/l

0.03

3902

10963

COPD/asthma/ILD related infections

5261

11178

2.47

307.65

4.2

2.6

2.06

1.37

mmol/l

28.23

3987

7815

Other bacterial diseases

6961

15771

3.18

307.65

5.7

3.1

1.86

1.63

mmol/l

4.43

5295

11387

Influenza and pneumonia

7228

15539

3.09

307.65

5.4

3.0

2.11

1.31

mmol/l

50.27

5574

10953

Asthma (mode)

3520

6999

2.76

307.65

3.4

2.5

1.82

1.09

mmol/l

23.34

2601

4786

Chronic lower respiratory diseases

6370

17750

1.97

307.65

4.3

3.6

2.06

1.42

mmol/l

31.55

4830

12645

Substance use, excluding alcohol

1356

3962

3.80

307.65

4.1

3.2

1.98

1.57

mmol/l

3.27

1067

2905

Preparatory care for dialysis

640

1004

9.67

307.65

13.7

3.3

-1.03

1.94

mmol/l

56.51

484

741

Bacterial infection, other or unspecified

4670

11359

3.91

307.65

5.8

3.1

1.85

1.75

mmol/l

0.87

3592

8257

Diabetes, insulin treatment (Kela reimbursement)

5807

16046

2.27

307.65

3.8

3.5

1.64

1.77

mmol/l

1.51

4177

11903

Type 2 diabetes, strict (exclude DM1)

4960

13081

2.31

307.65

3.4

3.0

1.74

1.80

mmol/l

0.40

3588

9679

Other dialysis

495

787

10.24

307.65

16.3

4.9

-0.00

1.74

mmol/l

16.37

359

594

Diseases of oesophagus, stomach and duodenum

5600

17319

1.99

307.65

4.0

3.6

1.56

1.73

mmol/l

2.60

4146

12600

Cardiovascular diseases (excluding rheumatic etc)

3017

6356

2.85

307.65

6.1

3.4

1.52

1.12

mmol/l

7.50

2222

4525

Provisional assignment of new diseases of uncertain etiology

3481

14359

2.58

307.65

5.7

3.5

2.18

1.61

mmol/l

17.02

2647

10366

Asthma (only as main-diagnosis), excluding more controls

3404

5983

3.32

307.65

3.8

2.4

1.94

1.01

mmol/l

35.43

2561

4119

5807

15614

1.96

307.65

4.3

3.1

1.88

1.63

mmol/l

5.24

4423

11169

Diseases of the respiratory system

2791

5825

2.50

307.65

3.9

2.6

2.01

1.12

mmol/l

25.09

2094

3968

Implicit bacterial Sepsis, including avohilmo

4319

9495

4.34

307.65

6.7

2.8

2.11

1.70

mmol/l

6.62

3315

6885

Asthma, excluding more controls

3667

5983

3.32

307.65

3.7

2.4

1.94

1.01

mmol/l

36.36

2757

4119

Persons encountering health services in other circumstances

2918

9912

3.18

307.65

4.0

3.5

1.76

1.66

mmol/l

0.73

2229

7233

Intestinal infectious diseases

5268

20214

2.02

307.65

5.4

3.4

1.49

1.71

mmol/l

3.88

3846

14726

Codes for special purposes

3485

14373

2.58

307.65

5.7

3.5

2.19

1.61

mmol/l

17.19

2650

10376

Explicit Sepsis, including avohilmo

3916

10303

3.88

307.65

6.6

3.0

1.77

1.62

mmol/l

1.34

2960

7436

Other septicaemia, including avohilmo

3470

9464

3.91

307.65

6.8

3.3

1.79

1.75

mmol/l

0.17

2627

6850

First line medication for Crohn's disease

6478

14906

2.46

307.65

5.4

3.1

1.68

1.55

mmol/l

1.65

4856

10586

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

6456

17834

2.61

307.65

5.3

3.4

1.69

1.67

mmol/l

0.15

4759

13018

Transplanted organ and tissue status

1207

2244

7.10

307.65

14.2

3.5

0.67

1.63

mmol/l

13.99

872

1685

Other chronic obstructive pulmonary disease, including avohilmo

3920

12301

2.87

307.65

4.9

3.3

2.59

1.64

mmol/l

39.39

3121

8928

Hypertensive diseases (excluding secondary)

2689

4594

3.63

307.65

5.5

2.7

1.47

1.31

mmol/l

1.26

1964

3375

Implicit Sepsis

6244

13633

3.75

307.65

5.9

2.9

2.05

1.59

mmol/l

12.50

4726

9888

COPD, early/later onset

3489

10725

3.03

307.65

5.1

3.3

2.71

1.61

mmol/l

45.87

2804

7732

ILD medications

6798

15542

2.49

307.65

5.4

3.0

1.67

1.58

mmol/l

0.91

5093

11062

Symptoms and signs involving the urinary system

4545

16213

2.24

307.65

4.4

3.7

1.65

1.80

mmol/l

1.72

3373

11942

Viral Sepsis

1912

4811

4.61

307.65

8.1

3.0

2.05

1.67

mmol/l

3.28

1468

3455

Later onset COPD, excluding more controls

1665

2819

5.17

307.65

5.0

2.6

2.70

1.16

mmol/l

35.65

1325

1904

Implicit viral Sepsis, including avohilmo

2443

7215

3.80

307.65

7.2

2.9

1.99

1.68

mmol/l

2.92

1860

5209

Asthma, hospital admissions 3, pneumonia

2520

10464

2.60

307.65

5.7

3.9

2.41

1.75

mmol/l

15.61

1987

7629

Medical observation and evaluation for suspected diseases and conditions

4012

6974

3.13

307.65

4.0

3.0

1.34

2.02

mmol/l

19.84

2951

5036

Persons encountering health services in other circumstances, wide

6118

16495

1.98

307.65

4.2

3.6

1.73

1.65

mmol/l

0.68

4476

12073

Insulin medication

4183

13202

2.85

307.65

4.7

3.6

1.61

1.77

mmol/l

1.56

2993

9776

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5527

16366

1.86

307.65

4.3

3.6

1.72

1.65

mmol/l

0.60

3952

11996

Biguanides

4853

14915

2.05

307.65

3.3

1.77

1.80

mmol/l

0.24

3513

11014

Excluding asthma or asthma-COPD overlap

3723

6946

2.81

307.65

3.8

2.5

1.92

1.10

mmol/l

28.87

2782

4742

Asthma (diagnoses ohter than nonallergic)

4676

20521

1.92

307.65

3.9

2.03

1.59

mmol/l

13.37

3524

14858

Iron deficiency anaemia

2861

11847

2.56

307.65

5.4

3.6

1.76

1.84

mmol/l

0.49

2145

8668

Other and unspecified anaemias

2929

11972

2.48

307.65

5.4

3.6

1.67

1.89

mmol/l

2.00

2122

8864

Bleeding

4583

17030

1.98

307.65

5.1

3.6

1.79

1.74

mmol/l

0.42

3355

12636

Insulin, fast-acting

2625

9805

2.94

307.65

5.0

3.7

1.59

1.66

mmol/l

0.31

1891

7185

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6149

11178

3.48

307.65

5.2

2.6

2.19

1.37

mmol/l

41.45

4753

7815

Pneumonia, organism unspecified

6848

15004

3.41

307.65

5.7

3.0

2.19

1.33

mmol/l

53.86

5311

10616

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

834

740

9.08

307.65

5.8

3.7

2.28

1.99

mmol/l

0.84

656

536

ILD medications: prednisolone, methylprednisolone, prednisone

6806

15105

2.66

307.65

5.4

2.9

1.70

1.60

mmol/l

1.15

5126

10770

ILD, hospital admission 2, with pulmonary infections

820

1926

4.98

307.65

6.3

2.9

2.41

1.32

mmol/l

11.70

658

1348

Early onset COPD, excluding more controls

1606

3143

5.86

307.65

5.3

2.5

2.73

1.10

mmol/l

43.85

1298

2177

Heart failure and antihypertensive medication

1974

2372

6.18

307.65

6.0

3.0

2.54

1.81

mmol/l

9.07

1520

1827

Depression medications

1127

1195

4.96

307.65

3.3

2.6

1.42

1.16

mmol/l

1.31

838

830

Inflammatory bowel disease treatment related agents

6584

16898

2.27

307.65

5.0

3.2

1.79

1.56

mmol/l

4.78

5008

12031

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6956

16261

3.07

307.65

5.6

3.1

2.18

1.34

mmol/l

53.04

5362

11540

Fever of other and unknown origin

3996

11173

3.36

307.65

5.5

3.2

1.75

1.67

mmol/l

0.69

3017

8044

Insulin, combination of fast acting with intermediate-acting or long-acting

4188

16144

2.53

307.65

4.7

3.5

1.62

1.74

mmol/l

1.11

2997

11899

Presence of cardiac and vascular implants and grafts

2671

8686

2.42

307.65

4.4

3.3

1.60

1.94

mmol/l

4.06

1934

6507

All-cause Heart Failure

4534

10594

3.32

307.65

5.5

3.1

2.52

1.54

mmol/l

39.56

3478

7757

Sleep apnoea, including avohilmo

7831

12915

4.05

307.65

3.1

3.9

1.61

1.82

mmol/l

4.18

5974

9286

Cardiovascular diseases

2697

5616

2.66

307.65

6.3

3.5

1.50

1.06

mmol/l

8.05

1979

3962

Other heart diseases, wide

4661

13103

2.25

307.65

4.8

3.4

1.90

1.37

mmol/l

16.70

3464

9510

Infections, IBD-co-morbidities

1134

961

9.32

307.65

6.6

4.0

1.51

1.83

mmol/l

1.16

852

696

Type 2 diabetes, definitions combined, including avohilmo

4897

12852

2.31

307.65

3.3

3.0

1.74

1.79

mmol/l

0.32

3546

9497

Antihypertensive medication - note that there are other indications

2644

5509

2.61

307.65

5.8

3.3

1.32

1.35

mmol/l

0.15

1901

3923

Sleep apnoea

8048

12682

4.48

307.65

3.1

3.9

1.62

1.82

mmol/l

4.24

6165

9145

Asthma, hospital admission 2, infections

3659

16455

2.30

307.65

4.8

3.9

2.13

1.62

mmol/l

14.25

2798

11923

ILD medications: immunosuppressive drugs

3515

13781

2.44

307.65

7.2

3.0

1.45

1.60

mmol/l

1.54

2584

9910

Gastro-oesophageal reflux disease

3785

15695

2.14

307.65

3.9

3.6

1.43

1.79

mmol/l

7.57

2837

11521

Other pulmonary diagnosis

3756

6946

2.84

307.65

3.8

2.5

1.95

1.10

mmol/l

31.10

2816

4742

Hypothyroidism, levothyroxine purchases

1016

1181

5.07

307.65

3.9

2.9

1.28

1.00

mmol/l

1.47

732

838

Hypertensive heart and/or renal disease

1756

4289

3.27

307.65

5.6

3.1

1.93

mmol/l

0.01

1313

3254

Respiratory insufficiency

1215

1270

13.37

307.65

9.4

3.0

4.33

1.10

mmol/l

88.66

1118

842

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4288

16278

2.45

307.65

4.9

3.4

2.01

1.75

mmol/l

4.37

3397

11838

2630

11797

2.35

307.65

4.9

4.1

1.99

1.58

mmol/l

7.38

2006

8573

Implicit bacterial Sepsis

4040

8937

4.48

307.65

6.9

2.8

2.09

1.72

mmol/l

5.48

3111

6486

Mood disorders, excluding more controls

4516

14049

1.96

307.65

3.5

3.4

1.66

1.69

mmol/l

0.23

3397

10210

Intracranial trauma

2981

6787

3.13

307.65

3.9

4.6

1.67

1.56

mmol/l

0.71

2173

4802

Fitting and adjustment of other devices

2521

8371

2.89

307.65

3.9

3.0

1.75

1.82

mmol/l

0.38

1891

6142

Care involving dialysis

1247

1744

10.70

307.65

12.7

3.2

-0.06

1.66

mmol/l

35.33

872

1279

Heart failure,strict

4204

8266

4.00

307.65

5.6

2.7

2.50

1.53

mmol/l

35.87

3236

6059

Other septicaemia

3430

9306

3.96

307.65

6.8

3.3

1.79

1.75

mmol/l

0.20

2596

6738

Persons encountering health services for specific procedures and health care

6392

16432

2.42

307.65

5.6

3.1

1.75

1.55

mmol/l

3.39

4691

11908

ILD differential diagnosis

3693

6999

2.77

307.65

3.8

2.5

1.92

1.09

mmol/l

29.47

2755

4786

Any reimbursement code in KELA

2486

4325

3.00

307.65

4.7

2.4

1.49

1.23

mmol/l

2.80

1819

2998

Hernia of abdominal wall, postoperative

1122

2979

4.08

307.65

5.1

2.6

1.55

2.02

mmol/l

3.59

829

2127

Obesity related asthma

2560

8483

3.35

307.65

3.7

3.5

2.13

1.69

mmol/l

7.82

2012

6261

Early onset COPD

1606

5253

3.44

307.65

5.3

3.2

2.73

1.50

mmol/l

27.75

1298

3787

Asthma, unspecified (mode)

3409

6540

4.06

307.65

4.0

2.5

2.09

1.11

mmol/l

37.84

2597

4469

Asthma-related pneumonia

2516

10446

2.60

307.65

5.7

3.9

2.42

1.74

mmol/l

15.78

1984

7614

COPD-related respiratory insufficiency

1379

2899

6.09

307.65

7.9

3.3

3.42

1.62

mmol/l

41.28

1200

2052

Hypothyroidism (congenital or acquired)

1035

1202

5.07

307.65

4.1

2.9

1.24

1.01

mmol/l

1.13

745

852

Benzodiazepine use

5450

18757

2.05

307.65

3.8

3.4

1.82

1.67

mmol/l

2.12

4136

13534

Insulin, intermediate and long-acting

3863

15192

2.66

307.65

4.6

3.6

1.59

1.74

mmol/l

1.38

2771

11221

Asthma, unspecified (mode), excluding more controls

3268

5675

4.46

307.65

4.0

2.4

2.07

1.02

mmol/l

41.31

2489

3914

Insulin, fast-acting or short human

2634

10327

2.79

307.65

5.0

3.8

1.59

1.64

mmol/l

0.24

1897

7551

Dyspnoea

6409

16906

2.96

307.65

4.4

3.5

2.03

1.59

mmol/l

14.26

4855

12201

Diseases of arteries, arterioles and capillaries (FINNGEN)

1362

2315

4.42

307.65

5.4

2.6

1.75

1.51

mmol/l

1.27

1015

1779

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1754

3883

2.97

307.65

4.4

2.4

1.63

1.40

mmol/l

1.70

1311

2851

Complications of medical and surgical care

3958

18316

2.03

307.65

4.9

3.4

1.70

1.78

mmol/l

0.54

2968

13393

Glucagon-like peptide-1 (GLP-1) analogues

1818

6758

2.91

307.65

3.3

1.52

1.73

mmol/l

1.49

1347

5107

Oedema, not elsewhere classified

2212

7234

3.26

307.65

4.7

3.3

2.08

1.82

mmol/l

2.17

1702

5267

Gout

1965

6530

2.83

307.65

5.4

3.5

1.53

1.89

mmol/l

3.03

1377

4798

Asthma (only as main-diagnosis)

3551

6885

3.03

307.65

3.8

2.5

1.95

1.09

mmol/l

31.25

2679

4701

Sleep disorders (combined)

6888

13292

2.88

307.65

3.3

4.1

1.67

1.77

mmol/l

1.20

5204

9477

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1818

6758

2.91

307.65

3.3

1.52

1.73

mmol/l

1.49

1347

5107

Oral corticosteroids

6489

16103

2.50

307.65

4.3

3.0

1.91

1.60

mmol/l

7.91

4966

11482

Type 2 diabetes, wide definition

4871

11832

2.78

307.65

4.2

3.1

1.78

1.86

mmol/l

0.58

3521

8858

Kidney transplant status

740

1304

8.19

307.65

16.1

4.9

0.24

1.60

mmol/l

15.91

481

973

Other CVD (FINNGEN)

780

1197

5.59

307.65

4.0

2.4

1.87

1.55

mmol/l

1.22

583

920

GASTRO-related operations

3986

7355

2.85

307.65

4.9

2.6

1.53

1.73

mmol/l

2.37

2907

5126

Disorders of lipoprotein metabolism and other lipidaemias

4070

12947

1.99

307.50

3.9

3.1

1.56

1.80

mmol/l

3.45

2894

9669

Dental caries

1643

5805

2.89

307.33

7.3

3.8

1.55

1.73

mmol/l

1.06

1226

4276

L04AA Selective immunosuppressants

1467

5244

3.08

306.09

10.2

3.5

1.07

1.74

mmol/l

8.65

1049

3864

Hard cardiovascular diseases

4167

13043

1.97

302.47

4.8

3.7

1.80

1.70

mmol/l

0.95

3134

9704

Pulmonary heart disease, diseases of pulmonary circulation

2058

8729

2.55

301.99

5.0

3.4

2.40

1.84

mmol/l

8.06

1597

6397

Convulsions, not elsewhere classified

1433

4989

3.06

301.98

5.0

3.4

1.55

mmol/l

0.00

1036

3546

Asthma/COPD (KELA code 203)

4750

17680

1.86

301.18

4.4

3.6

2.13

1.43

mmol/l

30.91

3638

12588

Other soft tissue disorders, not elsewhere classified

4776

15014

1.88

300.14

3.7

4.0

1.58

1.68

mmol/l

0.95

3492

10847

Abnormalities of heart beat

1860

7243

2.63

299.80

3.4

3.2

1.59

1.65

mmol/l

0.27

1370

5182

Disorders of other endocrine glands

2568

11796

2.27

296.02

6.4

4.0

1.60

1.69

mmol/l

0.60

1917

8622

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1439

2264

3.31

294.95

3.7

2.8

1.51

1.38

mmol/l

0.55

1063

1598

Other functional intestinal disorders

2749

11913

2.22

294.69

4.7

4.1

1.83

1.76

mmol/l

0.46

2052

8710

Valvular heart disease excluding rheumatic fever

2483

7960

2.36

293.37

5.0

3.5

2.11

1.48

mmol/l

11.90

1846

5901

Hypokalaemia

929

2614

4.04

290.40

5.5

3.4

2.90

1.99

mmol/l

6.50

742

1976

Non-rheumatic valve diseases

2435

7772

2.36

289.93

4.7

3.3

2.09

1.49

mmol/l

10.62

1801

5759

Diabetic nephropathy, excluding more controls

1325

3728

3.37

288.42

6.9

3.0

1.06

1.62

mmol/l

4.68

908

2724

ILD, hospital admissions 3, with pneumonia sepsis

736

1780

4.89

287.04

6.4

3.2

2.54

1.40

mmol/l

11.54

593

1241

Type 1 diabetes, wide definition

1368

4857

3.06

286.08

5.1

4.1

1.31

1.60

mmol/l

1.88

985

3544

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1011

3014

3.69

285.76

3.4

3.2

1.19

1.57

mmol/l

2.30

760

2199

Haemorrhage from respiratory passages

1956

7257

2.54

283.72

4.6

3.5

1.98

1.67

mmol/l

2.88

1467

5240

Hyperkalaemia

614

1314

5.79

282.00

6.6

3.4

1.35

2.03

mmol/l

2.54

416

966

Other disorders of urethra and urinary system

3621

13189

1.99

281.95

4.7

3.3

1.69

1.75

mmol/l

0.38

2696

9501

Mental and behavioural disorders due to tobacco

725

1766

4.83

279.77

4.8

3.5

1.81

1.74

mmol/l

0.19

589

1311

Disorders resulting from impaired renal tubular function

489

883

7.90

279.33

13.3

4.2

-0.14

1.65

mmol/l

15.05

321

662

Complications of procedures, not elsewhere classified

4048

17918

1.89

279.25

4.5

3.3

1.80

1.73

mmol/l

0.58

3011

13084

Any mental disorder

5188

14936

1.80

276.71

4.2

3.6

1.73

1.65

mmol/l

0.71

3881

10857

Smoking dependency

725

1782

4.79

276.49

4.8

3.4

1.81

1.76

mmol/l

0.12

589

1324

Anxiety disorders, excluding more controls

3775

12793

1.95

275.80

3.8

3.3

1.66

1.68

mmol/l

0.12

2838

9308

STROKE

2579

8053

2.26

275.75

4.1

2.9

1.73

1.76

mmol/l

0.16

1903

6049

Obesity, other/unspecified

1665

6663

2.65

272.52

3.9

3.2

1.98

1.63

mmol/l

2.98

1260

4805

Conduction disorders

1728

5542

2.68

271.61

4.5

3.3

1.95

1.49

mmol/l

4.72

1291

4100

Pain in limb

4185

14707

1.88

269.34

3.9

1.67

1.68

mmol/l

0.10

3092

10638

Fall on same level

5534

17482

1.74

269.26

4.1

3.9

1.71

1.57

mmol/l

1.75

4062

12643

Hyperlipidaemia, other/unspecified

2232

9141

2.34

269.13

4.2

3.2

1.71

1.91

mmol/l

1.46

1564

6895

Volume depletion

836

2330

4.15

266.92

6.4

3.7

1.79

1.91

mmol/l

0.29

603

1709

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1061

3439

3.47

265.39

5.6

3.5

1.34

1.91

mmol/l

4.60

837

2536

Vocal cord dysfunction

676

1358

4.70

263.70

4.2

3.0

1.68

1.52

mmol/l

0.49

515

1006

Depression

4500

17165

1.81

263.28

3.4

1.60

1.73

mmol/l

1.61

3350

12449

Other diseases of intestines

5067

16478

1.77

262.74

4.3

3.8

1.50

1.63

mmol/l

1.59

3720

11926

Venous thromboembolism

2958

14616

2.05

262.37

4.4

3.4

2.12

1.83

mmol/l

3.76

2249

10749

Diabetic maculopathy, excluding more controls

772

2051

4.26

261.57

5.9

3.4

1.04

1.87

mmol/l

5.56

545

1519

Gout, FINNGEN

1965

8656

2.45

261.34

5.4

3.4

1.53

1.83

mmol/l

2.31

1377

6334

Ischemic heart diseases

4095

13475

1.88

261.33

4.7

3.7

1.87

1.69

mmol/l

2.29

3072

10042

Lung cancer and mesothelioma

1048

2780

3.46

261.31

4.2

2.6

2.69

1.13

mmol/l

27.02

850

1890

Hypertensive Heart Disease

1443

4061

2.91

260.64

5.1

3.1

2.15

1.95

mmol/l

0.98

1085

3086

Suicide or other Intentional self-harm

1345

4978

2.91

259.66

3.5

3.3

1.44

1.60

mmol/l

0.75

1021

3628

Percutaneous Coronary Intervention

3953

13195

1.90

259.59

4.7

3.7

1.79

1.71

mmol/l

0.65

2959

9830

DVT of lower extremities and pulmonary embolism

2421

11623

2.21

258.05

4.5

3.4

2.14

1.84

mmol/l

3.21

1842

8562

Acute upper respiratory infections of multiple and unspecified sites

3797

15209

1.89

257.07

4.5

3.3

1.70

1.69

mmol/l

0.01

2822

11005

Infections of the skin and subcutaneous tissue

3161

16428

1.98

256.93

5.3

3.8

1.63

1.60

mmol/l

0.14

2378

11910

Mood disorders

4836

18110

1.76

255.74

3.5

1.63

1.74

mmol/l

1.18

3627

13152

Epilepsy

1659

6820

2.58

255.28

4.9

5.0

1.69

1.72

mmol/l

0.15

1226

4889

Mood [affective] disorders

4821

18091

1.76

254.75

3.5

1.63

1.74

mmol/l

1.21

3616

13138

Symptoms and signs involving the digestive system and abdomen

4814

13911

1.79

254.02

4.6

3.6

1.51

1.69

mmol/l

2.48

3504

10126

Later onset COPD

1914

6708

2.50

253.92

5.0

3.3

2.70

1.69

mmol/l

21.95

1529

4758

Autoimmune diseases excluding thyroid diseases

5052

16112

1.75

253.21

4.5

3.6

1.62

1.64

mmol/l

0.15

3701

11625

Pure hypercholesterolaemia

3620

12388

1.93

252.92

4.1

3.1

1.51

1.82

mmol/l

5.20

2620

9272

Pulmonary embolism

1807

7851

2.48

250.72

4.5

3.3

2.32

1.85

mmol/l

5.37

1380

5780

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1445

5652

2.71

248.29

3.3

3.2

1.39

1.53

mmol/l

0.65

1088

4027

Personality disorders, excluding more controls

1153

3991

3.05

248.11

3.2

3.0

1.79

1.46

mmol/l

2.01

847

2841

Implicit fungal Sepsis, including avohilmo

585

1323

5.20

247.85

8.0

2.6

2.39

1.83

mmol/l

2.49

450

949

Intestinal infectious diseases, including avohilmo, including avohilmo

5602

19022

1.69

247.73

4.8

3.4

1.53

1.74

mmol/l

3.80

4101

13898

Diseases of arteries, arterioles and capillaries

3564

14296

1.91

247.57

4.8

3.4

1.65

1.88

mmol/l

2.71

2588

10640

Coronary revascularization (ANGIO or CABG)

3911

13199

1.87

246.83

4.7

3.7

1.80

1.70

mmol/l

0.77

2927

9833

Pulmonary heart disease

1807

7930

2.46

245.01

4.5

3.4

2.32

1.88

mmol/l

4.87

1380

5845

Major coronary heart disease event

4180

14195

1.83

244.84

4.8

3.8

1.83

1.74

mmol/l

0.75

3137

10570

Disorders of gallbladder, biliary tract and pancreas

4752

17434

1.75

244.66

4.0

3.4

1.68

1.77

mmol/l

0.83

3457

12832

Anaemia in chronic diseases classified elsewhere

368

576

9.77

244.30

12.3

4.7

-0.03

1.95

mmol/l

12.60

253

425

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1840

8145

2.41

243.17

4.4

3.6

1.76

1.70

mmol/l

0.26

1302

5952

Constipation

4592

18309

1.76

243.11

4.3

4.0

1.91

1.66

mmol/l

4.27

3460

13362

Depression or dysthymia

3152

8856

2.02

242.91

3.4

3.6

1.61

1.62

mmol/l

0.08

2350

6430

Other reaction to severe stress, and adjustment disorders

1690

7162

2.48

242.72

4.5

3.2

1.42

1.63

mmol/l

1.54

1226

5148

Autoimmune diseases excluding thyroid diseases, strict definition

4883

15673

1.75

242.42

4.5

3.6

1.59

1.63

mmol/l

0.26

3566

11302

Symptoms and signs involving cognition, perception, emotional state and behaviour

4696

18564

1.75

242.04

3.5

3.6

1.70

mmol/l

0.06

3470

13531

Low back pain

3727

13923

1.87

241.94

3.3

3.4

1.83

1.67

mmol/l

1.82

2734

10107

Autoimmune diseases

5315

16249

1.71

240.61

4.3

3.7

1.54

1.63

mmol/l

0.86

3884

11725

Disorders of lens

3256

10752

1.96

235.68

4.9

3.1

1.67

1.80

mmol/l

1.06

2395

7999

Chronic laryngitis and laryngotracheitis

965

3167

3.39

235.31

3.4

1.37

1.93

mmol/l

4.91

745

2322

Emergency coronary revascularization (for ACS)

4286

15052

1.78

231.35

4.6

3.8

1.79

1.76

mmol/l

0.25

3188

11197

Pleural effusion

1092

3900

3.12

229.96

5.2

3.1

2.76

1.54

mmol/l

18.26

874

2767

Retention of urine

2107

8029

2.26

229.85

4.4

3.6

1.89

1.82

mmol/l

0.36

1567

5868

Used for control exclusion in common control thyroid runs

5005

15147

1.72

229.20

4.4

3.7

1.47

1.61

mmol/l

1.80

3654

10917

Examination and observation for other reasons

2517

6890

2.13

228.09

4.4

3.0

1.49

2.03

mmol/l

9.24

1819

4986

Gout, idiopatic and unspecified

1689

7475

2.47

227.20

5.5

3.5

1.49

1.80

mmol/l

2.11

1185

5456

Presence of other devices

1480

6034

2.60

226.99

3.9

3.4

1.53

2.06

mmol/l

6.51

1103

4509

Gout, unspecified

1432

5912

2.67

226.06

5.6

3.4

1.41

1.81

mmol/l

2.97

1000

4298

Injuries to the head

5376

19783

1.66

225.23

4.0

3.9

1.68

1.66

mmol/l

0.19

3901

14441

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3070

16429

1.91

224.94

5.1

3.4

1.71

1.80

mmol/l

0.68

2302

12051

Other bacterial intestinal infections

1195

4517

2.89

224.04

6.0

3.4

1.69

1.89

mmol/l

0.98

902

3321

Undetermined asthma, excluding more controls

664

1748

4.10

223.35

4.7

2.6

1.64

1.03

mmol/l

4.28

501

1224

Abdominal and pelvic pain

4667

13894

1.74

223.23

4.2

3.6

1.52

1.69

mmol/l

2.35

3395

10110

Other and unspecified disorders of skin and subcutaneous tissue

554

1312

5.07

223.16

5.6

3.4

0.86

1.91

mmol/l

7.37

452

965

Other diseases of urinary system

4737

15971

1.72

222.46

4.5

3.6

1.58

1.68

mmol/l

1.01

3504

11552

Recurrent or chronic depression

1736

5177

2.43

222.35

3.0

3.2

1.45

1.60

mmol/l

1.05

1272

3744

Gout, strict definition

1306

5222

2.78

221.36

5.9

3.5

1.43

1.83

mmol/l

2.64

921

3793

Osteopathies and chondropathies

2920

14376

1.94

220.95

4.8

3.5

1.88

1.77

mmol/l

0.75

2220

10574

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

4884

19137

1.69

220.80

4.9

3.4

1.44

1.74

mmol/l

6.57

3554

13974

3098

14764

1.90

219.77

4.0

3.4

1.73

1.63

mmol/l

0.64

2273

10750

Type of accident

1692

7553

2.39

219.28

4.5

3.6

1.74

1.72

mmol/l

0.08

1186

5535

Persons encountering health services for examination and investigation

2760

6977

2.05

218.57

4.0

3.0

1.45

2.02

mmol/l

10.92

2015

5037

Certain infectious and parasitic diseases, including avohilmo

3136

8318

1.95

216.25

4.4

2.9

1.73

1.68

mmol/l

0.28

2275

5956

2974

14508

1.91

214.13

4.0

3.4

1.75

1.61

mmol/l

0.89

2174

10565

Other disorders of skin and subcutaneous tissue

3662

17908

1.79

213.81

4.8

3.5

1.79

1.78

mmol/l

0.04

2771

13088

Genitourinary diseases

2694

6830

2.05

212.76

5.8

3.5

1.40

1.70

mmol/l

3.61

1969

5004

Asthma, hospital admissions , main diagnosis only

3982

20578

1.74

212.21

4.2

3.9

1.96

1.62

mmol/l

7.24

2997

14925

Anxiety (asthma-related co-morbidities)

2607

10264

2.00

211.87

3.5

3.4

1.52

1.60

mmol/l

0.54

1948

7397

Disorders of thyroid, IBD co-morbidities

601

946

4.54

210.46

3.5

3.2

1.69

1.73

mmol/l

0.07

436

679

Neurotic, stress-related and somatoform disorders

3988

16203

1.75

208.61

3.8

3.4

1.63

1.71

mmol/l

0.72

2982

11806

Other respiratory diseases principally affecting the interstitium

1245

5002

2.75

208.10

5.8

3.7

2.27

1.83

mmol/l

3.79

988

3662

Alcohol use disorder, Swedish definition

2813

13884

1.92

207.27

4.0

3.4

1.75

1.62

mmol/l

0.88

2073

10103

Hypertensive Renal Disease

381

701

6.77

207.16

7.8

2.8

0.87

2.09

mmol/l

6.74

279

504

Other arrhythmias

2682

10540

1.97

207.13

3.6

2.9

1.71

1.47

mmol/l

2.76

1969

7706

Use of hypnotics and sedatives

4943

17495

1.66

206.92

4.0

3.6

1.72

1.67

mmol/l

0.40

3659

12764

Anxiety disorders

4026

16377

1.74

206.37

3.8

3.4

1.64

1.71

mmol/l

0.65

3009

11933

Pain, not elsewhere classified

1366

5673

2.54

206.28

4.3

3.2

1.91

1.73

mmol/l

0.93

985

4114

Selective serotonin reuptake inhibitors

4520

14143

1.71

206.13

3.3

3.6

1.72

1.65

mmol/l

0.67

3383

10143

Problems related to lifestyle

659

1847

3.94

204.93

3.6

3.1

1.51

1.68

mmol/l

0.43

476

1359

Bacterial intestinal infections, IBD co-morbidities

1193

4714

2.76

204.76

6.0

3.6

1.64

1.84

mmol/l

0.99

902

3464

Mental and behavioural disorders due to alcohol

2595

13174

1.96

204.07

3.9

3.4

1.80

1.58

mmol/l

1.79

1907

9529

Diabetic nephropathy

1335

5611

2.68

201.82

6.9

3.4

1.05

1.77

mmol/l

7.79

917

4068

Explicit bacterial Sepsis

734

2240

3.66

201.59

6.3

3.0

1.88

1.58

mmol/l

1.22

568

1603

Explicit bacterial Sepsis, including avohilmo

741

2276

3.63

201.28

6.3

3.0

1.85

1.59

mmol/l

1.01

573

1628

Nerve, nerve root and plexus disorders

4877

18250

1.65

201.09

3.7

3.3

1.76

1.74

mmol/l

0.19

3606

13314

Diseases of liver

1901

9204

2.19

200.64

4.4

3.5

1.42

1.80

mmol/l

3.58

1379

6829

Unspecified haematuria

2362

9928

2.04

200.53

4.4

3.7

1.43

1.83

mmol/l

4.93

1716

7299

Factors influencing health status and contact with health services

1270

2355

2.81

199.59

3.8

2.5

1.56

1.86

mmol/l

1.78

954

1699

Undetermined asthma

664

1890

3.78

199.38

4.7

2.7

1.64

1.09

mmol/l

3.50

501

1312

Paroxysmal tachycardia

990

2912

2.98

196.71

4.6

2.9

1.73

1.37

mmol/l

2.07

724

2186

Fungal Sepsis

392

776

6.20

196.36

8.4

3.0

2.20

1.66

mmol/l

1.72

302

565

Psychiatric diseases

4396

13307

1.70

195.81

4.2

3.7

1.74

1.65

mmol/l

0.75

3257

9721

Implicit fungal Sepsis

370

698

6.57

195.73

8.5

2.7

2.28

1.66

mmol/l

2.00

288

503

Other retinal disorders

3337

14615

1.81

195.50

4.5

3.5

1.59

1.90

mmol/l

4.27

2397

10858

Gastrointestinal diseases

2461

6211

2.05

195.22

4.8

3.1

1.47

1.63

mmol/l

1.36

1808

4421

Other anxiety disorders

2018

8443

2.11

194.36

3.3

3.2

1.46

1.61

mmol/l

1.13

1500

6075

Familial hypercholesterolemia

987

3655

2.98

193.45

4.2

3.4

1.66

1.97

mmol/l

1.61

737

2735

Other bacterial intestinal infections, including avohilmo

1353

5793

2.50

193.36

5.6

3.3

1.65

1.88

mmol/l

1.37

1012

4255

Coronary atherosclerosis

3063

10768

1.87

193.26

4.2

3.2

1.87

1.81

mmol/l

0.42

2229

8089

Senile cataract

2941

9819

1.90

192.89

4.3

3.2

1.76

1.85

mmol/l

0.54

2168

7321

Cerebrovascular diseases

3671

15062

1.76

192.41

4.2

3.5

1.78

1.85

mmol/l

0.44

2670

11240

Diseases of the myoneural junction and muscle

886

3123

3.19

192.02

5.0

4.0

1.69

1.85

mmol/l

0.58

702

2297

Peripheral artery disease

2473

10415

1.98

190.46

5.1

3.4

1.71

1.94

mmol/l

1.88

1766

7704

Disorders of mineral metabolism

619

1773

3.97

188.79

5.9

3.5

2.14

1.84

mmol/l

1.04

471

1351

Enterocolitis due to Clostridium difficile

788

2632

3.37

187.63

7.0

3.6

1.66

1.96

mmol/l

1.23

602

1913

Unspecified urinary incontinence

636

1863

3.88

187.62

3.6

3.8

1.63

2.14

mmol/l

2.82

516

1407

Exposure to unspecified factor

4824

20879

1.62

186.97

4.1

3.9

1.72

1.65

mmol/l

0.57

3570

15193

Streptococcal septicaemia

661

1992

3.76

186.56

6.6

3.3

1.88

1.66

mmol/l

0.74

516

1422

Disorders of choroid and retina

3927

16708

1.70

185.57

4.4

3.4

1.55

1.86

mmol/l

5.19

2837

12388

Other interstitial pulmonary diseases

1065

4206

2.81

185.05

5.7

3.7

2.32

1.83

mmol/l

3.99

847

3083

Streptococcal septicaemia, including avohilmo

668

2037

3.71

184.91

6.6

3.3

1.85

1.66

mmol/l

0.56

521

1457

Myocardial infarction

2475

9221

1.97

184.66

4.7

3.3

1.86

1.81

mmol/l

0.22

1835

6908

All anxiety disorders

2659

11272

1.89

184.60

3.5

3.3

1.51

1.63

mmol/l

0.98

1983

8158

Glomerulonephritis

737

2400

3.51

184.46

10.0

4.4

0.98

1.68

mmol/l

5.30

515

1770

Hypothyroidism, drug reimbursement

466

680

5.01

183.78

3.9

2.8

1.63

1.21

mmol/l

1.83

345

489

Ischaemic heart disease, wide definition

3540

12848

1.76

182.74

4.2

3.2

1.88

1.83

mmol/l

0.34

2634

9622

Cholelithiasis, broad definition with cholecystitis

3962

16076

1.69

182.32

3.6

3.4

1.74

1.82

mmol/l

0.63

2893

11838

Interstitial lung disease endpoints

1065

4238

2.79

182.21

5.7

3.7

2.32

1.83

mmol/l

3.95

847

3105

Interstitial lung disease

1065

4238

2.79

182.21

5.7

3.7

2.32

1.83

mmol/l

3.95

847

3105

Diagnoses used for exclusion with ILD

1478

6748

2.35

182.17

4.7

3.4

2.32

1.79

mmol/l

5.96

1150

4922

Disorders of calcium metabolism

504

1288

4.55

182.05

5.9

3.5

2.08

1.87

mmol/l

0.49

391

971

Falls/tendency to fall

4726

14843

1.64

181.94

4.0

3.9

1.61

1.58

mmol/l

0.25

3472

10722

Other disorders of kidney and ureter

907

3333

3.04

181.86

9.6

3.8

0.71

1.85

mmol/l

13.09

610

2469

Liquid cancers, including Hilmo

1948

8633

2.10

181.18

4.8

3.8

1.89

1.83

mmol/l

0.30

1496

6386

Other symptoms and signs involving the digestive system and abdomen

950

3543

2.89

181.10

4.9

3.6

1.60

1.98

mmol/l

2.13

722

2650

ILD, hospital admissions

1048

4160

2.80

180.31

5.6

3.7

2.29

1.84

mmol/l

3.45

833

3045

Sub-endpoint used in defining T1D endpoints

1656

7787

2.22

180.02

5.2

4.0

1.32

1.65

mmol/l

2.66

1195

5611

Viral pneumonia (unknown virus, not influenza)

529

1421

4.30

178.16

6.7

4.0

2.20

1.65

mmol/l

3.09

441

1040

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2261

11980

1.96

178.06

3.9

3.5

1.83

1.58

mmol/l

2.04

1667

8726

Asthma, including avohilmo

5475

19782

1.56

177.38

3.9

1.95

1.56

mmol/l

12.27

4083

14306

Major coronary heart disease event excluding revascularizations

2915

10907

1.84

175.79

4.4

3.3

1.87

1.85

mmol/l

0.12

2159

8178

Finngen Rheumatological endpoints

4128

14470

1.66

173.70

3.8

3.4

1.59

1.64

mmol/l

0.37

2998

10505

Migraine

1745

6554

2.13

172.16

3.3

4.1

1.22

1.76

mmol/l

8.08

1225

4687

Alcohol use disorder, ICD-based

2103

11119

1.98

171.81

3.9

3.4

1.79

1.58

mmol/l

1.45

1556

8083

Dorsalgia

4359

14447

1.64

171.72

3.3

3.5

1.65

1.66

mmol/l

0.06

3173

10467

AV-block

1043

3543

2.70

169.20

4.8

3.2

1.92

1.54

mmol/l

2.28

774

2574

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2775

16006

1.80

168.07

4.9

3.4

1.72

1.81

mmol/l

0.59

2066

11760

Bacterial pneumoniae

1870

8328

2.06

167.30

5.6

3.0

2.53

1.39

mmol/l

28.04

1418

5917

Other cataract

2152

8456

1.98

166.06

5.1

3.2

1.81

1.84

mmol/l

0.10

1580

6299

Non-selective monoamine reuptake inhibitors

1718

8188

2.11

166.03

3.8

3.4

2.05

1.84

mmol/l

1.38

1333

5929

Other headache syndromes

1506

7089

2.19

165.54

3.1

3.9

1.51

1.94

mmol/l

5.27

1102

5100

Acute upper respiratory infections

4721

18354

1.58

163.88

4.2

3.3

1.74

1.73

mmol/l

0.04

3514

13327

Intracranial injury

2934

16168

1.75

161.62

3.9

4.0

1.72

1.68

mmol/l

0.27

2122

11820

Atherosclerosis, excluding cerebral and coronary sclerosis

2279

9837

1.92

159.62

5.2

3.4

1.66

1.94

mmol/l

2.32

1644

7285

Other and unspecified myopathies

650

2143

3.45

159.13

4.8

3.7

1.80

1.92

mmol/l

0.31

506

1559

Other external causes of accidental injury

3447

10347

1.71

158.27

3.8

3.9

1.62

1.65

mmol/l

0.17

2513

7484

Cholelithiasis

3727

15850

1.65

158.00

3.5

3.4

1.72

1.82

mmol/l

0.83

2721

11679

Lung diseases due to external agents

943

3791

2.73

157.14

5.5

3.6

2.54

1.79

mmol/l

6.80

740

2722

Follow-up examination after treatment for conditions other than malignant neoplasms

1737

5707

2.09

157.01

3.7

3.0

1.48

2.11

mmol/l

9.79

1325

4148

Diseases of the digestive system

2456

13920

1.83

156.36

5.8

3.8

1.57

1.76

mmol/l

1.49

1777

10232

Cellulitis

1268

5815

2.33

154.46

5.5

3.9

1.67

mmol/l

0.00

953

4247

Dizziness and giddiness

3442

16561

1.67

154.00

3.4

3.6

1.64

1.76

mmol/l

1.21

2574

12099

Myocardial infarction, without ST-elevation

2234

11227

1.89

153.54

4.6

3.5

1.84

1.87

mmol/l

0.09

1656

8226

Fentanyl

662

2228

3.25

153.13

5.0

3.4

2.46

1.93

mmol/l

2.61

520

1594

Osteoporosis

1442

6388

2.21

152.02

5.3

3.4

2.27

2.10

mmol/l

0.90

1121

4803

Morphin

256

437

7.60

151.80

6.9

3.4

3.86

2.15

mmol/l

7.09

216

305

Dysphagia

1333

6268

2.25

151.54

5.0

3.4

2.24

1.89

mmol/l

2.44

1027

4615

All influenza (not pneumonia)

804

3019

2.86

151.34

7.4

3.0

1.62

1.30

mmol/l

1.81

622

2146

Lower back pain or/and sciatica

4723

19435

1.55

150.39

3.4

1.85

1.68

mmol/l

2.51

3489

14145

ILD, hospital admissions 1, main diag only

915

3720

2.72

149.87

5.7

3.8

2.29

1.87

mmol/l

2.63

722

2718

Hydronephrosis

675

2334

3.16

149.41

5.8

2.8

0.91

2.10

mmol/l

8.91

455

1753

Leisure time condition

1050

4515

2.50

149.40

4.3

3.8

1.70

1.73

mmol/l

0.10

719

3305

Liquid cancers

1597

7624

2.10

149.37

5.0

3.9

1.86

1.84

mmol/l

0.07

1244

5618

Missing teeth due to accident, extraction or parodontitis

2952

15975

1.71

147.96

3.8

3.5

1.63

1.87

mmol/l

2.83

2217

11835

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1062

4481

2.50

147.59

9.9

5.2

1.38

1.37

mmol/l

0.03

794

3269

Iron deficiency anaemia secondary to blood loss (chronic)

959

3987

2.60

147.51

5.8

3.5

1.61

1.99

mmol/l

1.95

712

2933

Accidents

3395

10347

1.69

147.19

3.8

3.9

1.66

1.65

mmol/l

0.02

2470

7484

Stroke, excluding SAH

2980

12986

1.72

146.50

4.1

3.6

1.85

1.87

mmol/l

0.12

2186

9683

Ulcer of lower limb, not elsewhere classified

938

3901

2.63

145.31

5.9

3.6

1.95

1.90

mmol/l

0.12

718

2872

Polycystic ovarian syndrome, consortium definition

2592

8498

1.80

145.21

3.5

3.0

1.83

1.82

mmol/l

0.04

1900

6211

Stroke, including SAH

3081

13495

1.70

144.89

4.1

3.6

1.86

1.85

mmol/l

0.02

2249

10079

Schizophrenia or delusion, excluding more controls

1245

5692

2.25

144.80

3.5

3.2

2.43

1.66

mmol/l

9.12

955

4119

Pain in joint

2561

9020

1.80

144.72

3.5

3.7

1.33

1.73

mmol/l

6.79

1887

6591

Cutaneous abscess, furuncle and carbuncle

1328

6349

2.21

144.39

5.3

3.7

1.46

1.63

mmol/l

0.76

997

4622

Disorders of adult personality and behaviour

1214

5587

2.27

144.19

3.2

3.1

1.73

1.49

mmol/l

1.29

890

3993

Personality disorders

1153

5207

2.32

143.55

3.2

3.0

1.79

1.51

mmol/l

1.60

847

3739

Diverticular disease of intestine

3179

12103

1.68

142.89

3.7

3.3

1.64

1.88

mmol/l

2.97

2352

8937

Other specific joint derangements/joint disorders

3127

11865

1.69

142.19

3.6

1.36

1.63

mmol/l

4.17

2302

8592

ILD medications: azathioprine

774

2944

2.82

142.06

11.8

3.2

1.05

1.62

mmol/l

4.50

597

2117

Diseases of the skin and subcutaneous tissue

4310

14075

1.57

141.66

4.2

3.4

1.61

1.72

mmol/l

1.12

3174

10141

Open wound of head

2770

15718

1.71

141.34

4.3

4.0

1.70

1.67

mmol/l

0.12

2062

11557

Spondylopathies

3453

12747

1.65

141.08

3.5

3.4

1.89

1.76

mmol/l

1.22

2536

9350

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1089

4742

2.42

140.80

9.8

5.1

1.39

1.37

mmol/l

0.05

819

3474

External causes of morbidity and mortality

2651

7660

1.78

139.43

4.1

3.9

1.77

1.64

mmol/l

0.89

1946

5513

Disorders of parathyroid gland

1109

4969

2.36

138.65

6.2

3.4

1.55

2.11

mmol/l

4.37

821

3733

Autoimmune diseases related-to ILD

3697

19983

1.58

137.62

4.3

3.3

1.79

1.66

mmol/l

1.25

2772

14512

Other CVD

1231

5885

2.25

135.99

4.1

3.7

1.98

1.97

mmol/l

0.01

915

4304

Alcohol abuse, main dg, excluding more controls

758

2933

2.76

134.20

4.0

3.3

1.60

1.59

mmol/l

0.02

568

2128

Hypotension

1099

5066

2.34

133.53

3.9

3.6

1.93

2.01

mmol/l

0.25

816

3707

Other sleep disorders

566

1882

3.24

133.05

4.1

4.3

1.75

1.85

mmol/l

0.27

404

1361

Soft tissue disorders

4461

15209

1.54

132.90

3.6

4.0

1.52

1.67

mmol/l

1.74

3215

10976

Bacterial pneumonia, not elsewhere classified

1694

7902

1.96

132.29

5.4

3.0

2.55

1.39

mmol/l

25.83

1283

5614

Myalgia

1095

5016

2.29

131.93

3.2

3.4

1.64

1.82

mmol/l

1.00

832

3666

Hypothyroidism, strict autoimmune

3067

12470

1.66

131.66

3.8

3.2

1.65

1.71

mmol/l

0.31

2291

9025

Cystitis

3679

14103

1.59

131.44

4.3

3.6

1.65

1.72

mmol/l

0.43

2720

10167

Other/unspecified dorsalgia

1705

9046

1.93

131.30

3.7

3.4

1.93

1.78

mmol/l

0.89

1283

6601

Paralytic ileus and intestinal obstruction

1347

6711

2.11

130.91

5.1

3.5

1.96

1.93

mmol/l

0.09

1016

4924

Bipolar affective disorders

802

3217

2.63

130.69

3.3

3.2

1.36

1.62

mmol/l

1.13

611

2303

Pacemaker

2000

10556

1.85

129.69

4.4

3.7

1.96

1.88

mmol/l

0.38

1454

7767

Pain (limb, back, neck, head abdominally)

3178

9847

1.66

129.59

4.2

4.1

1.54

1.70

mmol/l

1.49

2327

7160

ILD-related respiratory insufficiency

337

843

5.06

129.08

9.0

4.0

3.03

1.95

mmol/l

4.78

285

620

Ischaemic Stroke, excluding all haemorrhages

2781

12564

1.69

128.85

4.1

3.6

1.87

1.89

mmol/l

0.10

2036

9358

Other diseases of the digestive system

1768

9745

1.91

127.83

6.0

3.7

1.60

1.84

mmol/l

1.65

1290

7146

Polyneuropathies and other disorders of the peripheral nervous system

1239

6076

2.18

127.80

5.4

3.6

1.53

1.81

mmol/l

1.68

978

4444

Diseases of the ear and mastoid process

4817

16447

1.50

127.43

3.7

3.6

1.49

1.74

mmol/l

4.78

3486

11962

Other dorsopathies, not elsewhere classified

4211

14531

1.54

126.88

3.3

3.5

1.55

1.66

mmol/l

1.08

3050

10525

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

4161

17601

1.53

126.57

4.1

3.3

1.90

1.71

mmol/l

2.39

3111

12863

Other pleural conditions

664

2507

2.93

125.93

6.0

3.2

2.78

1.53

mmol/l

12.93

540

1758

Pneumonitis due to solids and liquids

604

2178

3.11

125.78

5.5

3.6

2.46

1.81

mmol/l

3.34

471

1552

Other and unspecified polyneuropathies, also in other diseases

1108

5249

2.27

125.49

5.6

3.5

1.45

1.82

mmol/l

2.53

878

3841

Moderate visual impairment, binocular

306

722

5.25

125.39

6.3

4.2

0.92

2.06

mmol/l

4.46

238

518

Azathioprine

774

3141

2.64

124.52

11.8

3.6

1.05

1.59

mmol/l

4.15

597

2276

Familial hypercholesterolemia, with ischemic heart disease

621

2287

3.04

124.36

4.5

3.6

1.62

1.98

mmol/l

1.46

457

1679

Sensorineural hearing loss

3471

15006

1.59

124.26

3.8

3.7

1.70

1.86

mmol/l

1.76

2545

11157

Other abnormal uterine and vaginal bleeding

976

3051

2.41

123.90

3.6

3.2

1.99

2.07

mmol/l

0.27

743

2253

Specific personality disorders

981

4411

2.33

123.53

3.1

1.83

1.51

mmol/l

1.73

729

3167

Sequelae of cerebrovascular disease

1920

9286

1.85

123.48

4.1

3.5

1.73

1.94

mmol/l

1.56

1426

6853

Chronic apical periodontitis

4675

18004

1.49

121.82

3.4

3.5

1.57

1.76

mmol/l

2.81

3396

13166

Chronic nephritic syndrome

325

819

4.77

121.28

7.7

3.3

0.58

1.87

mmol/l

6.88

208

609

Candidiasis, including avohilmo

1385

7165

2.02

120.55

4.9

3.5

1.86

1.74

mmol/l

0.63

1027

5231

Mycoses

1388

7212

2.02

120.01

5.3

3.6

1.87

1.75

mmol/l

0.55

1042

5279

Myocardial infarction, strict

2141

8822

1.79

119.98

4.5

3.3

1.80

1.81

mmol/l

0.02

1574

6614

Viral hepatitis, IBD co-morbidity

190

291

6.93

119.38

3.4

2.8

1.92

1.56

mmol/l

0.52

146

204

Other problems related to primary support group, including family circumstances

725

2844

2.71

119.06

15.2

4.5

1.02

1.16

mmol/l

0.58

586

2041

Injuries to the thorax

2250

13505

1.73

118.96

3.9

3.5

1.92

1.74

mmol/l

1.37

1674

9878

Conductive and sensorineural hearing loss

3574

15632

1.56

118.86

3.8

3.7

1.71

1.84

mmol/l

1.24

2626

11591

Visual impairment including blindness (binocular or monocular)

513

1751

3.31

118.32

7.1

4.4

1.23

1.97

mmol/l

3.70

383

1289

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

881

3902

2.45

118.31

4.9

3.6

1.33

1.80

mmol/l

2.16

629

2878

Statin medication

2536

8595

1.70

117.47

4.2

3.1

1.45

1.86

mmol/l

5.95

1831

6391

Benign neoplasm of colon, rectum, anus and anal canal

2968

16088

1.61

116.92

4.1

3.4

1.55

1.93

mmol/l

6.00

2240

11919

Other diseases of blood and blood-forming organs, wide

1153

5682

2.16

116.75

6.0

3.8

2.13

1.77

mmol/l

2.53

851

4212

Emotionally unstable personality disorder

547

1922

3.03

116.07

3.1

2.9

1.63

1.36

mmol/l

0.85

411

1371

Candidiasis

748

3094

2.59

115.80

5.6

3.7

1.87

1.80

mmol/l

0.23

568

2267

Certain disorders involving the immune mechanism

990

4624

2.29

115.51

5.9

4.0

1.53

1.73

mmol/l

1.02

761

3409

Amputation

670

2658

2.78

115.18

6.0

3.5

1.44

1.88

mmol/l

1.78

491

1921

Elevated blood glucose level

558

2020

3.07

114.97

5.1

4.1

1.67

1.82

mmol/l

0.40

411

1478

Hyperparathyroidism

953

4344

2.31

114.49

6.3

3.4

1.37

2.11

mmol/l

5.95

694

3245

Acute peritonitis

453

1472

3.50

113.86

10.9

3.7

1.24

1.89

mmol/l

2.29

325

1081

Motor neuron disease (with DMD)

182

291

7.69

113.70

4.8

4.5

3.44

1.85

mmol/l

5.23

165

218

Motor neuron disease ALS

167

243

8.38

113.59

4.6

4.2

3.70

1.83

mmol/l

6.06

153

183

Other symptoms and signs involving the circulatory and respiratory systems

404

1214

3.67

113.44

5.0

3.9

1.71

1.63

mmol/l

0.12

312

871

Gastroduodenal ulcer

1343

7014

2.01

113.39

4.7

3.5

1.74

1.95

mmol/l

1.02

992

5086

Chronic periodontitis, complicated

2531

15435

1.65

112.94

3.9

3.4

1.49

1.83

mmol/l

4.85

1880

11482

Insulin, fast-acting (human)

665

2626

2.69

112.75

5.6

3.0

1.27

1.67

mmol/l

1.91

471

1905

Emphysema

491

1675

3.27

112.66

5.2

3.3

2.41

1.60

mmol/l

4.48

385

1171

Systemic connective tissue disorders

1622

9034

1.87

112.46

4.5

3.5

1.78

1.93

mmol/l

0.91

1226

6680

GI-bleeding

1721

9785

1.84

112.02

6.1

3.7

1.64

1.84

mmol/l

1.24

1247

7171

Symptoms and signs concerning food and fluid intake

618

2369

2.82

111.93

7.2

3.7

1.81

1.72

mmol/l

0.24

461

1718

Malignant neoplasm of bladder, including Hilmo

760

3195

2.56

111.49

4.7

3.6

0.65

1.84

mmol/l

11.71

570

2277

Viral and other specified intestinal infections, including avohilmo

1265

6249

2.03

111.23

7.8

3.5

1.26

1.48

mmol/l

1.31

893

4418

Acute sinusitis

2074

11245

1.72

109.40

3.9

3.1

1.48

1.68

mmol/l

1.83

1517

8162

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1219

6172

2.04

108.69

10.3

3.7

1.42

1.31

mmol/l

0.53

944

4319

Migraine without aura

667

2673

2.59

107.85

3.9

4.5

0.98

1.42

mmol/l

2.55

450

1859

Viral and other specified intestinal infections

1009

4724

2.18

107.70

9.0

3.6

1.21

1.47

mmol/l

1.49

709

3334

Hernia of abdominal wall

2130

12957

1.71

107.47

4.4

3.6

1.70

1.74

mmol/l

0.16

1567

9529

Diabetic retinopathy, excluding more controls

1529

4617

1.98

107.20

5.2

3.0

1.39

1.63

mmol/l

1.41

1100

3391

Other or unspecified ileus, impaction or obstruction

981

4699

2.21

106.69

5.0

3.5

2.12

1.99

mmol/l

0.44

729

3420

Spinal stenosis

2346

10655

1.68

106.54

3.8

3.5

1.91

1.85

mmol/l

0.31

1780

7905

Malignant neoplasm of bladder

497

1773

3.13

105.41

5.1

3.6

0.38

1.97

mmol/l

13.55

370

1251

Hyperkinetic disorders, excluding more controls

543

1849

2.88

105.04

6.0

4.2

0.91

1.01

mmol/l

0.32

367

1235

Exclusions for E4_PCOS_BROAD

965

4631

2.22

105.02

5.9

4.9

1.82

1.57

mmol/l

1.48

743

3408

Unspecified fall

2482

15447

1.63

104.97

4.3

4.0

1.77

1.69

mmol/l

0.45

1861

11262

Status post-ami

1373

5563

1.97

104.73

4.7

3.5

1.49

1.83

mmol/l

2.17

1011

4080

Diseases of peritoneum

595

2335

2.79

104.13

9.0

3.6

1.37

1.99

mmol/l

2.93

427

1717

Injuries to the abdomen, lower back, lumbar spine and pelvis

1928

11352

1.74

103.75

4.3

3.5

1.98

1.77

mmol/l

1.63

1430

8287

Follow-up care involving plastic surgery

254

594

4.89

102.71

4.4

2.6

1.27

1.80

mmol/l

1.30

199

444

Any operation in hilmo

136

16.82

102.47

3.1

1.1

1.29

0.29

mmol/l

0.89

Diseases of the eye and adnexa

3138

10249

1.57

102.28

4.4

3.5

1.47

1.56

mmol/l

0.69

2268

7442

Other viral diseases, including avohilmo

1657

9440

1.80

101.87

7.5

4.0

1.37

1.43

mmol/l

0.33

1221

6749

Exposure to other specified factors

3456

20198

1.50

101.86

4.0

3.8

1.37

1.68

mmol/l

5.49

2548

14711

Sulfonylureas

1680

7658

1.82

101.86

4.7

3.6

1.57

1.97

mmol/l

3.31

1181

5697

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2230

13372

1.66

101.35

3.6

1.48

1.76

mmol/l

3.40

1684

9798

Other intervertebral disc disorders

3312

13172

1.53

101.02

3.4

3.3

1.66

1.72

mmol/l

0.38

2432

9612

Other viral diseases

1354

7356

1.91

100.42

8.8

4.1

1.45

1.46

mmol/l

0.02

1005

5273

Diseases of the musculoskeletal system and connective tissue

2223

6713

1.70

100.29

4.6

4.5

1.35

1.54

mmol/l

1.63

1638

4801

Dermatitis

2741

17541

1.57

100.11

4.6

3.6

1.57

1.76

mmol/l

1.92

2049

12811

Unspecified mental disorder

1605

9200

1.80

99.82

3.4

3.2

2.22

1.62

mmol/l

7.56

1207

6691

Alcohol dependence

1260

6749

1.96

99.34

4.0

3.4

2.01

1.59

mmol/l

3.08

939

4880

Cystic kidney disease

285

759

4.56

99.26

12.8

4.5

0.38

1.83

mmol/l

8.85

184

560

Other disorders of ear

3979

17924

1.47

99.03

3.8

3.9

1.66

1.74

mmol/l

0.74

2906

13213

Malignant neoplasm, including Hilmo

3476

13694

1.51

98.76

4.1

3.6

1.78

1.64

mmol/l

1.42

2637

9964

Other disorders of glucose regulation and pancreatic internal secretion

532

2032

2.88

98.61

8.4

4.6

1.49

1.63

mmol/l

0.33

396

1503

Primary_lymphoid and hematopoietic malignant neoplasms

1270

6863

1.96

98.47

5.3

4.0

1.81

mmol/l

0.01

1004

5057

Arthrosis

2842

10071

1.58

98.25

3.2

3.3

1.69

1.80

mmol/l

0.80

2077

7394

Enlarged lymph nodes

710

3083

2.43

97.59

4.9

3.4

2.11

1.66

mmol/l

2.72

539

2243

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

953

4019

2.16

97.28

7.4

5.0

0.96

1.04

mmol/l

0.30

645

2790

Malignant neoplasm

3396

13437

1.51

97.24

4.0

3.6

1.77

1.65

mmol/l

1.12

2581

9789

Panic disorder

597

2395

2.62

97.22

3.4

3.1

1.54

1.48

mmol/l

0.14

428

1711

Generalized anxiety disorder

647

2688

2.51

97.19

2.9

3.1

1.15

1.41

mmol/l

1.15

486

1889

Symptoms and signs involving the skin and subcutaneous tissue

3101

19790

1.52

96.37

4.2

3.7

1.53

1.74

mmol/l

2.72

2345

14439

Kela-code for severe mental illness

1466

8281

1.83

96.21

3.4

3.2

2.28

1.63

mmol/l

7.82

1114

6022

Malignant neoplasm, wide definition

3469

13729

1.50

96.08

4.0

3.6

1.80

1.64

mmol/l

1.73

2637

9982

Benign neoplasm: Colon

2509

15264

1.59

95.97

4.1

3.5

1.49

1.93

mmol/l

7.06

1893

11338

Gonarthrosis [arthrosis of knee](FG)

3041

11578

1.55

95.95

3.2

1.79

1.81

mmol/l

0.11

2273

8561

Chronic ulcer of skin, not elsewhere classified

450

1604

3.13

95.62

5.7

3.3

2.01

1.99

mmol/l

0.03

340

1170

Malignant neoplasm

3396

13484

1.51

95.62

4.0

3.7

1.79

1.65

mmol/l

1.35

2586

9823

Acute suppurative otitis media

1093

5231

2.02

95.50

6.0

4.0

0.93

1.36

mmol/l

4.19

782

3695

Traumatic subdural haemorrhage

628

2426

2.56

95.45

3.8

2.02

2.01

mmol/l

0.00

448

1734

Intestinal stricture

1531

8814

1.82

95.45

5.6

3.7

1.87

1.84

mmol/l

0.11

1137

6513

Fracture of rib(s), sternum and thoracic spine

1528

8794

1.82

95.26

4.1

3.4

1.95

1.79

mmol/l

0.87

1163

6421

Shoulder lesions

3096

12375

1.53

94.84

3.3

3.4

1.68

1.82

mmol/l

1.30

2257

9039

KRA_PSY_EATING, excluding more controls

337

990

3.57

94.69

4.9

3.6

1.32

1.11

mmol/l

0.51

232

660

Idiopathic pulmonary fibrosis

525

2046

2.87

94.53

6.5

3.6

2.60

1.90

mmol/l

3.80

432

1468

Other diseases of anus and rectum

1413

7923

1.85

94.37

4.5

3.5

1.78

1.90

mmol/l

0.60

1047

5817

Arthropathies in other diseases classified elsewhere

260

664

4.53

94.23

6.7

3.4

1.58

1.85

mmol/l

0.50

196

502

Second line medication for Crohn's disease

2438

15758

1.59

94.18

6.2

3.6

1.58

1.69

mmol/l

0.77

1825

11606

Peripheral artery operations in Hilmo

739

3338

2.38

94.13

5.5

3.4

1.44

1.93

mmol/l

2.30

528

2409

Chronic tubulo-interstitial nephritis

240

574

4.75

94.13

8.6

2.4

0.38

2.20

mmol/l

9.20

164

430

Other systemic involvement of connective tissue (FG)

1115

5715

2.00

94.05

3.8

3.2

1.88

1.92

mmol/l

0.13

821

4245

Other diseases of liver

878

4232

2.19

94.02

4.4

3.5

1.48

1.81

mmol/l

1.58

638

3124

Noninfective enteritis and colitis

2079

12968

1.65

93.82

5.0

4.0

1.53

1.65

mmol/l

0.73

1528

9505

Migraine with aura

758

3416

2.29

93.75

3.1

3.8

1.04

1.66

mmol/l

5.18

529

2417

Hypothyreosis and Thyroxine purchase for inclusion criteria

3751

17116

1.46

93.68

3.8

3.5

1.74

1.71

mmol/l

0.25

2804

12433

Hypothyroidism, other/unspecified

3619

16475

1.47

93.41

3.8

3.5

1.71

1.69

mmol/l

0.09

2701

11958

Coxarthrosis [arthrosis of hip](FG)

2353

10269

1.62

93.30

3.4

3.3

1.88

1.86

mmol/l

0.08

1720

7627

Injuries to the hip and thigh

2315

13273

1.61

93.22

4.1

3.6

1.99

1.79

mmol/l

1.54

1715

9738

Abnormal results of function studies

503

1918

2.85

92.97

5.1

3.8

1.74

1.62

mmol/l

0.26

380

1395

Other joint disorders

3503

12472

1.49

92.56

3.5

3.7

1.43

1.64

mmol/l

2.59

2535

9013

Irritable bowel syndrome

1094

5706

1.99

92.43

3.3

3.2

1.45

1.87

mmol/l

3.46

785

4195

Other pulmonary heart/vessel disease

342

1068

3.69

92.41

8.3

4.4

2.80

1.91

mmol/l

3.41

291

787

Secondary right heart disease

313

925

3.93

92.34

8.1

4.2

2.81

1.91

mmol/l

3.05

265

677

Chronic gastritis

1257

6887

1.91

92.25

3.9

3.4

1.58

2.05

mmol/l

4.01

965

5050

Congenital malformations, deformations and chromosomal abnormalities

2310

14027

1.60

91.98

5.7

3.4

1.47

1.54

mmol/l

0.44

1676

10124

Internal derangement of knee

1535

8806

1.78

91.78

3.4

3.3

1.67

1.75

mmol/l

0.41

1147

6464

Other degenerative diseases of the nervous system

1009

3655

2.08

91.74

3.2

3.8

1.90

1.89

mmol/l

0.03

746

2620

Failure and rejection of transplanted organs and tissues

165

305

7.43

91.65

18.1

5.2

1.25

1.72

mmol/l

0.81

135

226

Acute alcohol intoxication, ICD10

969

4889

2.09

91.44

3.9

3.4

1.55

1.60

mmol/l

0.13

718

3567

Hernia

3864

18077

1.45

91.37

4.3

3.6

1.67

1.77

mmol/l

0.94

2874

13233

Injuries to the ankle and foot

2959

17054

1.52

91.01

3.7

1.39

1.62

mmol/l

2.85

2114

12429

Dorsopathies

4157

14881

1.44

90.84

3.6

1.60

1.64

mmol/l

0.27

3009

10769

Cystic kidney disease, including avohilmo

288

819

4.18

90.83

12.7

4.5

0.37

1.82

mmol/l

9.14

187

605

Cardiomyopathy

805

3797

2.24

90.78

5.2

3.2

1.97

1.49

mmol/l

2.58

571

2779

Charcot foot

162

291

6.94

90.60

8.0

2.8

1.44

1.78

mmol/l

0.49

118

212

Coxarthrosis

2163

8713

1.65

90.57

3.4

1.84

1.88

mmol/l

0.18

1584

6455

Symptoms and signs involving the nervous and musculoskeletal systems

2601

17235

1.55

90.24

3.7

4.0

1.99

1.69

mmol/l

3.96

1889

12674

L04AX Other immunosuppressants

2366

15350

1.58

90.15

6.3

3.6

1.62

1.70

mmol/l

0.51

1779

11309

Bacterial pneumonia (organism specified)

2075

11808

1.64

90.13

5.6

3.5

2.49

1.65

mmol/l

18.40

1572

8544

Visual disturbances and blindness

2359

15304

1.59

90.07

4.5

3.8

1.45

1.78

mmol/l

4.23

1712

11260

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

391

1326

3.24

90.07

4.2

4.0

1.42

1.44

mmol/l

0.03

280

965

Disorders of the thyroid gland

3880

17763

1.44

90.06

3.8

3.6

1.70

1.68

mmol/l

0.15

2856

12900

Polycystic kidney disease

233

576

4.96

89.90

11.4

4.5

0.28

1.85

mmol/l

7.89

146

434

Use of pramipexole

1056

5536

2.01

89.50

4.2

3.5

1.90

1.97

mmol/l

0.21

825

4130

Gonarthrosis

2597

9520

1.58

89.36

3.2

3.3

1.74

1.84

mmol/l

0.67

1946

7019

Adrenocortical insufficiency

277

772

4.19

89.26

6.8

4.5

2.20

1.60

mmol/l

1.95

215

584

Urinary track infection

1984

5991

1.70

89.02

4.3

3.4

1.71

1.70

mmol/l

0.05

1456

4343

Other/unspecified cytomegaloviral diseases

195

425

5.85

88.84

10.7

5.1

0.95

1.56

mmol/l

1.34

142

323

Injury, poisoning and certain other consequences of external causes

2076

6355

1.67

88.80

4.1

1.68

1.64

mmol/l

0.17

1510

4628

Injuries to the shoulder and upper arm

3701

20168

1.45

88.33

3.5

3.7

1.81

1.72

mmol/l

0.69

2708

14759

Chronic periodontitis, including avohilmo

4029

18336

1.43

87.91

3.6

3.3

1.50

1.81

mmol/l

6.02

2953

13509

Congenital malformations of the urinary system

425

1549

3.11

87.69

12.2

5.5

0.63

1.40

mmol/l

4.62

282

1150

Periodontitis

4029

18340

1.43

87.21

3.6

3.3

1.50

1.81

mmol/l

6.08

2954

13510

Other neurological diseases

3173

16953

1.49

87.19

4.1

3.6

1.81

1.80

mmol/l

0.03

2300

12556

Arthropathies

3605

12653

1.47

86.63

3.8

1.43

1.62

mmol/l

2.31

2580

9139

Fibrosis and cirrhosis of liver

469

1798

2.88

86.58

4.9

3.7

0.99

1.95

mmol/l

4.11

329

1328

Other noninfective gastroenteritis and colitis

1231

6836

1.88

86.52

6.0

4.5

1.37

1.68

mmol/l

2.13

915

5031

Cytomegalovirus infection, IBD co-morbidity

212

505

5.21

86.09

10.5

5.0

1.01

1.72

mmol/l

1.82

156

389

Any event in cancer register

3537

14410

1.46

85.68

4.0

3.7

1.72

1.63

mmol/l

0.68

2663

10450

Peripheral arterial reconstruction

944

4854

2.07

85.60

5.2

3.6

1.75

1.90

mmol/l

0.46

677

3529

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1161

6161

1.92

85.43

3.3

3.6

2.23

1.84

mmol/l

2.26

850

4551

Nephrotic syndrome

294

891

4.03

85.33

15.1

6.0

0.97

1.52

mmol/l

1.74

205

656

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

345

1118

3.33

85.17

3.1

1.83

1.36

mmol/l

1.44

258

804

Polyuria

1098

5925

1.95

85.09

3.9

3.6

1.74

1.81

mmol/l

0.30

834

4309

Somatoform disorder

687

3123

2.31

84.77

3.2

3.3

1.97

1.81

mmol/l

0.62

521

2277

Acidosis

202

470

5.34

84.52

8.7

4.0

0.51

1.70

mmol/l

2.33

151

366

Cytomegaloviral disease

214

520

5.05

84.51

10.4

4.8

1.01

1.77

mmol/l

2.04

157

395

Acute pancreatitis

955

4934

2.04

84.39

4.2

3.5

1.65

1.78

mmol/l

0.44

690

3643

Dermatitis and eczema

4709

20500

1.38

84.29

4.2

3.7

1.54

1.72

mmol/l

2.42

3488

14914

Alcohol abuse, main dg

758

3607

2.23

84.09

4.0

3.5

1.60

1.59

mmol/l

0.02

568

2640

Transport accidents

1778

9049

1.67

83.97

3.6

3.5

1.58

1.65

mmol/l

0.35

1309

6516

Gastric ulcer

886

4470

2.09

83.86

4.8

3.5

1.88

1.98

mmol/l

0.27

660

3240

Cytomegaloviral disease, including avohilmo

214

524

4.99

83.58

10.4

4.8

1.01

1.77

mmol/l

2.03

157

398

Amputation of toe

463

1801

2.86

83.48

5.8

3.6

1.39

1.94

mmol/l

1.91

331

1306

Angina pectoris

2319

9972

1.59

83.44

3.6

3.3

1.96

1.82

mmol/l

0.93

1682

7488

Diabetic retinopathy, strict definition

1064

5102

2.00

83.32

6.0

3.4

1.26

1.73

mmol/l

3.24

753

3651

Congenital malformations of the urinary system, including avohilmo

435

1646

2.97

83.31

12.0

5.4

0.62

1.40

mmol/l

4.85

292

1221

Suppurative and unspecified otitis media

1431

7370

1.77

82.95

5.1

3.8

1.15

1.47

mmol/l

2.94

1028

5238

Acute alcohol intoxication

1179

6551

1.88

82.60

4.2

3.5

1.73

1.59

mmol/l

0.52

882

4734

Diseases of external ear

1664

10175

1.70

82.56

4.7

3.8

1.34

1.71

mmol/l

4.18

1242

7447

Decubitus ulcer and pressure area

424

1587

2.98

82.46

5.9

3.5

2.40

2.07

mmol/l

0.77

329

1150

Other and unspecified dermatitis

2227

14556

1.57

82.25

4.7

3.7

1.51

1.76

mmol/l

2.70

1669

10674

Schizophrenia, schizotypal and delusional disorders

1256

7113

1.83

81.84

3.5

3.2

2.44

1.59

mmol/l

11.36

962

5183

Cardiomyopathies, Primary/intrinsic

597

2614

2.44

81.45

5.1

3.3

2.00

1.47

mmol/l

2.42

421

1901

Hypothyroidism, strict autoimmune, 3 medication purchases required

3312

15577

1.46

81.06

3.7

3.4

1.74

1.73

mmol/l

0.09

2488

11300

Osteomyelitis

423

1596

2.95

81.01

6.4

3.9

1.45

1.80

mmol/l

0.98

311

1170

Mental and behavioural disorders due to opioids

217

537

4.50

80.95

3.6

2.9

2.41

1.38

mmol/l

3.46

172

384

Solid cancers, including Hilmo

3287

13337

1.46

80.51

3.9

3.5

1.84

1.66

mmol/l

1.91

2479

9697

Cardiac arrest

308

797

3.51

80.19

6.5

2.8

2.08

1.51

mmol/l

1.38

231

596

Schizophrenia or delusion

1245

7077

1.82

80.10

3.5

3.2

2.43

1.59

mmol/l

11.01

955

5157

Dental operations

2596

8849

1.54

79.62

4.1

3.8

1.69

1.91

mmol/l

2.01

1921

6476

Speech disturbances, not elsewhere classified

534

2263

2.57

79.57

4.2

3.6

2.26

1.94

mmol/l

1.22

423

1635

Other gastritis (incl. Duodenitis)

1006

5387

1.95

79.44

4.1

3.5

1.79

1.92

mmol/l

0.50

724

3954

Carpal tunnel syndrome

2416

13953

1.54

79.42

3.4

3.3

1.77

1.81

mmol/l

0.21

1807

10257

Cirrhosis of liver, NAS

364

1292

3.18

78.63

4.7

3.7

0.97

1.85

mmol/l

2.61

246

952

Hypoglycaemia, other or unspecified

428

1647

2.86

78.44

8.4

5.0

1.54

1.62

mmol/l

0.16

322

1233

Hypercalcemia

311

1015

3.52

78.22

5.5

4.0

2.38

1.91

mmol/l

1.19

241

764

Osteoporosis with pathological fracture (FG)

399

1478

2.94

78.20

5.0

3.3

2.58

2.35

mmol/l

0.53

320

1141

Injuries to the knee and lower leg

4909

19819

1.36

78.07

3.8

3.7

1.69

1.68

mmol/l

0.10

3651

14367

Solid cancers

3196

13062

1.46

77.94

3.8

3.5

1.83

1.67

mmol/l

1.55

2425

9521

Focal epilepsy

1070

5894

1.91

77.72

4.7

4.4

1.66

1.68

mmol/l

0.05

788

4327

Emotional disorders starting during childhood or adolecense, excluding more controls

297

903

3.52

77.59

5.9

5.2

0.97

0.94

mmol/l

0.05

188

621

Disorders of psychological development

682

2970

2.27

77.59

9.8

6.0

1.02

1.16

mmol/l

0.55

490

2125

Other disorders of adrenal gland

323

1085

3.38

77.08

6.9

4.9

2.19

1.42

mmol/l

3.50

252

816

Neoplasms

2911

10429

1.49

76.94

4.4

3.9

1.55

1.45

mmol/l

0.72

2151

7353

Menorrhagia

1148

3469

1.90

76.51

3.4

3.2

1.86

1.95

mmol/l

0.34

862

2536

Diseases of pulp and periapical tissues, including avohilmo

4287

16249

1.39

76.38

3.4

3.9

1.58

1.71

mmol/l

1.46

3091

11854

Haemorrhoids and perianal venous thrombosis

1454

8680

1.72

76.32

3.6

3.3

1.71

1.90

mmol/l

1.26

1081

6394

Viral infections characterized by skin and mucous membrane lesions

1868

11950

1.61

76.15

5.8

3.9

1.46

1.66

mmol/l

1.52

1390

8733

Other condition

688

3279

2.22

76.03

4.7

3.5

1.87

1.72

mmol/l

0.52

502

2419

Cardiomyopathy (excluding other)

605

2745

2.34

75.82

5.0

3.2

1.98

1.49

mmol/l

2.15

427

1985

Pleural plaque

563

2505

2.45

75.38

4.4

3.2

2.20

1.45

mmol/l

4.76

445

1738

IgA nephropathy (IgA glomerulonephritis)

195

481

4.87

75.08

7.6

3.3

0.42

1.66

mmol/l

4.15

141

356

Functional dyspepsia

1069

5924

1.87

75.03

3.5

3.3

1.63

1.93

mmol/l

1.92

773

4347

Convalescence

286

899

3.49

74.86

3.2

2.7

1.17

1.90

mmol/l

3.19

224

667

Other disorders involving the immune mechanism, not elsewhere classified

252

746

3.97

74.69

7.4

5.8

0.55

1.64

mmol/l

4.60

186

556

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2471

15278

1.50

74.59

5.4

3.4

1.47

1.58

mmol/l

0.82

1798

11065

Other and unspecified effects of external causes

1159

6601

1.82

74.36

4.5

4.2

1.78

1.51

mmol/l

1.67

843

4793

Pain associated with micturition

599

2732

2.33

74.23

3.7

4.1

1.75

1.85

mmol/l

0.30

444

1986

Persistent mood disorders

786

3959

2.07

74.01

3.8

3.2

1.94

1.85

mmol/l

0.26

608

2872

Mental and behavioural disorders due to sedatives or hypnotics

347

1226

3.07

73.99

4.1

3.3

2.42

1.60

mmol/l

3.38

270

913

Alcoholic liver disease

554

2470

2.42

73.33

4.4

3.5

1.40

1.77

mmol/l

0.98

404

1805

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1163

5444

1.84

73.30

4.2

3.6

2.69

1.89

mmol/l

9.49

942

3992

Viral pneumonia (known virus, not influenza)

246

729

4.03

73.27

8.4

5.8

2.51

1.54

mmol/l

3.16

202

556

Pneumonia due to other infectious organisms, not elsewhere classified

215

573

4.26

73.16

5.4

2.8

2.07

1.49

mmol/l

1.53

161

401

Other arthritis (FG)

1268

7439

1.76

73.09

4.3

3.4

1.79

1.73

mmol/l

0.22

937

5487

Speech and linguistic disorders, excluding more controls

451

1707

2.66

72.89

10.0

6.1

1.12

1.18

mmol/l

0.14

325

1221

Superficial injury of lower leg

1131

6436

1.82

72.82

4.0

3.6

1.90

1.74

mmol/l

0.78

843

4682

Other diseases of pericardium

277

873

3.54

72.81

6.2

4.1

2.08

1.39

mmol/l

2.02

216

626

Fibromyalgia

378

1401

2.86

72.71

2.5

3.1

1.75

1.79

mmol/l

0.09

287

1026

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

241

709

4.02

72.29

7.6

5.9

0.53

1.63

mmol/l

4.46

178

525

Other blood glucose lowering drugs, excl. Insulins

748

3754

2.11

72.13

4.0

3.5

1.74

1.96

mmol/l

0.79

546

2816

Ventral hernia

1100

6252

1.84

71.72

4.5

3.5

1.78

1.87

mmol/l

0.32

816

4599

Benign neoplasms

3949

15731

1.39

71.54

3.9

3.6

1.52

1.65

mmol/l

1.33

2881

11317

Caries of dentine, including avohilmo

3338

12130

1.43

71.42

4.0

4.2

1.63

1.79

mmol/l

1.55

2457

8898

Phlebitis and thrombophlebitis (not including DVT)

981

5394

1.90

71.23

4.3

3.3

1.96

1.81

mmol/l

0.62

737

3991

Excessive, frequent and irregular menstruation

1288

3940

1.79

70.80

4.0

3.2

1.65

1.81

mmol/l

0.73

947

2830

Drug-induced cataract

199

523

4.60

70.63

13.3

3.8

0.99

1.96

mmol/l

2.87

156

396

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

454

1879

2.59

70.57

5.6

4.0

2.02

1.79

mmol/l

0.57

341

1393

Acute pancreatitis (for exclusion)

955

5243

1.91

70.20

4.2

3.4

1.65

1.80

mmol/l

0.52

690

3843

Ascites

405

1596

2.75

70.16

5.3

3.5

1.36

1.97

mmol/l

1.53

275

1182

Other symptoms and signs involving the nervous and musculoskeletal systems

1768

11387

1.60

70.14

3.6

3.9

1.98

1.66

mmol/l

3.28

1273

8371

Cholecystitis

709

3527

2.13

70.07

4.1

3.6

1.94

1.86

mmol/l

0.19

510

2603

Idiopathic gout

550

2500

2.39

69.93

5.3

3.4

1.95

1.85

mmol/l

0.19

388

1809

Mycoses, including avohilmo

3728

20862

1.38

69.90

4.0

3.6

1.74

1.67

mmol/l

0.59

2772

15181

Disorder of lipoprotein metabolism, unspecified

640

3073

2.21

69.67

4.6

3.3

1.38

1.96

mmol/l

2.65

467

2314

Unknown and unspecified causes of morbidity

327

1152

3.04

69.62

3.8

3.2

1.79

1.75

mmol/l

0.09

220

834

Phobic anxiety disorders

513

2232

2.39

69.50

4.4

3.4

1.27

1.39

mmol/l

0.33

385

1591

Agranulocytosis

573

2645

2.32

69.44

7.1

4.1

2.04

1.82

mmol/l

0.67

432

1977

Focal epilepsy, strict definition

983

5465

1.89

69.43

4.7

4.4

1.72

1.68

mmol/l

0.12

730

4020

Polyarthrosis

888

4271

1.95

69.27

3.8

3.4

2.39

2.08

mmol/l

1.67

679

3244

Diabetic retinopathy

1944

7890

1.60

69.11

5.0

3.6

1.50

1.78

mmol/l

2.23

1392

5719

Care involving use of rehabilitation procedures

2405

14820

1.49

69.02

5.4

3.2

2.23

1.61

mmol/l

12.84

1699

10846

Coagulation defects, purpura and other haemorrhagic conditions

920

5019

1.92

68.92

5.7

4.1

1.74

1.72

mmol/l

0.07

677

3689

Other viral diseases, not elsewhere classified, including avohilmo

1169

6779

1.78

68.89

8.4

4.4

1.40

1.44

mmol/l

0.13

861

4871

Status epilepticus

224

639

3.93

68.80

5.7

5.2

2.29

2.01

mmol/l

0.54

171

458

Donors of organs and tissues

116

195

7.10

68.73

5.7

2.6

1.52

1.59

mmol/l

0.08

137

Rheumatoid arthritis

1266

6652

1.74

68.51

4.0

3.4

2.14

1.89

mmol/l

1.57

939

4927

Noninfectious colitis NAS

666

3267

2.16

68.33

5.5

4.2

1.47

1.80

mmol/l

1.30

500

2428

Nonorganic sleeping disorders, excluding more controls

739

3738

2.05

68.25

4.3

3.5

1.59

1.55

mmol/l

0.13

546

2683

Other specified/unspecified arthritis

1104

6357

1.80

68.12

4.5

3.5

1.72

1.80

mmol/l

0.31

817

4693

Allergic asthma (mode), excluding more controls

650

3056

2.13

67.60

2.9

2.6

1.49

0.99

mmol/l

3.00

463

2103

Orthopaedic devices associated with adverse incidents

169

411

5.16

67.25

4.1

3.7

1.60

2.10

mmol/l

0.92

135

315

Nonsuppurative otitis media

977

4696

1.87

67.10

6.1

4.2

1.18

1.50

mmol/l

2.15

700

3331

Tubulo-interstitial nephritis, not specified as acute or chronic

328

1185

2.97

66.86

5.2

2.6

2.05

2.19

mmol/l

0.24

242

860

Rheumatism, unspecified

538

2444

2.31

66.70

3.4

3.3

1.93

2.07

mmol/l

0.39

416

1871

Non-allergic asthma (mode), excluding more controls

594

2764

2.20

66.62

5.0

2.8

2.34

1.06

mmol/l

17.31

445

1933

Childhood asthma (age<16), excluding more controls

424

1314

2.60

66.46

4.8

2.9

0.78

0.84

mmol/l

0.13

289

857

Open wound of lower leg

734

3779

2.04

65.66

4.8

3.7

1.85

1.80

mmol/l

0.14

547

2760

Deforming dorsopathies

1151

6776

1.76

65.54

4.7

3.7

1.87

1.79

mmol/l

0.34

882

5014

Inflammatory diseases of female pelvic organs

1995

9018

1.54

65.44

3.3

3.1

1.66

1.89

mmol/l

1.90

1480

6599

Misadventures to patients during surgical and medical care

659

3276

2.12

65.11

4.5

3.3

1.70

1.86

mmol/l

0.50

485

2420

Complications of internal orthopaedic prosthetic devices, implants and grafts

1024

5868

1.82

65.05

3.8

3.3

2.10

2.02

mmol/l

0.24

782

4350

Other symptoms and signs involving cognitive functions and awareness

2070

12384

1.52

64.92

3.7

3.6

1.86

1.87

mmol/l

0.06

1522

9130

Childhood asthma (age<16)

425

1337

2.57

64.64

5.4

3.0

0.78

0.87

mmol/l

0.21

290

873

Vitreous haemorrhage

525

2416

2.33

64.17

6.0

3.5

1.27

1.92

mmol/l

4.12

378

1776

Other viral diseases, not elsewhere classified

888

4888

1.90

63.95

10.2

4.7

1.52

1.44

mmol/l

0.30

660

3560

Combinations of oral blood glucose lowering drugs

1179

7056

1.73

63.72

3.3

3.5

1.66

1.83

mmol/l

0.82

815

5300

Exclusions for E4_PCOS_CONSORTIUM

2581

11233

1.46

63.67

3.8

1.90

1.68

mmol/l

2.33

1929

8141

Diseases of middle ear and mastoid

2202

12280

1.49

63.60

4.4

3.6

1.29

1.58

mmol/l

3.60

1584

8876

Fracture of lumbar spine and pelvis

1060

6162

1.79

63.42

4.7

3.5

2.04

1.94

mmol/l

0.38

803

4543

Fracture of femur

1327

7365

1.68

63.29

4.6

3.7

2.26

1.98

mmol/l

1.60

989

5417

Impingement syndrome of shoulder

975

5543

1.83

63.27

3.1

3.5

1.48

1.80

mmol/l

2.26

742

4130

Bronchiectasis

401

1661

2.61

62.62

6.6

3.4

2.35

1.77

mmol/l

2.32

325

1181

Unspecified acute lower respiratory infection

725

3782

2.01

62.35

6.9

3.5

2.43

1.65

mmol/l

6.55

556

2715

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

863

4765

1.90

62.35

3.2

3.4

1.87

1.89

mmol/l

0.05

620

3521

Irregular menses

1430

6671

1.64

62.27

3.2

2.9

1.53

1.64

mmol/l

0.56

1017

4824

Urticaria and erythema

1454

9202

1.63

62.18

5.1

4.0

1.53

1.62

mmol/l

0.51

1100

6754

Gonarthrosis,primary

3636

16271

1.37

62.10

3.3

3.5

1.73

1.84

mmol/l

0.97

2727

12026

Secondary uncertain malignant neoplasm

656

3322

2.09

61.82

4.3

3.6

2.13

1.90

mmol/l

0.77

526

2406

Acute pharyngitis

644

3189

2.08

61.80

6.6

3.5

1.13

1.36

mmol/l

1.03

471

2293

Cholecystectomy

2789

17019

1.42

61.42

3.3

3.4

1.70

1.84

mmol/l

1.09

2015

12535

Cervical disc disorders

1424

8997

1.63

61.41

3.6

3.5

1.69

1.82

mmol/l

0.73

1049

6652

Sequelae of external causes of morbidity and mortality

1130

6758

1.74

61.33

5.0

3.5

2.18

1.82

mmol/l

2.90

850

4988

Nonischemic cardiomyopathy

501

2302

2.32

61.16

5.4

3.7

2.41

1.77

mmol/l

2.78

380

1691

Delirium, not induced by alcohol and other psychoactive substances

681

3512

2.06

60.86

3.9

2.42

1.96

mmol/l

2.21

482

2594

Other and unspecified nonorganic psychotic disorders

708

3681

1.99

60.68

3.1

2.04

1.47

mmol/l

3.59

529

2688

Malignant neoplasm of respiratory system and intrathoracic organs

1023

4922

1.80

60.51

4.1

3.6

2.63

1.90

mmol/l

7.21

834

3573

Pleural plaque with presence of asbestos

469

2135

2.43

60.34

4.4

3.8

2.19

1.79

mmol/l

1.43

372

1525

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

198

566

3.86

60.32

7.3

2.6

1.41

1.38

mmol/l

0.03

144

427

Heartburn

492

2251

2.30

60.09

3.3

3.5

1.62

1.87

mmol/l

0.92

368

1668

Other systemic involvement of connective tissue

1137

6843

1.72

60.02

3.9

3.4

1.86

1.94

mmol/l

0.31

839

5062

DVT of lower extremities

846

4693

1.88

60.01

4.3

3.3

1.71

1.85

mmol/l

0.53

641

3467

Acquired absence of limb

104

184

7.35

59.79

6.4

3.5

1.16

1.77

mmol/l

0.66

139

Drug-induced osteoporosis with pathological fracture

148

355

5.17

59.77

6.6

3.6

2.42

1.90

mmol/l

0.90

119

276

Diabetic maculopathy

755

3855

2.00

59.75

5.9

3.4

1.05

1.69

mmol/l

3.73

535

2759

Right bundle-branch block

224

701

3.55

59.52

3.6

3.1

2.09

1.51

mmol/l

1.13

166

500

185

521

4.19

59.19

7.2

3.4

2.98

1.80

mmol/l

3.43

146

379

Other and unspecified tonsillitis

1174

5874

1.70

59.17

4.6

3.2

1.29

1.34

mmol/l

0.17

827

4170

Gout due to impairment of renal function

123

260

6.35

58.99

9.2

3.3

1.25

1.76

mmol/l

0.67

192

Diseases of pulp and periapical tissues and dental caries

2775

10136

1.43

58.94

4.2

4.1

1.59

1.84

mmol/l

2.70

2045

7445

Fracture of foot, except ankle

987

5740

1.78

58.91

3.6

1.54

1.67

mmol/l

0.48

725

4221

Hypocalcemia

184

519

4.19

58.82

6.3

3.8

1.58

1.76

mmol/l

0.21

144

393

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

716

3806

1.98

58.44

4.2

3.6

2.25

1.84

mmol/l

2.19

554

2766

Focal epilepsy, mode (most common among epilepsy diagnosis)

892

5077

1.84

58.21

4.3

4.4

1.73

1.69

mmol/l

0.13

659

3724

Meniscus derangement

2077

9409

1.50

58.18

3.3

1.75

1.84

mmol/l

0.56

1522

6954

Diseases of oral cavity, salivary glands and jaws

2416

8669

1.47

58.12

4.1

3.8

1.69

1.91

mmol/l

1.91

1757

6397

Dental caries, including avohilmo

3045

11314

1.40

57.91

4.0

4.1

1.60

1.83

mmol/l

2.73

2239

8299

Open wound of forearm

473

2170

2.32

57.90

4.3

3.5

1.23

1.72

mmol/l

1.82

337

1593

Adjustment and management of implanted device

815

4523

1.88

57.75

4.5

3.2

2.21

1.85

mmol/l

1.88

592

3295

Malignant neoplasm of bronchus and lung, including Hilmo

1010

4936

1.78

57.69

4.1

3.5

2.69

1.92

mmol/l

7.69

812

3593

Assault

527

2515

2.19

57.62

3.4

3.2

1.41

1.43

mmol/l

0.05

380

1839

Non-Hodgkin lymphoma, all, including Hilmo

622

3171

2.07

57.61

4.7

3.5

2.33

1.89

mmol/l

2.47

516

2297

Allergic asthma (mode)

650

3242

2.00

57.53

2.9

2.6

1.49

1.07

mmol/l

2.28

463

2227

Malignant neoplasm of urinary organs, including Hilmo

578

2881

2.13

57.26

4.9

3.7

1.28

1.86

mmol/l

2.91

416

2069

Other and unspecified drugs and medicaments

425

1881

2.42

57.03

5.6

3.8

2.10

1.78

mmol/l

0.90

319

1393

Other diseases of upper respiratory tract

4474

17986

1.31

56.34

4.0

1.53

1.76

mmol/l

4.12

3313

13116

Spondylosis

2129

11556

1.47

56.17

3.4

2.06

1.81

mmol/l

2.64

1543

8545

Mouth breathing

1696

11384

1.53

55.61

4.2

4.4

1.62

1.54

mmol/l

0.50

1212

8405

Use of disulfiram, acamprosate or naltrexone

401

1751

2.44

55.31

3.5

3.3

1.73

1.58

mmol/l

0.33

305

1303

Purpura and other haemorrhagic conditions

663

3506

2.00

55.21

5.6

4.4

1.76

1.73

mmol/l

0.09

491

2580

Urticaria

1169

7242

1.66

54.77

5.1

4.2

1.45

1.60

mmol/l

0.85

886

5273

Zoster [herpes zoster]

852

4872

1.83

54.72

4.8

3.5

1.57

1.97

mmol/l

2.09

634

3623

Nonalcoholic fatty liver disease

456

2112

2.29

54.49

3.3

3.4

1.65

1.71

mmol/l

0.13

327

1604

therapeutic use

207

658

3.59

54.39

4.4

3.6

1.57

2.07

mmol/l

1.12

162

504

Hypopituitarism

433

1983

2.37

54.15

6.0

4.9

1.66

1.36

mmol/l

1.40

331

1471

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

420

1896

2.39

54.12

5.1

3.6

2.04

2.00

mmol/l

0.07

318

1381

Other complications of surgical and medical care, not elsewhere classified

436

1991

2.32

53.84

5.0

3.7

2.07

1.91

mmol/l

0.37

321

1473

Chronic pancreatitis

587

3009

2.06

53.61

4.6

3.5

1.39

1.81

mmol/l

1.26

426

2231

Congenital malformations of the circulatory system

760

4115

1.90

53.57

9.2

5.8

1.76

1.30

mmol/l

4.17

602

3010

Artrosis, including avohilmo

3106

12583

1.37

52.83

3.1

3.5

1.69

1.72

mmol/l

0.18

2257

9216

Other disorders of bladder

580

2977

2.06

52.81

4.0

3.5

1.95

1.80

mmol/l

0.41

436

2152

Injuries to the wrist and hand

4028

20617

1.31

52.77

3.4

3.8

1.53

1.69

mmol/l

1.97

2894

15085

Other necrotizing vasculopathies (FG)

310

1236

2.72

52.65

6.0

3.4

1.52

2.09

mmol/l

2.09

243

913

Budesonide

541

2699

2.09

52.47

4.1

2.9

1.35

1.72

mmol/l

1.46

406

1960

Fracture of lower leg, including ankle

2142

14909

1.44

52.14

4.2

3.5

1.74

1.75

mmol/l

0.07

1629

10916

Other infectious diseases, including avohilmo

451

2129

2.26

51.69

5.1

3.9

1.93

1.80

mmol/l

0.31

321

1531

Tobacco use

281

1079

2.83

51.53

4.2

3.3

1.71

1.60

mmol/l

0.16

213

785

Non-allergic asthma (mode)

595

3047

1.99

51.51

5.0

2.8

2.33

1.14

mmol/l

15.24

446

2119

Isolated proteinuria

192

604

3.63

51.39

6.9

3.6

0.60

1.78

mmol/l

3.48

137

439

Other female pelvic inflammatory diseases

546

2757

2.06

51.19

3.4

3.1

1.66

1.99

mmol/l

1.39

412

2084

Impacted cerumen

602

3172

2.02

51.08

4.8

4.2

1.19

1.88

mmol/l

4.38

432

2340

Parkinson's disease, excluding more controls

479

2108

2.17

51.07

3.2

3.8

2.33

1.76

mmol/l

2.64

357

1508

1410

7950

1.58

51.05

3.8

3.6

1.94

2.08

mmol/l

0.68

1007

5938

Intentional self-harm by sharp object

156

427

4.09

51.01

3.1

4.0

0.81

1.04

mmol/l

0.26

111

295

Disorders of synovium and tendon

1938

11447

1.46

50.84

3.5

1.60

1.75

mmol/l

1.13

1462

8357

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

471

2278

2.20

50.66

6.6

3.7

1.55

1.80

mmol/l

0.70

361

1676

Striking against or struck by other objects

1385

9075

1.57

50.66

3.9

4.1

1.35

1.52

mmol/l

1.08

1013

6578

Sciatica+with lumbago

1880

11550

1.47

50.65

3.4

1.84

1.74

mmol/l

0.63

1416

8469

Acute bronchiolitis

456

1978

2.29

50.37

11.2

7.0

1.10

0.99

mmol/l

0.29

325

1429

Rotator cuff syndrome

2348

11611

1.42

50.30

3.2

3.4

1.70

1.85

mmol/l

1.23

1717

8527

Dissociative [conversion] disorders

180

543

3.59

50.19

3.6

3.2

1.75

1.56

mmol/l

0.26

137

378

Open wound of wrist and hand

1762

11729

1.48

50.18

3.2

3.7

1.39

1.58

mmol/l

1.43

1269

8492

Multiple myeloma, including Hilmo

268

1025

2.89

50.10

5.5

3.4

0.99

2.08

mmol/l

4.40

194

728

Other disorders of patella

587

3057

1.99

50.09

3.2

3.0

1.26

1.76

mmol/l

3.27

441

2247

Hyperplasia of prostate

1595

5974

1.55

50.06

3.7

3.6

1.64

1.65

mmol/l

0.02

1148

4316

Superficial injury of head

1061

6569

1.67

49.97

3.7

4.2

1.79

1.73

mmol/l

0.22

779

4820

Cerebral palsy and other paralytic syndromes

536

2731

2.07

49.80

7.7

4.3

1.92

1.73

mmol/l

0.58

414

2025

Other general symptoms and signs

285

1111

2.74

49.48

6.7

4.6

1.29

1.37

mmol/l

0.14

200

794

Otitis externa

959

5819

1.71

49.25

4.9

3.8

1.36

1.68

mmol/l

2.24

731

4242

Hepatic failure, not elsewhere classified

235

849

3.10

49.22

5.8

3.6

1.10

1.81

mmol/l

1.90

165

633

Haemorrhage, not elsewhere classified

224

784

3.14

49.19

6.0

3.5

2.17

1.77

mmol/l

0.58

161

562

Other disorders of veins

1516

10027

1.52

49.15

3.7

3.2

2.02

1.85

mmol/l

1.02

1172

7427

Psychotic depression

253

936

2.87

49.14

3.8

3.5

1.98

1.58

mmol/l

1.04

186

682

Other disorders of lacrimal gland

1421

9439

1.55

49.11

4.0

3.4

1.61

1.94

mmol/l

3.20

1049

7013

Neuromuscular dysfunction of bladder

425

2000

2.26

48.96

4.6

3.4

2.09

1.84

mmol/l

0.68

322

1455

Calcific aortic valvular stenosis, operated

1419

9096

1.55

48.95

4.4

3.7

2.01

1.92

mmol/l

0.36

1030

6661

Calcific aortic valvular stenosis

1419

9096

1.55

48.95

4.4

3.7

2.01

1.92

mmol/l

0.36

1030

6661

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1361

8827

1.56

48.94

3.6

3.7

1.15

1.51

mmol/l

3.48

977

6399

Intestinal adhesions without obstruction

412

1917

2.29

48.88

5.5

3.6

1.91

2.12

mmol/l

0.45

319

1419

Pneumonia due to Streptococcus pneumoniae

212

720

3.20

48.79

6.8

3.2

2.31

1.35

mmol/l

3.60

169

503

Renal tubulo-interstitial disorders in diseases classified elsewhere

157

6.97

48.72

7.6

2.6

0.64

2.11

mmol/l

3.02

118

Vitamin deficiency, wide

252

942

2.90

48.70

5.2

3.7

1.40

1.73

mmol/l

0.56

197

692

Vitamin deficiency

252

942

2.90

48.70

5.2

3.7

1.40

1.73

mmol/l

0.56

197

692

Other eating disorders

239

864

2.96

48.70

5.6

5.4

1.47

1.10

mmol/l

0.93

166

596

Organic, including symptomatic, mental disorders

2276

11539

1.42

48.67

3.4

3.7

2.10

1.90

mmol/l

1.58

1634

8634

Bronchitis, not specified as acute or chronic

369

1639

2.38

48.65

4.4

3.1

1.82

1.64

mmol/l

0.41

283

1166

Degeneration of macula and posterior pole

2093

11509

1.44

48.49

3.8

3.5

1.86

2.01

mmol/l

1.10

1508

8583

Other diseases of intestine

675

3732

1.89

48.47

4.9

3.4

1.94

1.96

mmol/l

0.04

495

2740

Lumbar disc prolapse

2304

12314

1.41

48.38

3.3

3.4

1.69

1.72

mmol/l

0.11

1703

9030

Post-traumatic stress disorder

297

1194

2.60

48.37

3.9

3.1

1.17

1.33

mmol/l

0.38

192

829

Disturbance of activity and attention

557

2818

2.01

48.32

6.6

5.0

0.86

1.00

mmol/l

0.47

373

1955

Operations 2 for CAVS

1410

9053

1.55

48.25

4.3

3.6

2.02

1.92

mmol/l

0.38

1021

6631

Calcific aortic valvular stenosis, diagnosis (helper)

1410

9053

1.55

48.25

4.3

3.6

2.02

1.92

mmol/l

0.38

1021

6631

Calcific aortic valvular stenosis, including rheumatic fever

1414

9074

1.55

48.24

4.3

3.6

2.01

1.92

mmol/l

0.35

1025

6646

Other arthrosis

1951

9150

1.46

48.13

3.5

3.3

1.74

1.84

mmol/l

0.60

1456

6769

Congenital malformations of heart and great arteries

689

3742

1.89

48.10

9.6

6.1

1.80

1.27

mmol/l

5.06

552

2726

Myocarditis

183

570

3.41

48.04

4.3

2.2

1.58

1.47

mmol/l

0.13

135

409

Other shoulder lesions

396

1822

2.28

47.83

3.7

3.4

1.38

1.83

mmol/l

1.73

293

1334

Other and unspecified urticaria

790

4586

1.79

47.81

4.6

4.3

1.23

1.62

mmol/l

2.77

606

3353

Dependence on enabling machines and devices, not elsewhere classified

143

402

4.74

47.78

31.8

5.5

1.40

0.93

mmol/l

0.95

110

297

Umbilical hernia

1138

7256

1.62

47.72

4.2

3.6

1.60

1.66

mmol/l

0.24

827

5273

Nonsuppurative otitis media, including avohilmo

1165

6408

1.61

47.60

5.0

3.8

1.24

1.49

mmol/l

1.65

813

4583

Drug-induced adrenocortical insufficiency

148

417

4.22

47.59

8.7

5.6

2.64

1.78

mmol/l

2.61

119

320

Injuries to the elbow and forearm

2780

17827

1.36

47.54

4.0

3.7

1.70

1.71

mmol/l

0.03

2036

13019

FESS (DNB20)

513

2612

2.06

47.44

3.3

1.46

1.73

mmol/l

1.04

386

1945

Visual disturbances

1960

13941

1.44

47.38

4.0

3.8

1.47

1.78

mmol/l

3.36

1413

10276

Eating disorder

344

1494

2.41

47.32

4.9

4.2

1.33

1.01

mmol/l

1.01

239

1020

Pneumothorax

341

1491

2.45

47.17

4.8

3.1

2.72

1.46

mmol/l

7.73

275

1040

Disorders of eyelid, lacrimal system and orbit

3435

19361

1.32

47.16

3.8

3.6

1.68

1.75

mmol/l

0.58

2524

14185

Collagenous colitis

428

2051

2.21

47.11

5.8

3.9

1.41

1.91

mmol/l

2.01

315

1528

Diffuse large B-cell lymphoma

277

1110

2.74

47.06

6.1

3.5

2.24

1.98

mmol/l

0.63

237

788

Diffuse large B-cell lymphoma, including Hilmo

277

1110

2.74

47.06

6.1

3.5

2.24

1.98

mmol/l

0.63

237

788

Diffuse large B-cell lymphoma, helper endpoint

277

1110

2.74

47.06

6.1

3.5

2.24

1.98

mmol/l

0.63

237

788

Otitis media, unspecified

555

2672

2.01

47.04

8.4

5.1

0.91

1.35

mmol/l

2.53

398

1906

Special screening examination for infectious and parasitic diseases

633

2460

1.91

46.87

2.6

2.4

0.76

1.80

mmol/l

12.48

471

1753

1038

6071

1.66

46.76

3.8

3.6

1.89

2.16

mmol/l

1.39

750

4514

Other local infections of skin and subcutaneous tissue

486

2447

2.10

46.71

5.8

4.2

1.76

1.66

mmol/l

0.20

380

1806

Abnormal findings on examination of urine, without diagnosis

262

1027

2.82

46.68

7.3

3.9

1.20

1.76

mmol/l

1.31

183

765

Malignant neoplasm of bronchus and lung

875

4375

1.74

46.53

4.0

3.5

2.62

1.97

mmol/l

5.18

708

3164

Paracetamol or NSAID medication

704

1917

1.90

46.52

3.8

4.7

1.47

1.53

mmol/l

0.13

508

1403

Left bundle-branch block

325

1396

2.47

46.48

4.0

3.0

1.57

1.64

mmol/l

0.13

248

1008

Primary gonarthrosis, bilateral

2137

12925

1.42

46.11

3.2

3.6

1.82

1.89

mmol/l

0.40

1622

9603

Conjunctivitis (acute, non atopic)

1175

7577

1.59

45.80

5.3

4.6

1.50

1.55

mmol/l

0.17

860

5554

Mental retardation, excluding more controls

293

1188

2.68

45.58

12.8

7.0

1.70

1.14

mmol/l

1.90

238

881

Pneumocystosis, including avohilmo

148

431

4.09

45.41

6.1

3.7

2.11

1.87

mmol/l

0.31

115

330

Pneumocystosis

148

431

4.09

45.41

6.1

3.7

2.11

1.87

mmol/l

0.31

115

330

Other diseases of hard tissues of teeth

2276

8499

1.41

45.35

4.4

3.8

1.49

1.92

mmol/l

6.13

1665

6283

Ethmoidectomy

523

2725

2.01

45.22

3.3

1.41

1.73

mmol/l

1.38

392

2028

Eating disorders

407

1930

2.20

45.19

4.7

4.1

1.55

1.20

mmol/l

1.29

287

1352

Non-small cell lung cancer, including Hilmo

712

3826

1.82

45.18

4.1

3.5

2.54

1.91

mmol/l

4.26

574

2758

Intentional self-harm by unspecified means

212

5.48

45.18

4.7

4.1

0.68

1.02

mmol/l

0.32

153

Thrombocytopenia, unspecified

380

1775

2.30

45.13

6.4

4.5

1.80

1.71

mmol/l

0.19

285

1298

Other and unspecified local infections of skin and subcutaneous tissue

458

2290

2.11

44.93

5.9

4.3

1.71

1.66

mmol/l

0.08

355

1691

Thiazolidinediones

503

2602

2.04

44.85

3.9

3.5

1.53

1.96

mmol/l

1.56

370

1949

Malignant neoplasm of urinary organs

476

2420

2.09

44.73

4.8

3.8

1.30

1.85

mmol/l

2.22

338

1728

Hyperkinetic disorders

595

3154

1.91

44.73

6.5

5.5

0.88

0.99

mmol/l

0.38

400

2177

Invasive ventilation

393

1869

2.26

44.68

11.7

4.4

3.08

1.57

mmol/l

11.88

282

1341

Disorders of vestibular function (Vertigo)

1842

12751

1.44

44.57

3.3

3.5

1.64

1.94

mmol/l

3.13

1360

9467

Weight loss

513

2684

2.03

44.49

5.1

4.4

1.87

1.81

mmol/l

0.11

377

1965

Sequelae with surgical and medical care as external cause

862

5233

1.71

44.47

4.8

3.6

2.23

1.86

mmol/l

2.36

637

3882

Other symptoms and signs involving the urinary system

485

2484

2.06

44.46

5.0

3.6

1.89

1.75

mmol/l

0.33

309

1787

Type 1 diabetes, definitions combined

427

2078

2.15

44.43

4.0

5.8

0.79

1.23

mmol/l

1.35

288

1519

Immunodeficiencies

275

1131

2.67

44.31

9.4

4.9

1.56

1.63

mmol/l

0.10

214

832

Focal brain injury

242

923

2.76

44.15

3.8

4.2

1.95

1.99

mmol/l

0.06

187

656

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1300

8676

1.54

44.06

4.4

3.9

2.00

1.75

mmol/l

1.71

957

6456

Type 1 diabetes, strict (exclude DM2)

425

2074

2.15

43.93

4.0

5.9

0.79

1.21

mmol/l

1.24

286

1514

Congenital malformations of cardiac septa

461

2281

2.14

43.83

10.7

7.7

1.81

0.98

mmol/l

8.83

381

1641

Assault by bodily force

318

1389

2.41

43.59

3.3

3.2

1.12

1.40

mmol/l

0.68

237

1019

Reimbursement for rheumatic diseases

2129

15467

1.39

43.43

4.5

3.6

1.93

1.75

mmol/l

1.46

1591

11364

Mixed and other personality disorders

308

1329

2.44

43.41

3.3

2.9

1.77

1.53

mmol/l

0.50

220

992

Diseases of inner ear

2120

14816

1.40

43.36

3.4

3.5

1.64

1.87

mmol/l

2.28

1563

10985

Duodenal ulcer

513

2702

2.00

43.26

4.6

3.7

1.58

1.89

mmol/l

0.80

365

1929

Benign neoplasm: Colon, unspecified

1101

7139

1.60

43.26

4.4

3.5

1.64

1.89

mmol/l

1.40

808

5257

Disorders of lacrimal system

1676

11587

1.45

43.15

3.9

3.4

1.63

1.91

mmol/l

2.85

1230

8568

Artificial joint operation, meniscal resection

3534

17620

1.30

43.01

3.1

3.5

1.81

mmol/l

0.05

2622

13033

Secondary and unspecified malignant neoplasm of lymph nodes

397

1919

2.20

42.84

4.8

3.8

2.31

1.80

mmol/l

1.94

322

1386

Emotional disorders and disorders of social functioning with onset specific to childhood

325

1426

2.42

42.79

6.2

0.97

0.90

mmol/l

0.15

208

1016

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

179

602

3.35

42.74

5.5

3.5

0.91

2.07

mmol/l

3.14

128

436

Multiple myeloma

179

602

3.35

42.74

5.5

3.5

0.91

2.07

mmol/l

3.14

128

436

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

477

2467

2.05

42.66

4.6

3.7

1.30

1.85

mmol/l

2.26

341

1759

Disorders of magnesium metabolism

145

6.93

42.64

5.4

3.4

2.41

1.93

mmol/l

0.39

120

Coxibs

1123

3733

1.62

42.54

3.0

4.2

1.67

1.75

mmol/l

0.28

828

2696

Non-small cell lung cancer

516

2706

1.98

42.52

4.2

3.6

2.45

1.95

mmol/l

2.21

425

1930

Amputation of foot

182

624

3.34

42.42

7.3

3.7

0.82

2.09

mmol/l

4.09

142

470

Type 1 diabetes, strict definition, subgroup 1

339

1539

2.32

42.34

3.5

6.2

0.77

1.05

mmol/l

0.56

224

1110

Other necrotizing vasculopathies

355

1657

2.30

42.21

6.2

3.6

1.48

2.06

mmol/l

2.38

277

1228

Secondary parkinsonism, excluding more controls

122

320

4.17

42.05

3.6

3.7

2.30

1.73

mmol/l

0.97

105

231

Other embolism and thrombosis

544

2944

1.93

42.02

4.0

3.4

1.93

1.85

mmol/l

0.20

398

2173

Extrapyramidal and movement disorders

1598

11217

1.46

41.94

3.4

3.6

2.04

1.86

mmol/l

1.27

1197

8251

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

3547

21678

1.29

41.92

4.4

3.8

1.49

1.69

mmol/l

2.61

2593

15837

Isolated proteinuria with specified morphological lesion

212

5.47

41.83

7.0

3.3

0.86

1.81

mmol/l

1.61

161

Unstable angina pectoris

1494

8086

1.49

41.82

3.7

3.4

1.92

1.87

mmol/l

0.17

1079

6003

Parkinson's disease, strict definition, excluding more controls

434

2016

2.08

41.76

3.1

3.8

2.24

1.78

mmol/l

1.84

321

1437

Systemic atrophies primarily affecting the central nervous system

254

1038

2.70

41.68

4.7

4.6

3.01

1.89

mmol/l

4.79

227

778

Endocarditis

192

677

3.10

41.61

6.8

3.0

1.71

1.50

mmol/l

0.31

137

474

Multiple myeloma and malignant plasma cell neoplasms

276

1173

2.58

41.52

5.5

3.8

1.00

2.07

mmol/l

4.52

199

872

Other specified and unspecified personality disorders

340

1560

2.29

41.40

3.9

3.0

2.26

1.53

mmol/l

2.60

252

1166

Pain and other conditions associated with female genital organs and menstrual cycle

617

2874

1.84

41.10

3.6

3.0

1.30

1.64

mmol/l

1.44

417

2043

Other skin changes

863

5351

1.67

41.00

5.0

3.7

1.41

1.91

mmol/l

3.98

648

3939

Valvular operations

596

3341

1.86

40.98

6.5

3.9

2.13

1.47

mmol/l

3.99

448

2414

Suppurative and necrotic conditions of lower respiratory tract

305

1359

2.43

40.89

6.1

3.8

2.36

1.82

mmol/l

1.45

227

994

Speech and linguistic disorders

518

2678

1.97

40.86

9.7

7.3

1.02

1.13

mmol/l

0.38

375

1937

Malignant neoplasm of kidney, except renal pelvis

429

2175

2.09

40.71

4.7

3.8

1.28

1.87

mmol/l

2.35

307

1563

Seropositive rheumatoid arthritis

896

5568

1.65

40.66

4.4

3.2

2.23

1.95

mmol/l

1.64

669

4163

Special screening examination for other diseases and disorders

426

2135

2.06

40.65

4.0

3.0

1.62

2.10

mmol/l

1.95

273

1545

Acetic acid derivatives and related substances

1103

3637

1.60

40.49

3.4

4.1

1.47

1.76

mmol/l

1.47

780

2618

Lack of expected normal physiological development

220

748

3.02

40.35

18.1

5.6

0.96

0.97

mmol/l

0.01

174

536

Fracture of shoulder and upper arm

1467

10190

1.47

40.30

4.0

3.9

1.98

1.81

mmol/l

0.88

1087

7533

Artificial opening status

286

1247

2.48

40.22

11.3

3.9

2.15

1.77

mmol/l

0.90

220

912

Asthma and allergy, excluding more controls

360

1676

2.18

40.09

3.1

2.9

1.18

0.92

mmol/l

0.69

253

1132

Adverse effects, not elsewhere classified

763

4608

1.71

39.93

5.1

4.4

1.86

1.60

mmol/l

1.34

572

3385

Type 1 diabetes, strict definition

353

1667

2.23

39.93

3.7

6.0

0.74

1.06

mmol/l

0.69

234

1206

Other and unspecified nerve root and plexus disorders, also in other diseases

766

4628

1.71

39.92

3.3

3.2

1.79

1.74

mmol/l

0.13

580

3430

Diabetic neuropathy

669

3931

1.81

39.89

6.3

3.6

1.54

1.66

mmol/l

0.34

483

2808

Non-follicular lymphoma

464

2438

2.02

39.89

4.6

3.8

2.30

1.89

mmol/l

1.83

384

1782

Injuries to the neck

860

5350

1.65

39.85

3.2

3.4

1.80

1.62

mmol/l

0.77

635

3872

Fluid overload

12.61

39.83

10.0

2.8

2.31

1.84

mmol/l

0.32

Hypoparathyroidism

194

708

3.01

39.65

5.2

3.7

2.62

1.87

mmol/l

1.84

158

528

Other infectious diseases

366

1770

2.20

39.57

5.4

4.0

1.91

1.85

mmol/l

0.10

258

1294

Diaphragmatic hernia

1419

9853

1.48

39.50

3.6

3.5

1.60

1.97

mmol/l

3.25

1085

7317

Anosmia

130

5.86

39.43

2.6

2.1

1.62

1.60

mmol/l

0.02

Acute laryngitis and tracheitis

468

2414

1.98

39.40

7.0

3.7

1.23

1.27

mmol/l

0.11

331

1725

Other (seronegative) rheumatoid arthritis, wide

741

4467

1.72

39.25

3.8

3.4

2.14

1.96

mmol/l

0.71

560

3339

Other extrapyramidal and movement disorders in other diseases

1003

6503

1.59

39.24

3.5

3.6

1.98

1.91

mmol/l

0.28

742

4823

Symptoms and signs involving speech and voice

1287

8782

1.50

39.20

3.9

3.5

2.00

1.84

mmol/l

0.94

1007

6475

Drug-induced neutropenia

332

1555

2.28

39.09

4.2

3.7

2.27

1.86

mmol/l

1.15

253

1187

Non-Hodgkin lymphoma, all

250

1042

2.61

39.05

5.6

3.6

2.35

1.98

mmol/l

0.94

210

737

Alcohol withdrawal state with delirium

336

1584

2.27

39.01

4.0

3.6

1.95

1.76

mmol/l

0.32

259

1171

Open wound of ankle and foot

454

2377

2.00

38.91

3.7

3.9

1.25

1.68

mmol/l

1.55

315

1744

Attention to artificial openings

233

944

2.70

38.69

9.4

3.1

2.70

1.84

mmol/l

2.44

173

682

Molar incisor enamel hypoplasia, with caries

182

729

4.48

38.62

27.2

7.1

0.88

mmol/l

0.01

150

517

Pruritus

468

2480

1.97

38.48

4.8

3.5

1.42

1.91

mmol/l

2.55

346

1825

Disorders of skin appendages

1777

12801

1.41

38.39

3.9

3.5

1.39

1.64

mmol/l

2.03

1305

9290

Fissure and fistula of anal and rectal regions

868

5465

1.63

38.21

3.2

3.3

1.59

1.83

mmol/l

1.20

640

3989

Abnormal weight loss

462

2462

1.99

38.01

4.9

4.3

1.81

1.83

mmol/l

0.05

341

1806

Cholangitis (primary sclerosing, PSC)

320

1495

2.29

37.98

7.5

4.1

1.17

1.71

mmol/l

1.39

226

1105

Localized swelling, mass and lump of skin and subcutaneous tissue

1265

8657

1.50

37.98

4.2

3.9

1.66

1.79

mmol/l

0.66

980

6368

Maltreatment syndromes

218

855

2.71

37.96

2.8

3.6

1.64

1.32

mmol/l

0.59

151

615

Primary hyperparathyroidism

466

2485

1.97

37.96

4.2

3.5

1.54

2.06

mmol/l

1.83

342

1910

Scoliosis

371

1827

2.13

37.83

7.0

4.6

1.99

1.70

mmol/l

0.95

300

1359

Other disorders starting during childhood or adolecense, excluding more controls

275

1152

2.45

37.56

15.5

6.9

0.78

1.00

mmol/l

0.51

187

818

Other obstructive and reflux uropathy

192

712

2.89

37.52

5.1

3.1

1.07

1.88

mmol/l

1.74

134

527

Varicose veins

2292

13020

1.35

37.43

3.8

3.4

2.10

1.84

mmol/l

2.52

1742

9627

Other diseases of stomach and duodenum

292

1319

2.35

37.40

4.1

3.5

1.94

1.99

mmol/l

0.08

209

945

Other and unspecified mood [affective] disorders

254

1076

2.47

37.18

3.0

3.4

1.38

1.46

mmol/l

0.12

197

770

Other specified/unspecified bacterial intestinal infections

312

1454

2.29

37.17

4.0

3.6

1.55

1.87

mmol/l

0.70

233

1068

Mixed hyperlipidaemia

201

772

2.82

37.00

4.5

3.3

1.22

1.91

mmol/l

1.15

138

586

Diseases of male genital organs

2156

8029

1.38

36.92

4.2

4.3

1.48

1.52

mmol/l

0.15

1564

5828

L01XE Protein kinase inhibitors

273

1215

2.44

36.87

4.1

3.7

1.55

1.97

mmol/l

0.91

203

913

Superficial injury of abdomen, lower back and pelvis

625

3663

1.77

36.69

3.9

3.8

1.92

1.66

mmol/l

0.99

450

2709

Amputation of ankle bones

149

495

3.42

36.59

7.6

3.5

1.09

2.04

mmol/l

1.74

106

368

Polymyalgia rheumatica

603

3516

1.79

36.58

3.7

3.6

2.03

2.17

mmol/l

0.37

441

2599

Asthma and allergy

359

1730

2.10

36.53

3.0

2.9

1.17

0.95

mmol/l

0.59

252

1177

Other ill-defined and unspecified causes of mortality

461

2489

1.96

36.51

4.6

3.6

2.87

1.97

mmol/l

5.33

349

1794

Corns and callosities

306

1426

2.28

36.40

5.0

3.4

1.65

1.87

mmol/l

0.46

237

1053

Intestinal malabsorption

228

938

2.62

36.38

6.1

3.6

0.90

1.88

mmol/l

2.55

146

697

Disturbances of skin sensation

927

5993

1.58

36.30

3.3

3.2

1.35

1.73

mmol/l

2.90

694

4334

Ovarian cyst

967

3528

1.60

36.12

3.0

1.75

1.90

mmol/l

0.54

696

2554

Seronegative rheumatoid arthritis

438

2320

1.97

36.06

3.5

3.2

2.05

1.99

mmol/l

0.13

329

1709

Infection due to other mycobacteria

104

276

4.32

35.99

5.8

3.0

1.93

2.13

mmol/l

0.17

207

Other metabolic disorders

456

2444

1.93

35.96

4.9

3.4

1.98

1.75

mmol/l

0.74

340

1837

Cerebral cysts

273

1221

2.38

35.91

6.4

4.1

1.71

1.68

mmol/l

0.04

182

905

Traumatic subarachnoid haemorrhage

157

534

3.14

35.89

3.1

3.8

1.88

2.09

mmol/l

0.23

113

378

Other follicular disorders

306

1431

2.25

35.75

3.9

3.4

1.35

1.54

mmol/l

0.33

224

1044

Dermatitis due to substances taken internally

262

1156

2.42

35.62

5.4

3.8

1.70

1.71

mmol/l

0.02

193

848

Superficial injury of wrist and hand

785

4912

1.64

35.58

3.7

4.2

1.39

1.54

mmol/l

0.60

560

3596

Barrett oesophagus

244

1050

2.50

35.33

3.7

1.41

1.90

mmol/l

1.01

186

758

Migraine with aura and triptan purchases

488

2682

1.87

35.31

2.9

3.3

0.81

1.51

mmol/l

4.57

333

1916

Crohn disease

488

2702

1.87

34.90

3.9

3.6

1.44

1.65

mmol/l

0.53

355

2017

Vascular disorders of the intestines

332

1623

2.17

34.86

4.6

3.5

1.45

2.22

mmol/l

2.67

242

1163

Transient ischemic attack

2063

12332

1.36

34.75

3.4

3.6

1.80

1.90

mmol/l

0.56

1483

9178

Protozoal diseases

176

659

2.98

34.63

5.8

3.7

1.97

1.79

mmol/l

0.26

132

495

Schizophrenia

557

3212

1.79

34.57

3.6

3.2

3.13

1.59

mmol/l

14.58

431

2371

Acute and transient psychotic disorders

412

2170

1.97

34.45

3.5

3.1

2.67

1.61

mmol/l

6.45

318

1617

Amenorrhoea

226

940

2.51

34.41

3.7

3.1

1.46

1.40

mmol/l

0.07

159

633

Endometriosis

927

3449

1.59

34.30

3.2

3.1

1.67

1.93

mmol/l

1.15

695

2510

Ill-defined and unknown causes of mortality

490

2749

1.88

34.25

4.5

3.7

2.88

1.94

mmol/l

6.13

370

1970

Other diseases of oesophagus

402

2114

1.99

34.07

4.9

3.5

2.17

2.00

mmol/l

0.33

302

1511

Urolithiasis

1322

9322

1.46

34.05

3.8

3.7

1.56

1.70

mmol/l

0.77

944

6784

Migraine without aura and triptan purchases

495

2763

1.84

34.03

3.6

3.2

0.87

1.42

mmol/l

3.21

323

1947

442

2387

1.91

33.92

4.0

3.2

1.53

1.72

mmol/l

0.53

292

1757

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

533

3044

1.80

33.88

3.2

3.0

1.37

1.64

mmol/l

0.81

395

2163

Benign neoplasm of other and unspecified endocrine glands

531

3049

1.82

33.85

3.9

3.5

2.25

1.89

mmol/l

1.53

398

2281

Hypoplasia of dental enamel

189

830

4.01

33.84

30.1

8.2

0.91

0.87

mmol/l

0.09

161

602

Other disorders of nervous system

310

1497

2.20

33.76

4.7

3.6

1.93

1.89

mmol/l

0.07

242

1112

Superficial injury of hip and thigh

644

3895

1.71

33.74

3.6

3.7

1.98

1.90

mmol/l

0.22

476

2858

Aortic aneurysm

1027

6783

1.53

33.72

4.0

3.4

1.90

1.80

mmol/l

0.36

757

4930

Immunodeficiency with predominantly antibody defects

157

562

3.12

33.60

10.4

4.0

1.59

1.68

mmol/l

0.10

123

413

Cluster headache, strict

124

380

3.45

33.58

3.5

4.1

1.47

1.81

mmol/l

0.39

282

Inflammatory bowel disease

1133

7770

1.49

33.57

4.4

3.4

1.68

1.64

mmol/l

0.14

824

5683

Necrosis of pulp, including avohilmo

2008

14949

1.35

33.53

3.3

3.4

1.52

1.61

mmol/l

0.59

1490

10903

Coxarthrosis, primary

2396

15338

1.32

33.48

3.3

3.6

1.93

1.89

mmol/l

0.25

1749

11446

Dilated cardiomyopathy

541

3144

1.81

33.47

4.9

3.8

2.02

1.72

mmol/l

0.93

382

2297

Pyothorax

235

1023

2.50

33.43

5.6

3.6

2.39

1.92

mmol/l

0.94

176

759

Persons with potential health hazards related to communicable diseases

1267

8788

1.46

33.40

6.8

4.2

1.62

1.35

mmol/l

1.98

841

6333

Other or ill-defined heart diseases

225

954

2.49

33.19

5.1

3.3

1.80

1.38

mmol/l

0.73

175

675

Mental and behavioural disorders due to use of other stimulants, including caffeine

121

370

3.52

33.14

2.9

1.81

1.18

mmol/l

1.45

263

Hypogonadotropic hypogonadism

163

597

2.99

33.09

2.4

3.7

1.26

1.53

mmol/l

0.61

132

455

Emotional disorders starting during childhood or adolescence

304

1461

2.23

33.08

5.9

6.6

0.99

0.90

mmol/l

0.19

192

1030

Other disorders of bone

698

4328

1.66

32.93

3.8

3.5

1.56

1.66

mmol/l

0.29

529

3167

Amyloidosis

135

450

3.35

32.73

5.6

3.6

1.46

2.21

mmol/l

1.46

101

350

Abnormal spermatozoa

605

3653

1.74

32.73

3.0

3.7

1.84

1.68

mmol/l

0.60

428

2626

Sulfasalazine

895

5879

1.55

32.57

3.9

2.9

1.97

1.68

mmol/l

1.69

669

4260

Malnutrition

178

702

2.94

32.49

11.8

6.9

1.95

1.51

mmol/l

0.70

139

513

Soft tissue disorders related to use, overuse and pressure

997

6712

1.52

32.47

4.0

3.4

1.73

1.90

mmol/l

0.79

742

4977

Infections with a predominantly sexual mode of transmission

862

5606

1.56

32.33

3.8

3.0

1.19

1.50

mmol/l

1.83

644

3974

Infection due to other mycobacteria, including avohilmo

105

302

3.93

32.28

5.7

2.9

1.87

1.97

mmol/l

0.08

224

Gonarthrosis, primary, with knee surgery

2281

13666

1.32

32.02

3.1

3.6

1.91

1.90

mmol/l

0.05

1707

10154

Non-small cell lung cancer, adenocarcinoma

307

1509

2.17

31.99

4.5

3.6

2.49

2.03

mmol/l

1.28

251

1081

Malignant neoplasm of digestive organs, including Hilmo

1626

8745

1.39

31.98

3.6

3.5

2.04

1.86

mmol/l

0.89

1170

6456

Sarcoidosis

506

2917

1.80

31.79

3.3

3.4

1.97

1.85

mmol/l

0.31

387

2191

Cluster headache, wide

130

424

3.24

31.78

3.4

4.1

1.55

1.80

mmol/l

0.30

317

Rheumatoid arthritis, including avohilmo

1366

9797

1.42

31.71

3.9

3.4

2.13

1.90

mmol/l

1.56

1010

7292

Pericarditis

167

631

2.85

31.70

6.7

2.9

1.91

1.45

mmol/l

0.64

125

447

Pyogenic arthritis

293

1416

2.18

31.65

4.6

3.5

1.69

2.03

mmol/l

0.81

218

1057

Blood alcohol or alcohol intoxication level

130

431

3.32

31.61

3.9

3.2

1.81

1.59

mmol/l

0.25

317

Agoraphobia

124

396

3.33

31.51

3.1

3.0

1.43

1.49

mmol/l

0.07

269

Protozoal diseases, including avohilmo

176

691

2.81

31.50

5.8

3.7

1.97

1.83

mmol/l

0.20

132

522

Other otitis externa (chronic)

300

1469

2.16

31.41

4.0

3.6

1.62

1.87

mmol/l

0.56

225

1077

Alzheimer disease, excluding more controls

576

2181

1.75

31.22

2.9

3.8

2.04

1.76

mmol/l

0.89

409

1571

Sequelae of injuries, of poisoning and of other consequences of external causes

840

5506

1.57

31.18

4.0

3.4

1.75

1.72

mmol/l

0.06

644

4061

Clear cell adenocarcinoma of kidney

231

1027

2.43

31.18

4.3

3.3

1.59

1.94

mmol/l

0.67

165

738

Atopic dermatitis, strict definition with reimbursement

1000

6512

1.50

31.08

5.0

4.4

1.20

1.38

mmol/l

0.83

728

4623

Car occupant injured in other and unspecified transport accidents

640

3940

1.67

31.04

4.0

3.3

1.74

1.64

mmol/l

0.30

490

2860

Oesophageal varices

218

950

2.49

30.97

6.9

3.8

0.81

1.83

mmol/l

3.00

163

697

Dental pulpitis, including avohilmo

3151

16147

1.26

30.87

3.0

3.5

1.54

1.62

mmol/l

0.61

2271

11811

Vasomotor and allergic rhinitis

1289

8980

1.43

30.60

3.5

4.3

1.32

1.61

mmol/l

2.55

932

6508

Schizoaffective disorder

278

1334

2.18

30.40

3.6

3.1

2.91

1.55

mmol/l

5.78

228

1000

Unspecified nephritic syndrome

133

461

3.23

30.26

8.7

3.0

0.86

1.87

mmol/l

2.32

337

Abnormal findings on examination of blood, without diagnosis

1970

13605

1.34

30.25

4.7

3.8

1.79

1.68

mmol/l

0.62

1455

9975

Pure hyperglyceridaemia

129

438

3.26

30.22

4.6

3.6

1.24

1.89

mmol/l

1.14

336

Other/unspecified rheumatoid arthritis

490

2845

1.79

30.13

4.2

3.5

2.21

2.06

mmol/l

0.35

362

2130

Zoster [herpes zoster], including avohilmo

1964

14488

1.33

29.82

4.0

3.5

1.62

1.86

mmol/l

1.97

1450

10707

Nonorganic sleeping disorders

739

4753

1.59

29.81

4.3

3.8

1.59

1.58

mmol/l

0.02

546

3431

Hyperosmolality and hypernatraemia

286

3.94

29.75

4.9

4.0

2.20

2.15

mmol/l

0.04

227

SLE (Finngen)

151

560

2.89

29.68

5.5

3.4

1.54

1.88

mmol/l

0.38

119

422

Follow-up examination after treatment for malignant neoplasms

369

1970

1.94

29.67

3.8

3.2

2.07

2.48

mmol/l

1.27

264

1452

Hidradenitis suppurativa

156

588

2.83

29.60

3.3

3.4

1.82

1.50

mmol/l

0.41

120

415

Septal defects

415

2290

1.92

29.44

9.9

8.2

1.78

0.97

mmol/l

7.49

342

1677

Simple and mucopurulent chronic bronchitis

207

899

2.47

29.37

7.9

5.8

2.16

1.59

mmol/l

2.00

166

645

Left ventricular outflow tract obstruction (LVOTO), broad definition

439

2494

1.85

29.35

6.6

4.8

1.69

1.56

mmol/l

0.33

341

1880

Inflammatory diseases of prostate (prostatitis)

551

3332

1.72

29.23

3.5

1.55

1.68

mmol/l

0.40

408

2413

Other diseases of lip and oral mucosa

1507

11143

1.38

28.97

4.0

3.7

1.58

1.78

mmol/l

1.57

1153

8282

Restless leg syndrome

543

3278

1.72

28.79

3.1

3.6

1.59

1.94

mmol/l

1.58

407

2448

Other enthesopathies

969

6637

1.49

28.79

3.3

1.38

1.85

mmol/l

4.22

716

4891

Crohn's disease NAS

271

1321

2.16

28.67

4.2

3.8

1.28

1.56

mmol/l

0.48

199

981

Disorders of ocular muscles, binocular movement, accommodation and refraction

1738

13028

1.34

28.53

5.7

4.0

1.51

1.57

mmol/l

0.27

1268

9492

Personal history of certain other diseases

261

3.84

28.49

3.1

3.4

1.04

1.14

mmol/l

0.09

179

Orchitis and epididymitis

407

2280

1.87

28.41

4.2

3.7

1.87

1.71

mmol/l

0.37

292

1641

Paralytic ileus

188

797

2.54

28.25

5.5

3.7

1.59

2.07

mmol/l

0.71

138

580

Disorders of oesophagus in diseases classified elsewhere

125

435

3.20

28.20

4.4

3.8

1.91

2.24

mmol/l

0.47

101

320

Postmenopausal osteoporosis with pathological fracture

271

1335

2.15

27.99

4.4

3.4

2.69

2.31

mmol/l

0.76

215

1024

Cervicalgia

730

4752

1.57

27.98

3.4

1.70

1.89

mmol/l

0.77

523

3507

Fall on and from stairs and steps

990

6863

1.48

27.98

3.8

3.6

1.54

1.80

mmol/l

1.32

731

5061

5-aminosalicylic acid

672

4294

1.60

27.84

4.7

3.0

1.55

1.57

mmol/l

0.06

497

3089

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

231

1080

2.29

27.59

5.0

3.4

2.27

2.06

mmol/l

0.33

172

774

Other diseases of arteries and capillaries

375

2068

1.90

27.57

5.7

3.6

1.28

1.88

mmol/l

2.24

281

1504

Gingival hyperplasia

233

1104

2.32

27.51

19.4

5.5

1.10

1.54

mmol/l

1.23

177

813

Calculus of kidney and ureter

1185

8518

1.42

27.47

3.8

3.7

1.51

1.71

mmol/l

1.13

840

6194

Deviated nasal septum

1193

8563

1.42

27.45

3.3

3.5

1.50

1.71

mmol/l

1.31

872

6248

Cardiodefibrillation

1463

10866

1.37

27.25

3.9

3.7

2.15

1.81

mmol/l

3.08

1073

8007

Drug-induced hypoglycaemia without coma

107

349

3.47

27.19

5.4

3.6

1.40

1.77

mmol/l

0.49

258

Congenital iodine-deficiency syndrome/hypothyroidism

147

566

2.83

27.18

3.7

3.9

1.67

2.01

mmol/l

0.39

109

418

Other renal tubulo-interstitial diseases

109

355

3.33

27.15

8.7

2.6

1.12

2.10

mmol/l

1.97

271

Dyshidrosis [pompholyx]

258

3.83

26.93

3.8

2.9

0.75

1.61

mmol/l

0.94

182

Disorders of sclera, cornea, iris and ciliary body

1963

15225

1.31

26.87

4.0

3.5

1.74

1.73

mmol/l

0.03

1403

11219

Abnormal involuntary movements

536

3286

1.69

26.87

4.0

3.9

1.89

1.71

mmol/l

0.52

396

2443

Pneumonia derived septicemia

189

825

2.49

26.84

10.3

4.2

1.92

1.59

mmol/l

0.62

147

609

Enthesopathies of lower limb, excluding foot

759

5026

1.54

26.82

3.3

3.4

1.39

1.78

mmol/l

2.43

548

3719

Benign intracranial hypertension

151

4.91

26.82

4.3

3.7

-0.54

0.82

mmol/l

0.83

107

Disorders of muscles

385

2154

1.85

26.77

3.9

3.7

1.93

1.81

mmol/l

0.25

288

1587

Fracture of skull and facial bones

777

5178

1.54

26.77

4.4

3.6

1.53

1.65

mmol/l

0.36

571

3802

Social phobias

275

1373

2.07

26.76

3.7

3.2

1.16

1.33

mmol/l

0.37

216

984

Malignant neoplasm of digestive organs

1467

8321

1.37

26.72

3.5

2.02

1.88

mmol/l

0.59

1040

6144

Respiratory disorders in diseases classified elsewhere

282

3.80

26.72

6.6

3.6

1.84

2.00

mmol/l

0.17

211

Asthma and opportunity respiratory infection

217

1003

2.32

26.70

6.8

3.7

2.16

1.92

mmol/l

0.47

174

737

Somnolence, stupor and coma

202

905

2.38

26.64

5.4

4.0

2.66

1.70

mmol/l

2.64

148

661

Dislocation, sprain and strain of joints and ligaments at neck level

502

3023

1.71

26.64

2.9

3.3

1.62

1.61

mmol/l

0.04

369

2209

Complications of cardiac and vascular prosthetic devices, implants and grafts

129

473

3.05

26.59

6.1

3.9

1.78

2.19

mmol/l

0.44

101

343

Ulcerative colitis, NAS

498

2999

1.71

26.58

5.3

3.6

1.34

1.68

mmol/l

1.34

366

2222

severe traumatic brain injury, does not include concussion

933

6487

1.48

26.20

3.9

3.6

1.93

1.86

mmol/l

0.20

682

4727

Event of undetermined intent

268

1346

2.09

26.15

3.6

1.39

1.61

mmol/l

0.34

203

970

Spontaneous rupture of synovium and tendon

327

1756

1.94

26.12

3.5

3.6

1.69

1.93

mmol/l

0.57

253

1294

Certain conditions originating in the perinatal period

438

2276

1.79

26.03

10.5

6.1

1.08

0.95

mmol/l

0.32

315

1591

Other disorders of electrolyte and fluid balance, not elsewhere classified

152

4.91

25.89

3.9

3.3

3.69

1.92

mmol/l

1.30

121

Acute posthaemorrhagic anaemia

171

723

2.54

25.88

7.1

3.6

1.64

2.07

mmol/l

0.60

129

534

Autism spe, excluding more controls

123

440

3.00

25.86

3.5

5.4

0.97

1.06

mmol/l

0.10

292

Generalized skin eruption due to drugs and medicaments

188

830

2.43

25.82

6.3

4.2

1.76

1.83

mmol/l

0.09

144

615

Spinal instabilities

131

488

2.90

25.73

3.0

3.6

1.74

1.89

mmol/l

0.15

105

368

Obsessive-compulsive disorder

227

1072

2.20

25.72

3.2

3.8

1.13

1.38

mmol/l

0.57

151

764

Spondylolisthesis/Spondylolysis

633

4077

1.59

25.58

3.3

3.5

1.76

1.91

mmol/l

0.57

466

3055

Microscopic polyangiitis

136

5.59

25.53

11.8

3.9

0.87

1.86

mmol/l

1.42

105

Disorders of plasma-protein metabolism, not elsewhere classified

126

5.48

25.46

4.1

2.9

2.46

1.86

mmol/l

0.54

Otitis externa, unspecified

443

2621

1.75

25.44

5.8

3.9

1.17

1.65

mmol/l

2.53

337

1949

Abscess of anal and rectal regions

318

1706

1.94

25.37

4.3

3.7

1.31

1.74

mmol/l

1.10

234

1248

ILD medications: nintedanib

100

6.39

25.36

4.5

3.6

2.22

2.15

mmol/l

0.05

Lesion of ulnar nerve

500

3054

1.69

25.32

3.9

3.3

2.03

1.78

mmol/l

0.76

358

2250

Other diseases of pancreas

349

1936

1.89

25.31

4.1

3.7

1.74

1.90

mmol/l

0.28

246

1449

Superficial injury of thorax

580

3678

1.63

25.22

3.8

3.6

2.04

1.77

mmol/l

1.03

419

2697

Amyloidosis, other/unspecified

109

375

3.24

25.16

5.9

3.5

1.32

2.15

mmol/l

1.60

296

Fitting and adjustment of external prosthetic device

9.83

25.14

6.4

3.5

1.65

2.39

mmol/l

0.74

Corticotropin deficiency

161

4.80

25.11

5.6

4.4

2.57

1.65

mmol/l

1.48

125

Wide developmental disorders, excluding more controls

195

864

2.37

25.08

5.7

7.2

0.89

0.98

mmol/l

0.14

130

611

Late syphilis

268

3.76

25.07

7.6

3.2

1.18

2.02

mmol/l

1.18

197

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

228

3.95

25.01

4.1

3.3

1.88

1.45

mmol/l

0.36

166

Chronic sinusitis

1380

10277

1.36

24.99

3.4

1.56

1.80

mmol/l

1.66

1021

7527

Stomatitis and related lesions

734

4919

1.53

24.76

4.3

4.1

1.54

1.65

mmol/l

0.36

539

3623

Alcohol-induced chronic pancreatitis

277

1440

2.03

24.73

4.2

3.5

1.59

1.73

mmol/l

0.18

203

1079

Colonic or urogenital fistula

947

6663

1.45

24.73

3.3

3.4

1.59

1.77

mmol/l

0.82

695

4893

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1728

8929

1.33

24.71

3.8

3.4

1.73

1.88

mmol/l

0.89

1265

6609

Unspecified chronic bronchitis

157

651

2.57

24.62

4.7

3.4

1.51

1.64

mmol/l

0.19

128

461

Asthma mixed form (mode), excluding more controls

156

640

2.53

24.60

3.6

2.7

2.52

0.98

mmol/l

6.71

105

432

Arterial embolism and thrombosis

269

1386

2.05

24.58

4.6

3.6

2.01

1.97

mmol/l

0.06

185

1008

ILD and respiratory illness in diseases classified elsewhere

6.47

24.56

7.7

3.1

2.30

2.47

mmol/l

0.12

Ulcerative colitis

836

5753

1.49

24.53

4.6

3.4

1.65

1.67

mmol/l

0.06

611

4211

Benign paroxysmal vertigo

1068

7689

1.42

24.50

3.4

3.5

1.69

2.00

mmol/l

2.09

796

5760

Periapical abscess

1639

12575

1.32

24.47

3.3

3.6

1.76

1.65

mmol/l

0.59

1195

9262

Drug-induced osteoporosis

268

3.72

24.39

5.1

3.4

1.75

1.89

mmol/l

0.12

200

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1669

8656

1.33

24.30

3.7

3.5

1.72

1.89

mmol/l

1.07

1228

6401

Unspecified contracted kidney

120

5.65

24.23

9.1

4.3

0.65

1.60

mmol/l

0.84

Benign neoplasm: Sigmoid colon

750

5081

1.52

24.22

4.3

3.5

1.21

1.90

mmol/l

5.57

590

3746

Malignant neoplasm of skin, including Hilmo

1861

9662

1.31

24.22

3.7

3.4

1.70

1.85

mmol/l

0.98

1377

7133

Allergic rhinitis

1035

7320

1.42

24.16

3.5

4.7

1.18

1.43

mmol/l

1.76

738

5279

Injuries to unspecified part of trunk, limb or body region

421

2496

1.75

24.14

4.2

4.1

1.85

1.75

mmol/l

0.20

309

1819

Nonhereditary hypogammaglobulinemia

192

4.26

24.14

7.4

3.5

1.90

1.71

mmol/l

0.13

142

Aortic valve malfunction, age under 60 years

371

2126

1.82

24.09

5.5

4.1

1.71

1.64

mmol/l

0.12

285

1611

Explicit fungal Sepsis, including avohilmo

132

5.21

24.07

9.5

2.6

1.89

1.53

mmol/l

0.25

Fall on same level involving ice and snow

2078

16447

1.28

24.07

3.5

1.70

1.76

mmol/l

0.36

1515

12084

Toxic effects of substances chiefly nonmedicinal as to source

425

2526

1.74

24.00

3.8

3.9

1.28

1.68

mmol/l

1.19

308

1858

Superficial injury of shoulder and upper arm

453

2738

1.71

23.97

3.6

3.7

2.04

1.77

mmol/l

0.84

331

2021

Other bursopathies

476

2915

1.68

23.90

4.3

3.5

2.05

1.94

mmol/l

0.28

386

2171

Malignant neoplasm of skin

1786

9341

1.31

23.88

3.7

3.4

1.64

1.86

mmol/l

1.60

1319

6908

Primary biliary cholangitis, wide definition

111

395

3.06

23.86

6.6

3.5

1.19

1.85

mmol/l

0.81

298

Osteonecrosis

265

1373

2.04

23.84

4.8

3.4

1.87

1.89

mmol/l

0.02

205

1027

Spondyloarthritis

620

4037

1.57

23.84

3.9

3.3

2.00

1.76

mmol/l

0.84

450

2941

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

252

1274

2.05

23.84

3.5

3.1

1.33

1.64

mmol/l

0.69

189

937

Benign neoplasm: Transverse colon

455

2768

1.71

23.83

4.5

3.7

1.31

1.88

mmol/l

2.55

349

2055

Oter anti-inflammatory and antirheumatic agents, non-steroids

870

3271

1.49

23.83

3.1

4.1

1.77

1.86

mmol/l

0.28

654

2382

Subjective visual disturbances

889

6226

1.46

23.82

3.3

3.4

1.37

1.84

mmol/l

3.45

641

4605

Personal history of risk-factors, not elsewhere classified

266

3.62

23.73

4.2

3.4

1.31

1.32

mmol/l

0.01

201

Non-small cell lung cancer, adenocarcinoma, helper endpoint

307

1677

1.94

23.69

4.5

3.6

2.49

1.92

mmol/l

1.81

251

1227

Personal history of other diseases and conditions

437

2616

1.72

23.55

8.8

4.0

1.11

1.20

mmol/l

0.18

313

1857

Olecranon bursitis

269

1407

2.01

23.52

4.5

3.5

1.86

1.74

mmol/l

0.22

209

1028

Primary coxarthrosis, bilateral

1134

8313

1.40

23.48

3.5

3.6

2.00

1.97

mmol/l

0.09

842

6182

Redundant prepuce, phimosis and paraphimosis

785

5300

1.49

23.47

4.1

3.7

1.74

1.52

mmol/l

0.90

564

3836

Late syphilis, including avohilmo

331

3.32

23.44

7.9

3.1

0.94

1.90

mmol/l

1.46

247

Eosinophilic disease (BM)

185

4.08

23.27

4.4

2.6

2.16

0.96

mmol/l

2.36

130

Seborrhoeic dermatitis

403

2388

1.75

23.17

5.1

3.8

1.53

1.78

mmol/l

0.68

315

1755

Neuralgia and neuritis, unspecified

198

929

2.24

23.15

3.8

3.4

1.70

1.87

mmol/l

0.30

145

688

Type1 diabetes, definitions combined, early onset

311

1708

1.91

23.15

3.8

6.5

0.77

1.08

mmol/l

0.58

196

1244

Infections with a predominantly sexual mode of transmission, including avohilmo

1081

7164

1.40

23.12

3.7

3.0

1.18

1.46

mmol/l

1.92

789

5026

Pneumococcal septicemia

182

835

2.36

23.09

9.5

4.6

1.95

1.69

mmol/l

0.43

142

612

Other diseases of biliary tract

353

2020

1.82

23.02

5.0

3.9

1.82

1.96

mmol/l

0.24

241

1500

Other diseases of blood and blood-forming organs

284

1527

1.95

22.83

3.7

3.5

2.50

1.85

mmol/l

1.87

202

1133

Other hearing loss

1109

7868

1.39

22.82

3.5

3.8

2.29

2.00

mmol/l

1.74

782

5839

Thoracic aortic aneurysm

594

3887

1.58

22.81

3.8

3.4

1.82

1.76

mmol/l

0.14

453

2841

Systemic lupus erythematosus

151

639

2.52

22.77

5.5

3.5

1.54

1.87

mmol/l

0.37

119

480

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

306

1692

1.89

22.46

4.3

3.6

1.71

1.90

mmol/l

0.35

215

1252

Gingivitis and periodontal diseases

3758

16288

1.20

22.43

4.1

3.7

1.49

1.81

mmol/l

5.90

2732

11971

Postmenopausal bleeding

776

2742

1.51

22.42

3.3

3.2

2.16

2.20

mmol/l

0.09

600

2086

Previous suicide attempt

202

4.00

22.39

3.3

4.3

1.35

1.56

mmol/l

0.17

153

Special screening examination for neoplasms

235

1189

2.06

22.33

5.3

3.1

0.88

2.15

mmol/l

7.33

174

880

Other and unspecified injuries of lower leg

288

1562

1.92

22.29

3.7

3.8

1.47

1.57

mmol/l

0.16

204

1145

Polyarteritis nodosa and related conditions

305

3.38

22.21

4.9

4.2

1.83

1.69

mmol/l

0.12

218

Explicit fungal Sepsis

132

4.99

22.20

9.8

2.6

1.94

1.53

mmol/l

0.27

Pneumonia due to Haemophilus influenzae

7.41

22.07

10.0

2.7

3.63

0.82

mmol/l

3.09

Myocardial infarction, unclassifiable

944

6049

1.43

22.02

5.0

3.6

2.10

1.92

mmol/l

0.65

712

4371

Benign neoplasm: Adrenal gland

313

1758

1.87

21.90

4.4

3.5

2.65

1.90

mmol/l

2.95

242

1325

Other noninflammatory disorders of uterus, except cervix

625

2734

1.56

21.79

3.5

3.2

2.11

2.19

mmol/l

0.19

491

2071

Allergic urticaria

316

1780

1.85

21.71

6.7

4.5

1.73

1.55

mmol/l

0.45

231

1318

Acute gastritis

277

1499

1.93

21.67

4.6

3.5

2.20

2.02

mmol/l

0.30

208

1085

Atopic dermatitis, strict definition

961

6772

1.41

21.67

5.3

4.8

1.13

1.33

mmol/l

0.96

698

4830

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1020

7435

1.40

21.64

3.0

3.4

1.82

1.67

mmol/l

0.69

744

5454

Pre-eclampsia

494

3118

1.62

21.63

3.2

2.8

1.65

1.63

mmol/l

0.05

360

2272

Trigger finger

479

3009

1.63

21.62

3.4

3.5

1.47

1.90

mmol/l

1.98

342

2255

Thyrotoxicosis, other and/or unspecified

629

4196

1.53

21.61

3.5

3.4

1.90

1.86

mmol/l

0.08

455

3104

Mental retardation

298

1668

1.94

21.60

13.6

8.6

1.68

1.03

mmol/l

2.65

242

1225

SLE, ICD10

143

607

2.52

21.48

5.6

3.4

1.48

1.86

mmol/l

0.43

114

453

SLE, strict definition

143

607

2.52

21.48

5.6

3.4

1.48

1.86

mmol/l

0.43

114

453

Abnormal findings on diagnostic imaging of central nervous system

202

986

2.16

21.45

4.8

3.7

1.73

1.61

mmol/l

0.20

139

724

Diseases of salivary glands

1101

8136

1.38

21.44

3.9

3.5

1.76

1.77

mmol/l

0.05

836

6005

Paraplegia, diplegia of upper limbs

119

467

2.80

21.43

7.3

4.0

2.41

1.88

mmol/l

0.76

352

Pollen allergy

675

4514

1.51

21.41

3.5

5.7

0.87

1.26

mmol/l

2.68

473

3245

Other disorders of white blood cells

230

1181

2.06

21.34

7.1

4.1

2.34

1.76

mmol/l

1.51

173

877

Sicca syndrome [Sjögren]

294

1629

1.88

21.32

3.9

3.4

1.78

2.05

mmol/l

0.65

221

1248

Adhesive capsulitis of shoulder

563

3684

1.57

21.30

4.0

3.4

1.67

1.93

mmol/l

0.98

415

2746

Diffuse brain injury

112

421

2.78

21.26

4.7

3.8

1.47

1.86

mmol/l

0.59

301

Discitis, unspecified

350

3.11

21.21

5.1

3.8

2.23

2.24

mmol/l

0.01

266

Other specified disorders of kidney and ureter

158

708

2.40

21.14

8.6

3.5

1.00

1.94

mmol/l

2.07

118

529

Cardiomyopathy, other and unspecified

273

1482

1.92

21.13

4.4

3.1

2.29

1.57

mmol/l

1.67

199

1065

Nail disorders

320

1827

1.82

21.02

4.9

3.8

1.47

1.68

mmol/l

0.48

237

1356

Acquired haemolytic anaemia

136

576

2.59

20.93

7.4

4.4

1.49

1.88

mmol/l

0.51

108

418

Amputation of thigh

160

725

2.38

20.88

6.8

3.8

1.27

1.95

mmol/l

1.15

133

523

Oesophagitis

221

1126

2.06

20.88

4.8

3.7

2.05

1.93

mmol/l

0.15

173

808

Appendectomy

2064

15785

1.26

20.85

3.3

1.72

1.67

mmol/l

0.29

1495

11553

Coronary artery bypass grafting

1013

5477

1.40

20.82

4.1

3.5

1.60

1.79

mmol/l

0.72

708

4004

Asthma mixed form (mode)

156

691

2.34

20.80

3.6

2.8

2.52

0.99

mmol/l

6.63

105

467

Lung transplant status

187

4.22

20.72

12.9

4.3

1.73

1.72

mmol/l

0.01

141

Specific development disorders of speech and language

336

1893

1.81

20.72

10.9

7.2

1.04

1.14

mmol/l

0.22

255

1375

Vertigo of central origin

339

3.12

20.66

3.4

3.6

0.94

2.18

mmol/l

1.95

255

Viral warts

373

2233

1.73

20.62

8.6

4.0

1.31

1.63

mmol/l

0.91

265

1633

Salpingitis and oophoritis

484

3081

1.61

20.61

3.6

3.2

2.05

1.99

mmol/l

0.13

371

2360

Lung transplantation

188

4.19

20.55

12.9

4.3

1.73

1.71

mmol/l

0.01

142

Mental retardation, wide definition

303

1731

1.89

20.46

13.5

8.5

1.68

1.09

mmol/l

2.23

246

1274

Acute generalized exanthematous pustulosis

195

959

2.15

20.45

6.1

4.2

1.74

1.85

mmol/l

0.16

150

716

Sudden idiopathic hearing loss

379

2288

1.72

20.37

3.7

2.12

1.95

mmol/l

0.37

284

1710

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

935

6784

1.40

20.35

3.2

3.5

1.44

1.58

mmol/l

0.60

668

4957

Basal cell carcinoma, including Hilmo

1645

8707

1.30

20.26

3.6

3.4

1.69

1.88

mmol/l

1.27

1210

6430

Other peripheral vertigo

351

2087

1.75

20.03

2.9

3.6

1.66

2.01

mmol/l

1.19

266

1559

Other symptoms and signs involving general sensations and perceptions

191

940

2.15

20.01

4.5

4.3

2.07

1.80

mmol/l

0.41

143

693

Pre-eclampsia or eclampsia

527

3438

1.56

20.01

3.3

2.8

1.68

1.69

mmol/l

0.02

387

2522

Scabies

199

993

2.11

19.99

4.2

3.9

1.60

1.50

mmol/l

0.14

148

734

Monoamine oxidase A inhibitors

367

2202

1.72

19.97

3.4

1.86

mmol/l

0.00

274

1618

Superficial injury of ankle and foot

444

2796

1.63

19.95

3.9

4.3

1.43

1.53

mmol/l

0.21

310

2069

Recurrent dislocation and subluxation of joint

211

1070

2.04

19.88

3.6

3.2

1.33

1.63

mmol/l

0.59

155

795

Inflammatory disease of uterus

353

2094

1.72

19.85

3.2

2.9

1.44

1.70

mmol/l

0.68

260

1498

Abnormal findings on diagnostic imaging of other body structures

491

3170

1.59

19.85

4.1

3.5

2.08

1.77

mmol/l

1.03

368

2335

Behavioural syndromes associated with physiological disturbances and physical factors

3319

18920

1.20

19.82

3.4

3.7

1.59

1.71

mmol/l

1.38

2409

13847

Vitamin B12 deficiency anaemia

403

2488

1.68

19.82

3.6

3.5

1.52

1.99

mmol/l

1.49

268

1803

Poisoning by narcotics and psychodysleptics [hallucinogens]

242

3.41

19.82

4.0

1.83

1.27

mmol/l

0.80

179

Other inflammatory liver diseases

252

1367

1.93

19.72

4.4

3.5

1.81

1.86

mmol/l

0.07

188

1020

Bulimia nervosa (incl. atypical)

101

375

2.81

19.67

3.0

3.1

1.07

1.04

mmol/l

0.02

257

Noninflammatory disorders of female genital tract

1090

4012

1.38

19.66

3.9

3.2

1.36

1.79

mmol/l

3.21

808

2874

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

531

3486

1.55

19.57

3.5

2.9

1.30

1.37

mmol/l

0.18

382

2440

Thyroiditis, ILD-related definition

377

2292

1.69

19.54

3.8

3.5

1.57

1.73

mmol/l

0.36

283

1697

Primary adrenocortical insufficiency

196

3.81

19.53

5.2

3.8

1.74

1.44

mmol/l

0.23

150

ILD medications: pirfenidone

223

3.69

19.49

4.5

3.2

2.36

1.93

mmol/l

0.51

170

Secondary polycythaemia

124

521

2.59

19.33

3.9

3.5

2.94

1.80

mmol/l

2.22

382

Folate deficiency anaemia

229

3.61

19.31

4.0

3.0

2.66

2.04

mmol/l

0.62

169

Benign neoplasm: Caecum

434

2752

1.64

19.30

4.6

3.6

1.32

1.96

mmol/l

2.88

335

2039

Allergic contact dermatitis

415

2590

1.64

19.29

3.3

3.5

1.59

1.79

mmol/l

0.46

294

1892

Disorders of myoneural junction and muscle in diseases classified elsewhere

137

4.49

19.29

8.7

3.2

1.73

1.88

mmol/l

0.10

106

Other abnormalities of plasma proteins

376

2.95

19.28

5.3

3.9

2.51

1.93

mmol/l

0.81

274

Mixed disorders of conduct and emotions, excluding more controls

353

2.89

19.28

6.7

5.3

1.41

1.11

mmol/l

0.47

245

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

120

505

2.69

19.17

6.8

5.8

1.53

1.47

mmol/l

0.08

374

Basal cell carcinoma

1584

8469

1.29

19.10

3.6

3.5

1.69

1.89

mmol/l

1.39

1163

6257

Molar incisor enamel hypoplasia

306

1727

1.85

19.01

23.3

7.3

0.95

0.87

mmol/l

0.21

243

1229

Other/unspecified synovitis and tenosynovitis

375

2294

1.68

18.96

3.5

3.4

1.47

1.87

mmol/l

1.43

285

1687

Other disorders of optic [2nd] nerve and visual pathways

279

1586

1.85

18.91

6.1

4.9

1.42

1.61

mmol/l

0.40

198

1171

Atypical mycobacterium lung infection

242

3.46

18.86

5.4

3.6

1.99

1.89

mmol/l

0.07

185

5.67

18.86

6.6

3.1

2.25

2.39

mmol/l

0.09

Inflammatory diseases of the central nervous system

310

1812

1.78

18.82

4.5

3.8

1.64

1.71

mmol/l

0.13

240

1341

Impotence

248

1363

1.91

18.80

3.8

3.5

1.51

1.79

mmol/l

0.59

185

990

Vascular diseases of the intestine

179

881

2.16

18.80

4.5

3.4

1.44

2.04

mmol/l

1.25

130

652

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

871

6343

1.40

18.79

4.4

3.4

2.23

1.92

mmol/l

1.88

650

4743

Sequelae of injuries of head

208

1077

2.03

18.79

4.3

3.8

1.37

1.65

mmol/l

0.54

155

807

Keratitis

1215

9292

1.33

18.74

4.2

3.5

1.70

1.75

mmol/l

0.16

870

6866

Excessive vomiting in pregnancy

211

1092

1.99

18.71

2.4

2.7

1.22

1.57

mmol/l

0.78

143

794

Faecal incontinence

307

1790

1.77

18.67

4.1

3.3

1.55

2.18

mmol/l

2.40

236

1377

Dermatophytosis

524

3484

1.55

18.67

4.7

3.6

1.85

1.77

mmol/l

0.18

393

2561

Behavioural disorders, excluding more controls

365

2.84

18.64

3.9

5.1

1.12

1.30

mmol/l

0.17

258

Vitamin D deficiency

339

2.94

18.62

5.3

3.8

1.56

1.43

mmol/l

0.09

249

Dementia, including avohilmo

1890

10366

1.26

18.62

3.1

3.8

2.01

1.95

mmol/l

0.23

1333

7746

Acute myeloid leukaemia and myelodysplastic syndromes

120

505

2.57

18.60

5.9

3.8

1.55

1.95

mmol/l

0.50

360

Lupus nephritis

6.71

18.60

6.4

3.6

-0.34

1.39

mmol/l

1.80

Background retinopathy and retinal vascular changes

108

433

2.71

18.60

5.0

3.7

0.86

1.94

mmol/l

2.37

327

Seropositive rheumatoid arthritis, wide

896

6567

1.39

18.57

4.4

3.4

2.23

1.92

mmol/l

1.94

669

4914

Crohn's disease of large intestine

191

964

2.08

18.52

4.0

3.5

1.25

1.59

mmol/l

0.55

142

712

Nontraumatic intracranial haemmorrhage

764

5460

1.43

18.51

4.2

3.5

1.96

2.00

mmol/l

0.09

533

4013

Haemolytic anaemias

175

864

2.17

18.43

7.0

4.7

1.54

1.74

mmol/l

0.27

137

620

Systemic lupus erythematosus, unspecified

123

524

2.51

18.41

4.8

3.4

1.58

1.82

mmol/l

0.22

393

Psoriatic and enteropathic arthropathies

366

2243

1.68

18.38

3.2

3.1

1.91

1.82

mmol/l

0.15

264

1654

Nosocomial condition (hospital)

116

4.85

18.37

5.4

3.6

1.70

1.93

mmol/l

0.18

Ingrowing nail

211

1107

2.00

18.34

4.3

3.7

1.60

mmol/l

0.01

154

825

Abdominal aortic aneurysm (AAA)

435

2769

1.61

18.28

4.7

3.5

2.00

1.93

mmol/l

0.12

308

1978

Other/unspecified seropositive rheumatoid arthritis

885

6491

1.39

18.28

4.4

3.4

2.23

1.92

mmol/l

1.92

660

4856

Disease of hard tissues of teeth, NOS

1889

7914

1.26

18.26

3.0

3.6

1.51

1.96

mmol/l

6.86

1399

5857

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

475

3093

1.58

18.23

7.5

6.6

1.44

1.22

mmol/l

0.82

356

2265

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

521

3443

1.54

18.19

4.1

3.6

1.92

2.09

mmol/l

0.46

382

2510

Postprocedural endocrine and metabolic disorders, not elsewhere classified

355

2163

1.68

18.16

3.9

3.2

2.04

1.76

mmol/l

0.85

266

1635

Other benign neoplasms of skin

1309

10163

1.31

18.12

3.8

3.5

1.61

1.88

mmol/l

1.79

939

7549

Specific development disorders of scholastic skills

242

1312

1.92

18.08

8.4

5.5

0.95

1.01

mmol/l

0.10

161

931

Viral infections of the central nervous system

252

1403

1.87

18.08

4.3

3.6

1.99

1.62

mmol/l

0.83

185

1043

Ovarian dysfunction

191

966

2.03

18.07

3.5

2.5

1.15

1.19

mmol/l

0.06

133

665

Osteonecrosis due to drugs

337

3.00

18.06

4.2

3.9

1.97

2.08

mmol/l

0.09

260

Bitten or struck by other mammals

380

2363

1.65

18.04

4.2

3.9

1.33

1.55

mmol/l

0.64

286

1742

Adult respiratory distress syndrome

281

3.20

18.03

7.1

3.1

2.88

2.07

mmol/l

1.19

213

Colorectal cancer, including Hilmo

973

6760

1.37

17.93

3.6

3.4

1.97

1.91

mmol/l

0.17

707

4959

Carrier of infectious disease

114

476

2.57

17.90

6.6

3.4

1.91

1.81

mmol/l

0.11

348

Scabies, including avohilmo

503

3338

1.54

17.90

4.5

4.1

1.41

1.46

mmol/l

0.11

367

2417

Other specified/unspecified systemic involvement of connective tissue

201

1047

2.00

17.80

4.8

3.3

1.87

1.91

mmol/l

0.06

157

782

Squamous cell neoplasms and carcinomas of the skin

423

2714

1.61

17.80

4.2

3.6

1.90

2.11

mmol/l

0.49

316

1961

Disorders of conjunctiva

2944

19242

1.20

17.75

4.2

3.9

1.55

1.67

mmol/l

1.14

2177

14019

Persistent delusional disorders

270

1544

1.82

17.72

3.3

3.4

2.52

1.79

mmol/l

1.98

214

1146

Ulcer of oesophagus

268

1534

1.82

17.66

4.8

3.6

2.15

1.94

mmol/l

0.36

196

1095

Infective dermatitis

413

2638

1.61

17.65

3.6

1.71

1.82

mmol/l

0.19

305

1945

Diseases of spleen

375

2.81

17.54

4.8

3.8

1.85

1.70

mmol/l

0.16

290

Pediculosis, acariasis and other infestations

233

1282

1.90

17.48

4.2

3.8

1.66

1.53

mmol/l

0.20

174

958

Pediculosis, acariasis and other infestations, including avohilmo

593

4091

1.48

17.40

4.4

4.1

1.52

1.49

mmol/l

0.06

429

2974

Dermatophytosis, including avohilmo

2270

18416

1.22

17.39

3.5

1.69

1.67

mmol/l

0.10

1706

13438

Secondary malignant neoplasm of other and unspecified sites

395

2.76

17.37

2.7

3.6

2.73

2.23

mmol/l

0.46

293

Hypoplasia of dental enamel , including avohilmo

284

1621

1.84

17.35

22.4

7.0

0.95

0.86

mmol/l

0.19

224

1150

Disorders of optic nerve and visual pathways

348

2144

1.68

17.34

5.5

4.5

1.50

1.63

mmol/l

0.27

250

1578

Rare circulating lymphoid malignancy, including Hilmo

162

798

2.19

17.32

5.6

6.7

1.67

1.54

mmol/l

0.19

132

589

Crohn's disease of small intestine

239

1327

1.87

17.30

3.7

3.4

1.44

1.64

mmol/l

0.33

167

986

Mental disorders, not otherwise specified

248

1391

1.84

17.23

3.2

3.1

1.81

1.47

mmol/l

0.67

170

1033

Fracture at wrist and hand level

1161

8900

1.32

17.20

3.2

3.7

1.66

1.65

mmol/l

0.04

848

6517

Myelodysplastic syndrome, including Hilmo

145

684

2.27

17.17

5.6

3.5

1.51

1.95

mmol/l

0.57

106

487

Postprocedural disorders of digestive system, not elsewhere classified

156

757

2.20

17.16

13.8

4.5

1.60

1.85

mmol/l

0.27

106

562

Other infective otitis externa

235

1305

1.88

17.14

5.0

3.8

1.19

1.80

mmol/l

1.92

184

971

Other specified/unspecified soft tissue disorders

178

901

2.06

17.13

4.3

3.5

2.10

2.18

mmol/l

0.09

139

668

Fall involving bed

178

910

2.10

17.11

4.4

4.7

2.50

2.05

mmol/l

0.57

130

671

Anorexia (incl.atypical)

197

1030

1.98

17.10

3.8

1.85

1.30

mmol/l

1.63

145

730

Colorectal cancer

880

6251

1.38

17.06

3.5

3.4

1.98

1.93

mmol/l

0.14

634

4574

Fracture of forearm

1895

13859

1.24

17.04

3.8

3.6

1.84

1.82

mmol/l

0.08

1397

10200

Chronic rhinitis, nasopharyngitis and pharyngitis

1039

7880

1.34

17.00

3.6

3.8

1.52

1.76

mmol/l

1.63

778

5807

Pilonidal cyst

262

1500

1.80

16.97

3.2

1.36

1.41

mmol/l

0.09

201

1090

Other factor of the environment

214

3.41

16.90

4.6

3.0

2.21

1.82

mmol/l

0.30

159

Mental and behavioural disorders due to cannabinoids

377

2.67

16.86

2.8

2.9

2.34

1.10

mmol/l

2.31

274

Complications of genitourinary prosthetic devices, implants and grafts

113

483

2.50

16.85

4.8

3.5

2.19

2.14

mmol/l

0.05

355

Other predominantly sexually transmitted diseases, not elsewhere classified

439

2862

1.56

16.84

3.6

2.9

1.33

1.46

mmol/l

0.39

320

2039

Atrial septal defect

253

1455

1.87

16.84

10.2

7.8

1.81

0.96

mmol/l

6.18

209

1047

Fibroblastic disorders

826

6073

1.39

16.83

4.0

3.6

1.55

1.87

mmol/l

1.51

589

4449

Pneumoconiosis due to asbestos and other mineral fibres

121

537

2.46

16.83

7.3

3.9

2.63

1.91

mmol/l

1.14

383

Ankle and foot

151

3.98

16.75

3.4

3.3

0.98

1.83

mmol/l

0.96

111

Other viral hepatitis, including avohilmo

212

1145

1.92

16.74

3.6

3.3

1.77

1.56

mmol/l

0.37

163

837

Total colectomy

171

865

2.09

16.68

6.7

3.5

0.61

1.76

mmol/l

2.13

121

640

Total colectomy operation

171

865

2.09

16.68

6.7

3.5

0.61

1.76

mmol/l

2.13

121

640

Congenital malformations and deformations of the musculoskeletal system

398

2549

1.61

16.64

8.4

7.2

1.48

1.12

mmol/l

1.46

299

1857

Primary biliary cholangitis (PBC)

353

2.76

16.64

4.3

3.2

0.99

1.87

mmol/l

1.15

275

Wet age-related macular degeneration

724

5041

1.42

16.61

3.5

3.6

2.01

2.17

mmol/l

0.49

501

3735

Evidence of alcohol involvement determined by blood alcohol level

270

3.08

16.60

3.3

2.8

1.85

1.62

mmol/l

0.21

199

Selective deficiency of immunoglobulin G [IgG] subclasses

120

4.45

16.58

9.4

4.5

2.29

1.56

mmol/l

0.71

Alcohol-induced acute pancreatitis

158

780

2.15

16.57

3.6

3.4

1.14

1.67

mmol/l

0.77

109

578

Retinal vascular occlusion

471

3149

1.54

16.49

4.3

3.6

1.67

2.07

mmol/l

1.40

361

2311

IBD patients in KELA-register

712

5128

1.41

16.39

4.4

3.4

1.47

1.60

mmol/l

0.41

517

3751

Osteomyelitis of vertebra

6.75

16.36

7.4

3.3

2.44

2.76

mmol/l

0.14

Mixed specific developmental disorders

217

1132

2.01

16.33

15.6

9.3

0.79

0.84

mmol/l

0.10

161

829

Strabismus

949

7141

1.35

16.30

5.9

4.6

1.52

1.53

mmol/l

0.03

690

5233

Coxarthrosis, primary, with hip surgery

1750

13192

1.25

16.30

3.2

3.6

1.85

1.92

mmol/l

0.33

1275

9866

Excessive earwax

2388

18112

1.21

16.29

3.8

1.70

1.77

mmol/l

0.51

1772

13398

Retinal vascular disorders

477

3205

1.53

16.29

4.3

3.6

1.66

2.06

mmol/l

1.41

365

2348

Benign neoplasm: Rectum, anus and anal canal

752

5488

1.40

16.25

4.1

3.5

1.65

1.91

mmol/l

1.00

566

4059

Problems related to social environment

125

566

2.34

16.24

4.1

3.5

3.47

1.82

mmol/l

3.80

406

Endometriosis of rectovaginal septum and vagina

214

1169

1.89

16.22

3.0

3.1

1.61

2.25

mmol/l

1.38

168

870

Benign neoplasm: Ascending colon

540

3723

1.49

16.22

4.5

3.6

1.48

1.89

mmol/l

1.88

424

2769

Burns and corrosions

491

3316

1.52

16.22

4.0

4.5

1.43

1.55

mmol/l

0.28

358

2444

Intracerebral haemorrhage

506

3444

1.51

16.16

4.0

3.7

1.95

2.00

mmol/l

0.10

355

2515

Pain in thoracic spine

466

3110

1.53

16.13

3.3

3.4

1.88

1.81

mmol/l

0.17

345

2282

Testicular dysfunction

163

820

2.09

16.12

3.2

3.1

1.44

1.52

mmol/l

0.13

120

606

Chronic viral hepatitis

168

851

2.05

16.10

3.4

2.8

1.97

1.53

mmol/l

0.77

129

620

Other ulcerative colitis

206

1119

1.92

16.09

5.7

3.5

1.48

1.67

mmol/l

0.33

150

828

Abnormal serum enzyme levels

732

9606

0.72

16.07

4.2

3.8

1.73

1.63

mmol/l

0.32

536

7009

Inflammatory disease of cervix uteri

193

1027

1.95

16.02

3.5

3.3

2.05

2.17

mmol/l

0.19

140

782

Viral infections of the central nervous system, including avohilmo

266

1561

1.76

15.96

4.3

3.8

1.96

1.63

mmol/l

0.78

196

1156

Psoriasis vulgaris

630

4472

1.44

15.94

4.1

3.5

1.95

1.70

mmol/l

0.74

451

3303

Assault by unspecified means

337

2.76

15.93

2.7

3.2

1.69

1.38

mmol/l

0.32

235

Other fall from one level to another

856

6385

1.37

15.93

3.8

4.5

1.39

1.56

mmol/l

0.71

624

4654

Spondylopathies (FG)

396

2562

1.58

15.85

3.6

3.1

1.96

1.74

mmol/l

0.55

284

1864

Acquired absence of organs, not elsewhere classified

223

3.27

15.82

5.1

3.6

1.31

1.97

mmol/l

0.50

167

Chondropathies

491

3334

1.51

15.73

3.6

3.5

1.44

1.67

mmol/l

0.63

368

2464

Sequelae of other external causes

219

1225

1.86

15.63

5.7

3.7

2.09

1.78

mmol/l

0.67

166

901

Flat foot [pes planus] (acquired)

300

1825

1.69

15.62

3.0

3.4

1.51

2.01

mmol/l

1.56

212

1376

Anomalies of dental arch relationship, including avohilmo

684

4456

1.42

15.60

8.2

4.4

1.29

1.37

mmol/l

0.36

497

3229

Heart failure and hypertrophic cardiomyopathy

100

423

2.60

15.59

5.1

3.9

1.62

1.90

mmol/l

0.36

327

Evidence of alcohol involvement determined by level of intoxication

194

3.44

15.52

4.3

3.7

1.67

1.53

mmol/l

0.09

135

Other viral hepatitis

199

1081

1.91

15.48

3.7

3.3

1.87

1.54

mmol/l

0.61

152

792

Benign neoplasm: Rectum

673

4868

1.42

15.42

4.1

3.5

1.71

1.88

mmol/l

0.53

496

3599

Testicular hypofunction

146

718

2.15

15.40

3.4

3.1

1.45

1.54

mmol/l

0.15

106

534

Hyperhidrosis

104

443

2.45

15.39

2.3

3.3

1.31

1.58

mmol/l

0.24

318

Unspecified misadventure during surgical and medical care

227

1294

1.83

15.30

4.8

3.5

1.61

1.87

mmol/l

0.44

179

955

Respiratory conditions due to other external agents

102

438

2.53

15.27

3.5

3.2

3.63

1.89

mmol/l

5.65

333

Open wound of hip and thigh

136

654

2.19

15.22

4.1

3.8

0.59

1.54

mmol/l

2.04

100

483

Chronic diseases of tonsils and adenoids

2573

13686

1.20

15.20

4.2

4.0

1.30

1.67

mmol/l

6.39

1883

10042

Bacterial, viral and other infectious agents, including avohilmo

314

1951

1.66

15.15

7.0

4.4

1.72

1.55

mmol/l

0.35

230

1438

Psoriasis

938

7141

1.34

15.14

4.1

3.4

2.01

1.73

mmol/l

1.33

689

5266

Oligomenorrhoea

104

446

2.43

15.13

3.7

3.2

1.00

1.83

mmol/l

1.65

315

Other endocrine disorders

334

2044

1.67

15.01

14.2

7.7

1.16

1.07

mmol/l

0.16

240

1498

Small fibre neuropathy

142

702

2.17

15.00

4.9

3.9

1.80

1.81

mmol/l

0.01

115

524

Conjunctivitis

2554

17402

1.19

14.99

4.3

3.9

1.55

1.68

mmol/l

1.08

1894

12689

Benign neoplasm: Descending colon

283

1725

1.71

14.97

4.5

3.6

1.55

1.91

mmol/l

0.84

213

1276

Other orthopaedic follow-up care

189

1022

1.92

14.96

3.2

2.6

1.91

1.86

mmol/l

0.07

138

743

Oxicams

818

3425

1.38

14.95

3.5

4.1

1.85

1.81

mmol/l

0.09

593

2483

Bacterial, viral and other infectious agents

292

1790

1.68

14.89

7.2

4.0

1.75

1.56

mmol/l

0.40

218

1318

Atopic dermatitis

1844

12071

1.23

14.84

4.1

3.9

1.24

1.57

mmol/l

3.74

1342

8754

Sequelae of injuries of neck and trunk

123

576

2.26

14.80

4.7

3.6

2.39

1.66

mmol/l

1.42

100

429

Cramp and spasm

186

1008

1.93

14.80

3.8

4.5

1.74

1.65

mmol/l

0.12

133

758

Hydrocele

465

3170

1.51

14.79

5.0

4.1

1.63

1.67

mmol/l

0.09

332

2277

Motor disorders, excluding more controls

153

750

2.21

14.75

18.6

7.9

0.35

0.93

mmol/l

1.89

114

552

Need for other prophylactic measures

240

1406

1.79

14.75

11.3

4.6

1.48

1.70

mmol/l

0.39

177

1054

Amiodarone users

402

2669

1.56

14.74

4.9

3.8

2.09

1.83

mmol/l

0.57

296

1956

Chronic hepatitis, not elsewhere classified

137

670

2.16

14.71

4.2

3.3

0.98

1.88

mmol/l

1.75

105

504

Other strabismus

757

5593

1.37

14.66

6.4

4.7

1.43

1.49

mmol/l

0.20

550

4095

Alzheimer’s disease (Atypical or mixed), excluding more controls

299

1364

1.68

14.64

2.8

3.8

1.87

2.00

mmol/l

0.19

204

973

Pulmonary oedema

390

2.58

14.64

7.7

3.5

1.65

2.01

mmol/l

0.39

282

Diabetes mellitus in pregnancy

643

2908

1.42

14.61

2.6

0.97

1.22

mmol/l

0.88

399

2010

Childhood allergy (age < 16)

496

2807

1.49

14.61

6.9

6.7

0.67

0.83

mmol/l

0.48

327

1923

Autism

129

620

2.21

14.55

3.6

5.4

0.96

1.00

mmol/l

0.05

426

Contact with and exposure to communicable diseases

888

6706

1.34

14.55

5.0

4.3

1.65

1.24

mmol/l

3.05

560

4792

Unspecified protein-energy malnutrition

138

4.04

14.52

4.6

5.6

2.70

1.83

mmol/l

0.75

101

Other and unspecified injuries of ankle and foot

165

864

2.00

14.51

5.0

4.4

2.07

1.65

mmol/l

0.64

120

640

Thyrotoxicosis

774

5766

1.36

14.50

3.5

3.4

2.04

1.89

mmol/l

0.47

572

4300

Dementia

1748

9800

1.24

14.50

3.1

3.8

1.97

mmol/l

0.02

1232

7323

Unspecified event, undetermined intent

110

497

2.36

14.49

3.9

1.14

1.64

mmol/l

0.57

357

Autoimmune hepatitis, wide definition

163

850

2.00

14.49

4.4

3.5

2.14

1.83

mmol/l

0.43

123

637

Papulosquamous disorders

1317

10526

1.27

14.47

3.9

3.4

1.85

1.77

mmol/l

0.31

962

7815

Myelodysplastic syndrome

264

2.97

14.38

5.6

3.8

1.95

2.14

mmol/l

0.12

197

Other disorders of amino-acid metabolism

106

4.57

14.37

5.8

6.6

0.81

1.75

mmol/l

0.52

Cardiac murmurs and other cardiac sounds

349

2224

1.59

14.36

5.7

5.5

1.41

1.32

mmol/l

0.22

253

1583

Henoch-Schönlein purpura nephritis (HSPN)

5.64

14.33

9.1

3.2

0.78

1.06

mmol/l

0.13

Inflammatory bowel disease, strict (require KELA)

712

5247

1.38

14.32

4.4

3.5

1.47

1.59

mmol/l

0.39

517

3844

Unspecified/other endometriosis

217

1209

1.79

14.27

3.2

2.9

1.46

1.57

mmol/l

0.19

154

826

Panhypopituitarism

396

2.56

14.27

5.4

3.9

2.23

1.75

mmol/l

1.00

294

Open wound of abdomen, lower back and pelvis

130

631

2.18

14.25

4.8

4.0

1.89

1.52

mmol/l

0.45

458

Listeriosis

5.15

14.22

3.6

2.8

1.99

2.03

mmol/l

0.02

Listeriosis, including avohilmo

5.12

14.20

3.6

2.8

1.99

2.03

mmol/l

0.02

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

295

1808

1.67

14.17

14.9

7.5

0.69

0.95

mmol/l

0.68

200

1331

Vasculitis limited to skin, not elsewhere classified

115

535

2.29

14.16

5.3

3.4

2.33

2.02

mmol/l

0.44

393

Myeloid leukaemia

126

609

2.21

14.14

5.7

3.8

0.90

2.01

mmol/l

3.07

100

447

Any event in hilmo or specialist outpatient

+∞

14.10

3.7

0.0

3.06

—

mmol/l

—

Myasthenia gravis

337

2.68

14.05

4.6

4.0

1.47

1.79

mmol/l

0.33

251

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

251

1507

1.73

14.02

3.9

4.3

2.60

1.94

mmol/l

1.95

208

1094

Presbycusis

555

3900

1.44

13.98

3.3

3.7

2.35

2.22

mmol/l

0.32

379

2875

Artificial joint re-operation

272

1672

1.69

13.96

3.8

3.6

2.17

2.10

mmol/l

0.11

202

1265

Disorders of continuity of bone

326

2087

1.60

13.86

4.2

3.5

1.83

1.69

mmol/l

0.27

244

1559

Secondary malignant neoplasm of respiratory and digestive organs

376

2.57

13.86

2.9

3.6

1.08

2.10

mmol/l

1.20

274

Herpesviral [herpes simplex] infections

385

2557

1.54

13.85

5.6

3.5

1.37

1.79

mmol/l

1.66

290

1903

Other and unspecified vascular occlusions

365

2404

1.57

13.84

4.1

3.6

1.70

2.12

mmol/l

1.21

278

1759

Severe visual impairment, binocular

113

4.27

13.84

7.0

3.2

0.48

1.63

mmol/l

0.88

Hydrocephalus in other diseases

113

4.24

13.80

6.1

4.4

2.42

1.66

mmol/l

0.64

Excessive attrition of teeth

1955

16165

1.21

13.75

4.8

3.5

1.36

1.61

mmol/l

2.49

1393

11827

Alzheimer’s disease (Late onset), excluding more controls

439

1919

1.51

13.71

2.8

3.8

2.06

1.86

mmol/l

0.44

303

1372

Psoriatic arthropathies

309

1958

1.62

13.70

3.2

1.99

1.87

mmol/l

0.20

222

1465

Other Crohn's disease

226

1324

1.76

13.70

3.9

3.3

1.34

1.55

mmol/l

0.32

167

982

Alcohol abuse counselling and surveillance

311

2.72

13.68

3.9

3.1

1.27

1.58

mmol/l

0.23

228

Papilloedema, unspecified

105

478

2.35

13.66

5.1

0.60

1.47

mmol/l

1.29

345

Complications following infusion, transfusion and therapeutic injection

300

2.76

13.66

7.5

4.5

1.79

1.91

mmol/l

0.09

227

Retinal detachments and breaks

1265

10140

1.27

13.65

4.1

3.4

1.60

1.90

mmol/l

2.22

943

7548

Recurrent dislocation of patella

139

698

2.05

13.61

3.5

3.4

1.05

1.29

mmol/l

0.36

512

Secondary parkinsonism+Parkinsonism in other disease

126

618

2.17

13.57

3.6

2.28

1.93

mmol/l

0.58

109

462

Polycystic ovarian syndrome

133

657

2.08

13.57

2.8

2.4

1.01

0.93

mmol/l

0.11

439

Pre-eclampsia or poor fetal growth

655

4775

1.38

13.54

3.2

2.7

1.51

1.53

mmol/l

0.05

476

3400

Myeloproliferative diseases

306

1948

1.63

13.53

3.8

3.6

1.85

1.99

mmol/l

0.24

216

1436

Colectomy operation

606

4406

1.41

13.51

4.5

3.6

1.59

1.94

mmol/l

1.10

434

3281

Pregnancy hypertension

933

6424

1.31

13.41

3.1

2.9

1.67

1.66

mmol/l

0.03

670

4693

Deficiency of other B group vitamins

399

2.46

13.38

5.0

3.8

1.63

1.95

mmol/l

0.29

304

Hemiplegia

193

1092

1.84

13.35

5.4

3.9

1.76

1.71

mmol/l

0.06

145

801

Erosion of teeth , including avohilmo

811

6158

1.34

13.34

5.6

3.6

1.16

1.57

mmol/l

3.21

586

4466

Malignant neoplasm of heart, mediastinum and pleura

299

2.76

13.30

4.3

4.7

2.74

2.01

mmol/l

1.05

223

Protein-energy malnutrition of moderate and mild degree

304

2.86

13.29

9.5

7.9

1.83

1.47

mmol/l

0.27

220

Conotruncal defects

132

686

2.25

13.28

15.4

9.6

2.25

0.78

mmol/l

8.72

114

501

malignant neoplasm of male genital organs, including Hilmo

1125

5319

1.29

13.23

3.4

3.5

1.57

1.62

mmol/l

0.17

802

3824

Visual field defects

308

1973

1.61

13.22

4.6

3.7

1.51

1.96

mmol/l

1.37

218

1442

Other and unspecified follicular disorders

157

836

1.96

13.22

4.3

3.4

1.02

1.64

mmol/l

1.31

107

606

Lifestyle-related condition

219

3.06

13.20

4.8

2.7

2.15

1.92

mmol/l

0.15

156

Other and unspecified vasculitis limited to skin

105

486

2.31

13.14

5.4

3.5

2.36

2.06

mmol/l

0.38

356

Delayed milestone in childhood

242

1379

1.89

13.13

21.1

10.3

0.93

0.72

mmol/l

0.55

190

1010

Use of biperiden

186

1047

1.85

13.09

3.2

3.3

2.93

1.75

mmol/l

3.89

147

772

Ankylosing spondylitis

273

1702

1.65

13.01

3.9

3.4

2.11

1.74

mmol/l

0.86

200

1252

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1050

7147

1.29

13.00

3.1

3.0

1.64

1.71

mmol/l

0.26

749

5262

Injury of other and unspecified intrathoracic organs

235

1415

1.72

13.00

3.7

3.6

1.85

1.80

mmol/l

0.06

167

1054

Other arterial embolism and thrombosis

124

614

2.14

13.00

5.0

3.5

2.12

2.05

mmol/l

0.08

447

Gluteal tendinitis

148

776

1.98

12.97

2.7

3.5

1.49

1.98

mmol/l

1.09

116

604

Shock, not elsewhere classified

167

3.36

12.93

6.0

3.7

1.81

1.82

mmol/l

0.00

127

Infection of intervertebral disc (pyogenic)

279

2.79

12.93

5.7

3.6

1.67

2.20

mmol/l

0.46

200

Dislocation, sprain and strain of joints and ligaments of knee

1851

13975

1.21

12.92

2.9

3.3

1.56

1.61

mmol/l

0.31

1348

10166

Congenital malformations of cardiac chambers and connections

351

2.96

12.92

20.3

10.5

1.80

0.69

mmol/l

3.24

263

Methotrexate

399

2711

1.50

12.79

4.2

3.1

1.89

1.84

mmol/l

0.10

285

1983

Other diseases of spinal cord

128

645

2.10

12.79

7.6

4.1

2.98

1.83

mmol/l

2.43

475

Other disorders of penis

405

2771

1.51

12.75

5.5

5.0

1.22

1.55

mmol/l

1.24

291

2003

Non-small cell lung cancer, squamous

200

1160

1.79

12.73

3.7

3.6

2.46

2.03

mmol/l

0.89

165

812

Abnormal blood-pressure reading, without diagnosis

155

830

1.94

12.73

5.2

3.6

1.50

1.64

mmol/l

0.20

121

604

Burns and corrosions of external body surface, specified by site

390

2649

1.51

12.69

4.1

4.5

1.55

1.57

mmol/l

0.04

282

1953

Vulvovaginal ulceration/inflammation in other diseases

177

986

1.84

12.68

3.8

3.1

1.27

1.68

mmol/l

0.71

123

716

Other noninflammatory disorders of vagina

212

1245

1.75

12.66

2.9

3.2

1.76

1.99

mmol/l

0.37

150

919

Persons encountering health services for specific procedures, not carried out

254

1565

1.66

12.66

3.1

2.8

2.14

1.66

mmol/l

1.08

185

1140

Radiculopathy

533

3831

1.42

12.65

3.5

3.4

2.04

1.93

mmol/l

0.33

390

2820

Systemic sclerosis (FG)

364

2.47

12.65

5.6

2.9

2.00

1.78

mmol/l

0.23

283

Mesothelioma, including Hilmo

289

2.75

12.64

4.2

3.8

2.94

2.19

mmol/l

1.04

209

Disorders of refraction and accommodation

950

7398

1.30

12.61

7.1

4.5

1.50

1.47

mmol/l

0.10

692

5394

Myositis

107

507

2.24

12.58

5.0

3.7

1.77

2.04

mmol/l

0.29

374

Biological medicines for asthma

391

2.42

12.55

2.7

3.3

1.44

1.60

mmol/l

0.19

291

Endometriosis of ovary

405

2600

1.49

12.55

3.0

3.1

1.70

1.99

mmol/l

1.00

304

1924

Endometriosis of pelvic peritoneum

368

2235

1.52

12.54

2.9

1.48

1.86

mmol/l

1.63

269

1636

Benign thyroid growths and nodules

985

7183

1.29

12.53

3.3

3.4

2.29

2.03

mmol/l

1.29

749

5368

Kela reimbursement Agammaglobulinemia (D80-84)

166

3.37

12.51

8.2

3.5

1.07

1.48

mmol/l

0.29

116

Other/unspecified enthesopathies, not elsewhere classified

272

1714

1.63

12.44

3.6

3.4

1.51

2.00

mmol/l

1.33

203

1266

Mild mental retardation

144

769

2.01

12.43

8.0

6.1

2.44

1.33

mmol/l

2.62

109

565

Secondary parkinsonism

122

612

2.12

12.41

3.6

3.5

2.30

1.99

mmol/l

0.48

105

454

Other specific arthropathies, wide

368

2.45

12.39

3.7

3.2

3.01

1.82

mmol/l

2.27

284

Symptoms and signs involving emotional state

118

583

2.12

12.36

3.8

4.4

1.27

1.51

mmol/l

0.38

422

Iron deficiency

104

488

2.22

12.35

6.7

6.3

1.40

0.98

mmol/l

0.59

340

Exclusion endpoint for clefts

141

754

2.05

12.32

12.9

9.3

1.62

1.02

mmol/l

1.29

113

559

Disorders of phosphorus metabolism and phosphatases

113

4.08

12.32

8.0

4.8

2.65

1.73

mmol/l

0.97

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

5.11

12.32

4.6

3.5

2.04

1.76

mmol/l

0.19

Diplopia

449

3151

1.46

12.31

3.5

3.6

1.66

1.92

mmol/l

0.88

320

2333

Triptan medication for migraine, min. 3 purchases

1466

8967

1.23

12.29

2.8

3.1

1.29

1.61

mmol/l

3.32

1045

6521

Complications predominantly related to the puerperium

570

4154

1.39

12.25

2.5

2.9

1.67

1.61

mmol/l

0.16

406

3018

Kyphosis

257

2.79

12.21

6.3

4.4

2.85

2.49

mmol/l

0.26

199

Other and unspecified disorders of white blood cells

162

897

1.90

12.19

7.3

3.8

2.47

1.82

mmol/l

1.27

120

672

Effects of foreign body entering through natural orifice

836

6465

1.31

12.19

4.2

4.1

1.34

1.56

mmol/l

0.94

624

4736

Calculus of lower urinary tract

229

1399

1.71

12.19

3.8

3.6

2.16

1.89

mmol/l

0.52

170

1004

Cluster headache, strict, including avohilmo

158

864

1.89

12.17

3.2

1.37

1.55

mmol/l

0.25

112

629

malignant neoplasm of male genital organs

1097

5240

1.28

12.16

3.4

3.6

1.52

1.62

mmol/l

0.34

777

3763

Other specified/unspecified necrotizing vasculopathies

288

2.70

12.16

6.0

3.7

1.41

1.69

mmol/l

0.28

220

Mixed conductive and sensorineural hearing loss

424

2955

1.47

12.10

4.0

3.9

1.77

1.96

mmol/l

0.50

329

2220

Crystal arthropathies, rheuma endpoint

412

2.37

12.09

5.1

3.5

1.66

2.22

mmol/l

0.57

300

Other coagulation defects

253

1580

1.65

12.09

5.6

3.7

1.74

1.76

mmol/l

0.02

183

1168

Other and unspecified injuries of head

280

1795

1.61

12.02

4.6

4.4

2.16

1.75

mmol/l

1.08

196

1316

Acute and subacute iridocyclitis

603

4460

1.38

12.01

3.9

3.5

1.83

1.80

mmol/l

0.07

427

3301

Primary Sclerosing Cholangitis, IBD and UDCA required

105

505

2.22

12.01

11.2

5.0

0.54

1.53

mmol/l

1.55

375

!Aliquae complicationes praecoces traumatis

170

958

1.85

12.00

5.3

3.8

1.67

1.76

mmol/l

0.10

124

710

Early complications of trauma

170

958

1.85

12.00

5.3

3.8

1.67

1.76

mmol/l

0.10

124

710

Toxic effect of other and unspecified substances

207

2.97

11.97

2.7

3.2

2.08

1.50

mmol/l

0.48

145

Disorders of vitreous body and globe

1780

14137

1.20

11.95

4.1

3.5

1.61

1.89

mmol/l

2.95

1319

10547

Mesothelioma

233

2.93

11.94

4.1

3.8

2.76

2.11

mmol/l

0.76

171

Ventricular septal defect, a heart condition

184

1084

1.87

11.91

12.9

10.0

1.89

0.77

mmol/l

6.55

154

793

Membranous nephropathy

4.74

11.90

6.7

2.4

-0.16

2.09

mmol/l

1.65

Hyperaldosteronism

115

573

2.13

11.89

4.3

3.6

2.41

1.85

mmol/l

0.63

437

Aspergillosis

188

3.17

11.89

7.8

3.8

2.35

1.89

mmol/l

0.52

139

Superficial injury of forearm

336

2243

1.53

11.88

4.1

4.0

1.66

1.65

mmol/l

0.02

244

1640

Organ-limited amyloidosis

4.24

11.87

5.8

4.0

1.42

2.27

mmol/l

0.57

Other noninfective disorders of lymphatic vessels and lymph nodes

129

669

2.01

11.78

4.5

3.3

2.75

1.91

mmol/l

1.80

489

Spondylopathies in diseases classified elsewhere

275

2.72

11.76

3.9

3.8

1.77

2.52

mmol/l

0.81

206

Other and unspecified abdominal hernia

160

892

1.88

11.76

5.0

3.7

2.45

2.00

mmol/l

0.64

116

656

Metabolic disorder, other/unspecified

4.84

11.74

15.0

8.6

0.85

1.26

mmol/l

0.21

Syphilis

107

522

2.17

11.71

6.7

3.4

1.18

1.87

mmol/l

1.10

387

Syphilis, including avohilmo

107

522

2.17

11.71

6.7

3.4

1.18

1.87

mmol/l

1.10

387

Colorectal adenocarcinoma

718

5400

1.34

11.71

3.2

3.5

1.93

1.92

mmol/l

0.03

524

3957

Other disorders of eyelid

1599

12576

1.21

11.71

3.5

3.6

1.79

1.96

mmol/l

1.15

1200

9345

Iridocyclitis

722

5504

1.33

11.70

3.7

3.5

1.90

1.80

mmol/l

0.31

512

4066

Anterior Iridocyclitis

643

4825

1.36

11.66

3.8

3.5

1.82

1.77

mmol/l

0.13

458

3560

Schizotypal disorder

346

2.43

11.65

3.4

2.9

2.04

1.59

mmol/l

0.49

250

Wegener granulomatosis

312

2.57

11.65

6.8

3.6

1.43

1.90

mmol/l

0.57

235

Other specified congenital malformation syndromes affecting multiple systems

125

658

2.11

11.64

13.5

9.9

1.72

0.97

mmol/l

1.65

101

494

Achalasia of cardia

336

2.49

11.61

3.8

1.85

1.89

mmol/l

0.04

247

Fracture of neck

237

1476

1.67

11.61

4.0

3.7

2.00

1.92

mmol/l

0.11

182

1086

Viral hepatitis, including avohilmo

228

1401

1.67

11.59

3.5

3.4

1.73

1.57

mmol/l

0.27

173

1038

Congenital malformations of great arteries

193

1149

1.85

11.58

14.9

10.6

1.94

0.63

mmol/l

12.07

169

806

Other crystal arthropathies

420

2.32

11.57

5.1

3.6

1.66

2.14

mmol/l

0.46

319

Recurrent aphthous stomatitis , including avohilmo

495

3573

1.42

11.56

4.7

4.4

1.65

1.72

mmol/l

0.20

361

2661

L04AC Interleukin inhibitors

203

1212

1.73

11.56

2.5

3.5

1.86

1.60

mmol/l

0.44

147

910

Thrombotic microangiopathy

107

3.93

11.55

10.2

3.6

1.08

1.63

mmol/l

0.30

Aspergillosis, including avohilmo

191

3.11

11.55

7.8

3.7

2.35

1.86

mmol/l

0.56

142

Recurrent and persistent haematuria

158

3.30

11.48

4.2

2.9

1.70

1.51

mmol/l

0.11

120

Trochanteric bursitis

426

2996

1.45

11.46

3.7

3.4

1.91

2.14

mmol/l

0.72

321

2255

Generalized epilepsy

172

988

1.82

11.45

4.4

6.1

0.85

1.34

mmol/l

0.98

121

725

Blindness, monocular

180

3.12

11.44

6.1

3.6

2.54

1.60

mmol/l

1.00

136

Autism spe

123

638

2.04

11.38

3.5

6.9

0.97

0.89

mmol/l

0.10

443

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

202

2.95

11.37

4.6

3.3

2.45

1.96

mmol/l

0.48

150

Mitochondrial myopathy

4.87

11.37

4.1

4.7

0.80

1.05

mmol/l

0.12

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

187

1108

1.80

11.36

10.9

8.6

1.74

1.09

mmol/l

2.02

150

823

Encephalopathy

233

2.87

11.36

8.8

3.9

2.26

1.89

mmol/l

0.26

175

Other and unspecified injuries of shoulder and upper arm

129

679

1.99

11.35

3.7

3.4

1.87

1.72

mmol/l

0.17

492

Other drug-induced secondary parkinsonism

198

3.02

11.35

4.9

3.6

2.10

2.01

mmol/l

0.06

156

Dislocation of lens

290

2.59

11.35

3.7

3.9

1.93

2.18

mmol/l

0.18

215

Acute nephritic syndrome

423

2.30

11.34

9.2

3.6

1.22

1.87

mmol/l

0.99

312

Chronic lymphocytic leukaemia, helper endpoint

126

660

2.02

11.34

4.3

3.5

2.09

1.87

mmol/l

0.26

468

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

126

660

2.02

11.34

4.3

3.5

2.09

1.87

mmol/l

0.26

468

Chronic lymphocytic leukaemia

126

660

2.02

11.34

4.3

3.5

2.09

1.87

mmol/l

0.26

468

Other and unspecified mental retardation

169

992

1.94

11.34

17.5

10.4

0.99

0.89

mmol/l

0.17

141

718

Synovial cyst of popliteal space [Baker]

239

1496

1.64

11.32

3.8

3.6

2.12

2.04

mmol/l

0.12

188

1112

Other and unspecified mononeuropathies, also in other diseases

118

604

2.06

11.31

4.1

3.4

1.88

1.87

mmol/l

0.01

451

Arterial embolism and thrombosis of lower extremity artery

150

831

1.90

11.30

4.3

4.0

1.99

1.95

mmol/l

0.04

102

620

Cluster headache, wide,, including avohilmo

164

929

1.82

11.29

3.2

1.44

1.59

mmol/l

0.22

118

686

Temporomandibular joint disorders, including avohilmo

1223

9642

1.24

11.28

2.7

3.2

1.63

1.62

mmol/l

0.03

890

6981

Other immunodeficiencies

276

2.69

11.25

7.1

6.3

1.55

1.31

mmol/l

0.22

204

Atrial septal defect, secundum type

198

1202

1.78

11.25

10.5

9.2

2.01

1.01

mmol/l

5.77

165

889

Postprocedural disorders of nervous system

192

1136

1.73

11.24

2.9

3.2

1.46

1.63

mmol/l

0.30

136

850

Disorders of speech understanding and production

258

1632

1.64

11.23

10.9

7.5

1.27

1.06

mmol/l

0.48

195

1197

Disorders of adrenal gland, other and/or unspecified

4.20

11.23

5.1

5.3

2.21

1.14

mmol/l

0.73

Unspecified visual impairment (binocular)

408

2.35

11.22

12.0

5.7

1.33

1.77

mmol/l

0.57

296

Erythema intertrigo

110

552

2.11

11.21

6.0

3.7

2.19

1.96

mmol/l

0.22

411

Abscess of lung

356

2.43

11.18

6.6

3.9

2.31

1.94

mmol/l

0.32

257

Other bacterial agents as the cause of diseases classified to other chapters

235

2.83

11.15

9.6

5.0

1.34

1.58

mmol/l

0.21

175

Thiamine deficiency

105

3.91

11.13

3.7

3.0

-0.10

1.96

mmol/l

2.33

Unspecified jaundice

188

1114

1.75

11.13

5.4

3.6

1.85

1.84

mmol/l

0.01

136

797

Corneal ulcer

573

4256

1.37

11.12

4.3

3.6

1.70

1.74

mmol/l

0.09

404

3138

Sleep disorders

2990

18031

1.15

11.11

3.1

3.6

1.55

1.74

mmol/l

2.28

2159

13199

Metatarsalgia

277

1800

1.57

11.08

2.9

3.5

1.46

1.92

mmol/l

1.61

204

1341

Disorders of vitreous body

1722

13817

1.20

11.07

4.1

3.5

1.60

1.90

mmol/l

3.27

1273

10313

Congenital malformations of trachea and bronchus

274

2.73

11.06

14.8

7.5

1.99

1.52

mmol/l

0.55

204

Cerebral palsy

100

492

2.21

11.01

19.8

7.5

1.33

1.09

mmol/l

0.28

359

Any dementia, excluding more controls

1354

7647

1.23

11.01

3.2

3.6

2.06

1.95

mmol/l

0.50

965

5599

Other enthesopathy of foot (+metatarsalgia)

295

1947

1.55

10.98

2.8

3.5

1.52

1.92

mmol/l

1.41

218

1449

Malignant neoplasm of colon, including Hilmo

643

4851

1.34

10.97

3.9

3.4

1.81

1.97

mmol/l

0.42

470

3538

Other benign neoplasms of uterus

175

1022

1.78

10.95

3.6

3.4

2.47

2.31

mmol/l

0.20

140

775

Hypertension, portal

5.15

10.93

3.9

3.1

1.27

1.01

mmol/l

0.14

Coeliac disease

402

2830

1.45

10.89

3.9

4.1

1.35

1.74

mmol/l

1.21

300

2084

Actinomycosis, including avohilmo

5.22

10.86

7.3

1.8

2.77

1.73

mmol/l

0.47

6-mercaptopurine

122

638

1.99

10.86

3.6

5.3

0.96

1.45

mmol/l

0.83

464

Hepatomegaly and splenomegaly, not elsewhere classified

186

3.01

10.79

7.1

3.6

1.56

1.77

mmol/l

0.13

135

Other specified/unspecified spondylopathies

484

2.16

10.78

3.7

3.6

2.40

2.31

mmol/l

0.08

360

Other and unspecified types of non-Hodgkin lymphoma, hilmo

169

985

1.80

10.78

4.3

3.7

2.28

1.95

mmol/l

0.61

128

750

Injury of muscle and tendon at shoulder and upper arm level

1223

10032

1.24

10.77

3.1

3.6

1.52

1.70

mmol/l

1.14

886

7419

Crossbite

376

2422

1.48

10.75

11.5

6.6

1.06

1.09

mmol/l

0.07

271

1721

Perforation of tympanic membrane

333

2270

1.50

10.73

5.2

3.7

1.68

1.80

mmol/l

0.26

242

1667

Injury of unspecified body region

281

1852

1.56

10.73

4.4

4.2

1.82

1.73

mmol/l

0.14

215

1356

In situ neoplasms

1342

11110

1.22

10.72

4.1

3.4

1.66

1.92

mmol/l

1.72

1015

8150

Achilles tendinitis

327

2219

1.51

10.72

3.3

3.4

1.17

1.77

mmol/l

2.30

229

1653

Other autoimmune haemolytic anaemias

282

2.61

10.71

3.4

4.0

2.04

1.81

mmol/l

0.18

212

Other specified and unspecified disorders of lens

165

3.15

10.68

2.1

4.2

1.94

2.26

mmol/l

0.19

124

Oesophageal obstruction

136

744

1.91

10.67

4.3

3.7

2.03

2.05

mmol/l

0.02

103

532

Malignant neoplasm of prostate, including Hilmo

1084

5148

1.26

10.66

3.4

3.6

1.62

mmol/l

0.02

770

3695

Contusion of other and unspecified parts of foot

183

1088

1.74

10.66

3.7

4.8

1.32

1.46

mmol/l

0.20

131

798

Otalgia

314

2122

1.52

10.62

3.8

5.6

1.27

1.62

mmol/l

1.04

225

1609

Viral hepatitis

214

1325

1.66

10.60

3.6

3.3

1.81

1.56

mmol/l

0.46

162

979

Mantle cell lymphoma

212

2.89

10.60

4.6

3.8

2.47

2.39

mmol/l

0.06

155

Residual foreign body in soft tissue

170

992

1.77

10.59

3.8

3.6

1.66

1.73

mmol/l

0.09

121

726

Lactose intolerance

114

589

2.02

10.59

4.3

3.9

2.02

1.76

mmol/l

0.34

449

Lichen simplex chronicus and prurigo

216

1344

1.66

10.58

4.7

3.4

2.14

1.90

mmol/l

0.38

157

998

Intermittent heterotropia

268

1756

1.58

10.58

8.9

6.4

1.32

1.17

mmol/l

0.32

196

1276

Hyperfunction of pituitary gland

156

889

1.81

10.57

4.6

3.5

1.54

1.53

mmol/l

0.01

118

651

Conduct disorder

489

2.15

10.54

3.9

6.0

1.20

1.22

mmol/l

0.02

356

Manic episode

100

493

2.11

10.54

3.2

3.1

1.85

1.92

mmol/l

0.05

352

Outcome of delivery

133

1470

0.55

10.53

1.9

2.7

1.16

1.25

mmol/l

0.14

1039

Other misadventures during surgical and medical care

101

504

2.12

10.48

4.4

3.7

1.98

1.93

mmol/l

0.05

382

Congenital malformations of the respiratory system, including avohilmo

131

724

1.98

10.46

13.8

9.7

1.68

1.36

mmol/l

0.61

100

543

Hallux valgus (acquired)

941

5347

1.27

10.46

3.3

3.2

1.83

1.98

mmol/l

0.61

715

4007

Biological medication for rheuma

507

3731

1.38

10.46

3.2

3.7

1.63

1.53

mmol/l

0.27

366

2748

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

405

2.27

10.43

4.6

4.2

3.02

1.96

mmol/l

1.93

297

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

285

2.56

10.43

9.0

5.0

1.42

1.56

mmol/l

0.13

208

Malignant neoplasm of prostate

1066

5082

1.26

10.42

3.4

3.6

1.56

1.62

mmol/l

0.18

754

3645

Leiomyoma of uterus

1618

7599

1.20

10.39

3.1

2.17

1.99

mmol/l

1.05

1216

5682

Hypertension, Pulmonary Arterial

151

3.21

10.38

8.2

4.1

2.26

1.64

mmol/l

0.70

112

Other disorders starting during childhood or adolescence

285

1889

1.56

10.36

16.1

8.0

0.66

0.88

mmol/l

0.51

195

1363

Nonalcoholic steatohepatitis

168

3.07

10.32

5.2

3.3

0.41

1.63

mmol/l

1.04

126

Tonsillectomy and adenotomy

1639

9595

1.20

10.32

5.0

4.1

1.07

1.39

mmol/l

3.40

1147

6897

Impetigo

199

1225

1.69

10.31

7.8

6.4

1.72

1.24

mmol/l

0.95

148

889

Endometriosis ASRM stages 3,4

549

4096

1.36

10.31

3.0

1.68

1.91

mmol/l

0.75

415

3015

conjunctival haemorrhage

279

1857

1.55

10.23

4.4

3.6

1.60

1.91

mmol/l

0.74

201

1375

Other and unspecified psoriasis

232

1482

1.61

10.21

4.0

3.6

2.30

1.83

mmol/l

0.96

179

1093

Aneurysms, operations, SAH

524

3897

1.37

10.19

4.3

3.4

1.93

2.00

mmol/l

0.14

383

2911

Puerperal sepsis

317

2159

1.50

10.17

2.9

3.2

2.19

1.90

mmol/l

0.73

233

1665

Postinfectious hypothyroidism

4.21

10.17

4.0

3.9

1.41

1.76

mmol/l

0.23

Endocrine disorders, other/unspecified

343

2.35

10.17

3.7

3.2

2.43

1.89

mmol/l

0.47

263

Myocardial infarction, with ST-elevation

662

5099

1.32

10.16

4.6

3.6

1.70

1.83

mmol/l

0.34

481

3684

Injuries involving multiple body regions

137

762

1.87

10.16

3.0

3.5

2.01

1.75

mmol/l

0.34

561

Juvenile arthritis (FINNGEN)

168

991

1.76

10.15

5.6

4.9

1.04

1.19

mmol/l

0.22

122

710

Right ventricular outflow tract obstruction

426

2.42

10.11

17.3

9.4

2.03

0.91

mmol/l

4.05

323

Open wound of shoulder and upper arm

416

2.22

10.10

4.1

3.7

1.55

1.75

mmol/l

0.18

300

Other and unspecified trigeminal disorders

275

2.52

10.10

3.0

2.00

1.93

mmol/l

0.04

216

Congenital malformations of the respiratory system

124

683

2.00

10.09

14.4

10.1

1.76

1.28

mmol/l

1.04

514

Other benign neoplasm of uterus: Other parts/unspecified

141

795

1.86

10.07

3.4

3.5

2.55

2.43

mmol/l

0.12

110

599

Failed induction of labour

128

695

1.88

10.02

2.0

2.4

-0.13

1.06

mmol/l

2.83

446

Polyp of the female genital tract

720

3134

1.31

10.01

3.0

3.1

1.77

2.06

mmol/l

1.26

528

2326

Superficial injuries involving multiple body regions

101

511

2.07

10.01

3.3

3.5

2.02

1.68

mmol/l

0.33

377

Assault by sharp object

288

2.47

10.00

4.1

2.8

1.78

1.42

mmol/l

0.29

207

Urethritis and urethral syndrome

377

2.26

9.99

4.9

3.2

2.09

1.99

mmol/l

0.06

277

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

5.10

9.96

5.5

3.2

1.37

2.48

mmol/l

0.68

Intracranial and intraspinal abscess and granuloma

248

2.64

9.95

3.5

3.3

2.01

1.85

mmol/l

0.13

182

Diabetes insipidus

166

3.04

9.93

5.7

4.1

2.55

1.94

mmol/l

0.50

125

Actinomycosis

5.21

9.91

7.8

1.8

2.28

1.39

mmol/l

0.43

Fenamates

447

2195

1.41

9.87

3.4

4.0

1.76

1.86

mmol/l

0.20

334

1603

Other and unspecified visual disturbances

338

2350

1.47

9.85

3.7

1.49

1.93

mmol/l

1.45

249

1746

Complications following abortion and ectopic and molar pregnancy

107

555

2.01

9.84

4.2

3.2

2.76

1.88

mmol/l

1.68

442

Cushing syndrome

195

2.83

9.83

3.9

3.5

2.55

1.94

mmol/l

0.37

148

Other congenital malformations

341

2380

1.47

9.82

9.2

6.8

1.53

1.28

mmol/l

0.73

249

1747

Urethral stricture

227

1459

1.61

9.82

4.7

3.6

1.78

1.77

mmol/l

0.01

170

1036

Malignant neoplasm of mesothelium and soft tissue

155

905

1.79

9.81

4.1

4.4

2.80

1.87

mmol/l

2.31

133

639

Malignant neoplasm of colon

531

3983

1.36

9.80

3.8

3.5

1.80

2.00

mmol/l

0.50

378

2892

Crohn disease (strict definition, require KELA, min 2 HDR)

194

1198

1.67

9.78

3.6

1.27

1.50

mmol/l

0.35

140

885

Sequelae of injuries of upper limb

300

2041

1.50

9.78

3.9

3.6

1.62

1.76

mmol/l

0.29

234

1546

Anti-inflammatory and antirheumatic products, non-steroids

1071

4354

1.25

9.76

3.6

4.7

1.56

1.68

mmol/l

0.43

768

3149

Allergic contact dermatitis due to drugs in contact with skin

422

2.18

9.74

4.9

3.4

1.70

1.82

mmol/l

0.12

317

Hypersomnia

262

2.54

9.71

2.8

3.2

1.70

2.19

mmol/l

0.44

195

Other nutritional anaemias

191

2.84

9.66

2.9

3.6

2.36

2.05

mmol/l

0.20

139

Symptoms and signs involving appearance and behaviour

130

3.26

9.63

2.5

3.0

2.35

1.39

mmol/l

0.60

Degeneration of the brain due to alcohol

103

536

2.05

9.62

4.0

3.7

1.83

1.70

mmol/l

0.14

399

Traction detachment of retina

158

3.07

9.62

6.5

3.1

1.36

1.83

mmol/l

0.29

108

Sequelae of infectious and parasitic diseases, including avohilmo

238

1549

1.58

9.61

3.7

3.3

2.05

1.74

mmol/l

0.51

178

1140

Benign neoplasm: Rectosigmoid junction

159

943

1.76

9.56

3.5

3.8

1.40

2.12

mmol/l

1.65

119

711

Sequelae of infectious and parasitic diseases

233

1511

1.58

9.56

3.7

3.3

2.07

1.73

mmol/l

0.57

174

1117

Other and unspecified disorders of adult personality and behaviour

4.18

9.55

4.0

2.4

1.10

1.07

mmol/l

0.01

Eustachian salpingitis and obstruction

221

1415

1.60

9.52

3.8

3.1

1.20

1.58

mmol/l

0.95

167

1026

Palindromic rheumatism

181

2.88

9.52

4.3

3.6

3.26

1.94

mmol/l

1.44

145

Myeloproliferative diseases (CML excluded)

263

1757

1.54

9.51

3.8

3.6

2.07

2.00

mmol/l

0.09

186

1299

Antenatal screening

246

2088

0.65

9.50

2.0

2.8

1.22

1.32

mmol/l

0.16

159

1483

Portal vein thrombosis

348

2.31

9.50

8.6

3.9

1.60

1.83

mmol/l

0.20

253

Medical abortion

1618

7391

1.19

9.50

3.4

3.1

1.97

1.88

mmol/l

0.46

1215

5420

Plantar fascial fibromatosis

272

1823

1.52

9.49

3.4

1.73

1.92

mmol/l

0.45

197

1354

Toxic effect of corrosive substances

3.91

9.48

4.1

2.7

2.46

0.91

mmol/l

1.50

Mixed disorders of conduct and emotions

487

2.07

9.48

6.7

5.9

1.41

0.98

mmol/l

0.76

344

Suggestive for eosinophilic asthma

289

1966

1.51

9.47

3.7

3.4

1.70

1.83

mmol/l

0.29

218

1444

Deep endometriosis

244

1600

1.56

9.46

2.8

3.1

1.52

1.93

mmol/l

0.82

187

1172

Propionic acid derivatives

1066

4348

1.25

9.44

3.7

4.7

1.55

1.68

mmol/l

0.48

767

3143

Diseases of appendix

2354

18391

1.15

9.43

3.4

1.67

1.68

mmol/l

0.01

1728

13419

Appendicitis, broad definition

2331

18267

1.15

9.42

3.4

1.67

mmol/l

0.02

1709

13327

Lateral epicondylitis

354

2499

1.44

9.41

3.2

3.3

1.07

1.77

mmol/l

3.37

257

1863

Malignant neoplasm of breast, HER2-negative, including Hilmo

1051

5474

1.24

9.39

2.8

3.0

2.16

1.97

mmol/l

0.92

818

4074

Covid-19 suspected case

591

4521

1.32

9.39

6.5

3.5

1.96

1.43

mmol/l

2.81

454

3219

Malignant neoplasm of breast, including Hilmo

1051

5474

1.24

9.38

2.8

3.0

2.16

1.97

mmol/l

0.92

818

4074

Degeneration of nervous system due to alcohol

103

541

2.03

9.38

4.0

3.6

1.83

1.71

mmol/l

0.13

396

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

208

1321

1.62

9.36

3.4

3.6

1.29

1.55

mmol/l

0.44

150

986

Malignant neoplasm of breast, HER2-negative

1035

5422

1.24

9.35

2.8

3.0

2.19

1.98

mmol/l

1.01

809

4050

Other juvenile arthritis

148

864

1.78

9.33

5.9

5.1

0.82

1.17

mmol/l

0.62

108

618

Malignant neoplasm of breast

1036

5428

1.24

9.33

2.8

3.0

2.19

1.98

mmol/l

1.03

809

4051

Hypersplenism

4.04

9.30

5.7

3.2

1.46

1.47

mmol/l

0.01

Hypotension due to drugs

339

2.33

9.29

3.4

4.0

0.83

1.89

mmol/l

0.91

259

Bell's palsy

364

2593

1.43

9.28

4.1

3.5

1.74

1.86

mmol/l

0.31

267

1922

Hypertrophy of breast in women and men

505

3787

1.35

9.24

2.5

3.2

1.63

1.77

mmol/l

0.42

373

2824

Benign neoplasm: Parathyroid gland

214

2.70

9.24

4.1

3.5

1.39

1.99

mmol/l

0.62

162

Crohn disease (strict definition, require KELA)

195

1224

1.64

9.22

3.6

1.27

1.50

mmol/l

0.37

140

903

Other intracranial haemorrhages

138

796

1.82

9.22

4.1

1.55

2.12

mmol/l

0.81

596

Campylobacter enteritis

101

527

2.01

9.21

4.1

3.5

1.98

1.73

mmol/l

0.22

390

Injury of eye and orbit

429

3143

1.39

9.20

3.4

3.7

1.62

1.57

mmol/l

0.13

311

2296

Fibrosis of liver

163

3.02

9.19

6.5

3.2

1.48

1.85

mmol/l

0.16

121

Habit and impulse disorders

255

2.48

9.19

3.0

3.4

1.16

1.43

mmol/l

0.21

187

Other hammer toe(s) (acquired)

502

3421

1.36

9.16

3.3

3.4

2.08

2.17

mmol/l

0.21

371

2629

Deep bite

472

3086

1.38

9.15

9.0

5.7

1.25

1.27

mmol/l

0.05

333

2214

Disorder of the sleep-wake schedule

441

2.13

9.14

7.2

7.7

1.14

1.24

mmol/l

0.09

319

Allergic purpura

113

614

1.93

9.12

5.6

3.9

1.69

1.75

mmol/l

0.06

450

Family history of certain disabilities and chronic diseases leading to disablement

130

733

1.82

9.11

3.2

2.6

0.98

1.54

mmol/l

1.30

526

Secondary thrombocytopenia

252

2.53

9.11

3.8

3.6

2.02

1.82

mmol/l

0.14

180

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

448

2.11

9.10

4.5

4.0

1.87

1.73

mmol/l

0.14

340

Thyrotoxicosis with diffuse goitre

368

2632

1.42

9.09

2.9

3.3

2.08

1.85

mmol/l

0.45

263

1951

Implicit parasitic Sepsis, including avohilmo

109

3.48

9.08

7.5

2.4

1.80

1.72

mmol/l

0.04

Algoneurodystrophy

514

2.00

9.08

3.2

3.0

1.66

1.65

mmol/l

0.01

376

Postzoster neuralgia

335

2.30

9.06

6.6

3.6

2.60

2.00

mmol/l

0.52

260

Trigeminal neuralgia

180

1114

1.66

9.04

2.8

3.2

1.84

1.89

mmol/l

0.05

138

829

Other other unspecified disorders of the circulatory system

146

861

1.77

9.00

5.3

4.3

2.38

1.85

mmol/l

0.87

111

645

Abnormalities of gait and mobility

464

3465

1.37

8.99

3.4

4.6

2.13

1.78

mmol/l

1.20

346

2556

Degenerative macular diseases

417

3060

1.39

8.99

3.9

3.5

1.64

2.18

mmol/l

2.25

304

2244

Adenomyosis (Endometriosis of uterus)

329

2308

1.45

8.97

3.1

3.2

1.97

2.14

mmol/l

0.37

259

1729

Chronic mastoiditis

103

548

1.98

8.95

3.5

3.7

1.30

1.84

mmol/l

0.98

408

Cardiomyopathy in other diseases

105

3.53

8.94

5.4

3.1

1.89

1.84

mmol/l

0.03

Chondrocostal junction syndrome [Tietze]

125

704

1.84

8.94

3.4

1.41

1.80

mmol/l

0.42

100

527

Infective bursitis

109

590

1.94

8.93

5.2

3.8

1.91

2.01

mmol/l

0.12

429

Any prescribed medicine buy

3.88

8.91

7.1

6.5

1.06

-0.05

mmol/l

0.53

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

360

2.19

8.91

3.1

3.2

1.01

2.10

mmol/l

1.72

254

Diseases of tongue

195

1235

1.62

8.90

4.5

3.6

1.47

2.12

mmol/l

1.49

146

918

Mantle cell lymphoma, including Hilmo

300

2.37

8.84

4.9

3.6

2.09

2.22

mmol/l

0.11

219

Memory loss

138

2303

0.58

8.84

3.6

1.63

2.04

mmol/l

0.78

104

1705

Benign neoplasm: Skin of other and unspecified parts of face

349

2493

1.43

8.84

4.0

3.5

1.43

1.93

mmol/l

1.74

236

1837

Other salmonella infections

120

670

1.86

8.83

5.3

3.6

1.70

1.83

mmol/l

0.15

494

Implicit parasitic Sepsis

3.66

8.80

7.2

2.3

1.67

1.87

mmol/l

0.10

Occupational exposure to risk-factors

132

762

1.81

8.80

4.8

3.7

2.02

1.75

mmol/l

0.46

104

562

Granulomatous disorders of skin and subcutaneous tissue

480

2.03

8.76

5.5

3.6

0.46

1.89

mmol/l

2.87

355

Viral encephalitis, not elsewhere classified/unspecified

441

2.09

8.74

4.5

4.0

1.90

1.71

mmol/l

0.19

335

Other diseases of peritoneum

145

859

1.75

8.70

2.9

3.4

1.80

1.98

mmol/l

0.27

103

647

Other injuries of upper limb, level unspecified

251

2.48

8.68

4.3

1.44

1.33

mmol/l

0.08

185

Need for immunization against other single infectious diseases

6.11

8.67

11.5

7.9

0.95

1.36

mmol/l

0.44

Hodgkin lymphoma, hilmo

104

560

1.94

8.67

4.0

3.6

2.25

1.70

mmol/l

0.82

411

Specific developmental disorder of motor function

156

945

1.81

8.66

18.4

8.6

0.36

0.96

mmol/l

2.07

117

691

Acute lymphadenitis

184

1158

1.63

8.66

4.9

4.3

1.67

1.49

mmol/l

0.32

136

843

Speech therapy

848

6862

1.25

8.64

3.8

3.6

2.95

1.84

mmol/l

13.22

598

5089

187

1177

1.62

8.63

3.5

3.7

2.73

2.13

mmol/l

1.10

135

820

Post-traumatic wound infection, not elsewhere classified

107

583

1.92

8.61

5.1

3.7

1.29

1.73

mmol/l

0.57

430

Other epidermal thickening

166

1023

1.68

8.60

5.8

3.7

1.52

1.92

mmol/l

0.75

125

745

Malignant neoplasm of rectum, including Hilmo

406

2987

1.39

8.60

3.1

3.5

2.16

1.86

mmol/l

0.76

292

2168

Ankylosing spondylitis, ICD10

260

1768

1.51

8.57

3.9

3.5

2.06

1.70

mmol/l

0.86

190

1318

Cyst of kidney

255

1732

1.52

8.57

5.0

3.4

1.76

1.96

mmol/l

0.34

176

1268

Acne vulgaris

224

1471

1.55

8.56

3.2

3.7

0.99

1.09

mmol/l

0.18

149

1029

Hypersensitivity pneumonitis due to organic dust

310

2.31

8.56

7.3

3.7

2.01

1.80

mmol/l

0.16

241

Lactose intolerance, other/unspecified

519

1.97

8.55

4.4

3.5

1.98

1.85

mmol/l

0.13

401

Lymphoid leukaemia

232

1553

1.55

8.48

4.9

5.1

1.54

1.77

mmol/l

0.44

170

1166

Wide developmental disorders

196

1265

1.62

8.45

5.6

8.4

0.89

0.91

mmol/l

0.02

130

893

Other and unspecified paralytic syndromes

286

2.36

8.44

4.1

3.7

1.68

1.91

mmol/l

0.20

210

Cachexia

3.58

8.44

5.4

4.6

3.87

2.03

mmol/l

1.80

Disorders of purine and pyrimidine metabolism

120

3.29

8.43

5.5

3.8

1.91

1.92

mmol/l

0.00

Necrobiosis lipoidica, not elsewhere classified

3.64

8.41

3.5

2.3

-0.90

1.14

mmol/l

1.29

Polyarteritis nodosa

125

3.18

8.41

5.4

3.0

1.85

1.51

mmol/l

0.16

Systemic sclerosis

433

2.06

8.35

5.6

3.2

2.00

1.95

mmol/l

0.04

330

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

256

2.45

8.35

3.4

5.0

2.13

2.36

mmol/l

0.17

182

Nontoxic single thyroid nodule

212

1390

1.56

8.34

2.7

3.5

1.68

1.99

mmol/l

0.63

146

1051

Renal cell carcinoma of kidney

119

676

1.83

8.34

5.2

3.4

0.98

1.95

mmol/l

1.65

484

Malignant neoplasm of rectum

335

2402

1.43

8.33

3.0

3.5

2.36

1.92

mmol/l

1.28

248

1744

Other contact dermatitis

234

1567

1.53

8.30

5.3

3.4

1.65

1.79

mmol/l

0.25

178

1160

Malignant neoplasm of bone and articular cartilage, including Hilmo

416

2.09

8.25

5.7

5.2

1.92

1.90

mmol/l

0.02

303

Volvulus

104

570

1.91

8.21

6.2

3.9

1.93

2.12

mmol/l

0.19

428

Alzheimer’s disease, strict definition

679

6871

0.79

8.20

2.8

3.7

1.95

2.14

mmol/l

0.61

479

5051

Other specified/unspecified dorsopathies

110

612

1.86

8.20

3.7

3.4

2.06

2.13

mmol/l

0.08

452

All dysplastic lesions of the vulva

118

670

1.82

8.19

4.0

3.0

1.27

1.91

mmol/l

1.20

515

Behavioural disorders

522

1.96

8.19

3.9

6.0

1.12

1.18

mmol/l

0.05

376

Insomnia

2845

17638

1.13

8.17

2.9

3.4

1.52

1.74

mmol/l

2.88

2051

12913

Polycythaemia vera

121

696

1.81

8.15

4.1

3.4

2.40

1.91

mmol/l

0.55

498

Tuberculosis of other organs, strict

487

1.99

8.13

4.2

3.9

1.93

2.04

mmol/l

0.10

361

Non-small cell lung cancer, squamous, helper endpoint

200

1307

1.58

8.12

3.7

2.46

1.93

mmol/l

1.23

165

943

Juvenile rheumatoid arthirtis

308

2.23

8.11

3.7

4.1

1.77

1.62

mmol/l

0.12

224

Mild or no visual impairment, binocular

3.53

8.10

5.1

4.4

0.38

1.63

mmol/l

0.72

Other proliferative retinopathy

3.60

8.07

3.3

3.2

1.66

1.76

mmol/l

0.05

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

158

972

1.66

8.07

3.1

2.4

1.26

1.41

mmol/l

0.18

108

691

Whooping cough

3.58

8.06

6.0

3.0

0.13

0.88

mmol/l

0.55

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

315

2214

1.44

8.06

8.6

7.0

0.86

1.12

mmol/l

0.81

231

1595

Disorders of tooth development and eruption

474

2915

1.34

8.06

7.6

4.1

1.58

1.60

mmol/l

0.06

358

2130

Encephalitis

110

618

1.86

8.04

4.6

4.3

1.87

1.60

mmol/l

0.35

462

Complex cardiac defects

262

2.58

8.03

17.7

9.2

1.08

1.00

mmol/l

0.09

200

162

2.78

7.98

4.5

3.4

1.70

1.03

mmol/l

0.67

116

Viral warts, including avohilmo

682

5436

1.27

7.96

6.1

4.0

1.48

1.57

mmol/l

0.26

478

3940

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

387

2.11

7.96

4.1

3.8

1.06

1.93

mmol/l

1.40

288

Systemic sclerosis, icd10

441

2.02

7.96

5.6

3.2

2.00

1.97

mmol/l

0.02

336

Retinal haemorrhage

102

563

1.90

7.94

3.8

3.7

1.46

2.13

mmol/l

1.07

422

Dystonia

173

1098

1.62

7.93

3.5

3.6

1.78

1.80

mmol/l

0.02

144

821

Other and unspecified acquired haemolytic anaemias

206

2.60

7.92

4.4

3.3

1.62

1.79

mmol/l

0.08

154

Progressive systemic sclerosis

3.81

7.90

7.3

3.9

1.34

1.90

mmol/l

0.33

Reactive arthropathies

246

1682

1.49

7.89

3.5

3.4

1.63

1.92

mmol/l

0.59

184

1260

Ulcerative ileocolitis

123

716

1.78

7.88

3.5

3.2

1.34

1.69

mmol/l

0.47

533

Dislocation, sprain and strain of joints and ligaments of thorax

118

680

1.80

7.86

3.8

3.4

1.81

1.70

mmol/l

0.13

504

Autoimmune hyperthyroidism

166

1043

1.63

7.85

2.8

3.2

2.31

1.85

mmol/l

0.62

113

786

Other disorders of conjunctiva

472

3606

1.33

7.81

4.0

3.6

1.64

1.87

mmol/l

0.68

340

2669

Other or unspecified common variable immunodeficiency

4.48

7.80

6.0

3.4

1.94

0.92

mmol/l

0.64

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

328

2.18

7.79

8.5

4.4

1.65

1.17

mmol/l

0.58

233

Pulmonary eosinophilia, not elsewhere classified

232

2.46

7.78

4.1

2.6

1.91

1.94

mmol/l

0.02

168

Blepharochalasis

958

7940

1.22

7.78

3.3

3.5

1.68

2.05

mmol/l

2.80

728

5987

Other aneurysm

201

1328

1.56

7.78

5.3

3.5

2.01

1.91

mmol/l

0.16

146

965

Vascular dementia (undefined)

170

1071

1.62

7.74

2.9

3.8

2.27

2.14

mmol/l

0.17

110

783

Prolonged pregnancy

124

1769

0.59

7.74

1.8

2.7

1.03

mmol/l

0.00

1200

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

3.43

7.74

5.8

3.6

2.59

1.73

mmol/l

0.43

Vestibular neuronitis

279

1965

1.45

7.73

2.9

3.7

1.48

1.91

mmol/l

1.52

204

1471

Varicella [chickenpox]

168

1068

1.63

7.72

6.0

4.3

1.51

1.28

mmol/l

0.42

130

776

Moderate mental retardation

218

2.61

7.72

8.4

6.0

1.64

1.43

mmol/l

0.14

163

Acne

290

2040

1.44

7.71

4.0

3.9

1.15

1.17

mmol/l

0.03

201

1434

Congenital malformations of the musculoskeletal system, not elsewhere classified

297

2.25

7.70

8.8

4.6

1.83

1.21

mmol/l

0.81

214

Hypermobility syndrome

129

764

1.73

7.68

2.7

3.2

1.79

1.45

mmol/l

0.71

556

Dementia due to Parkinsons disease, excluding more controls

383

2.07

7.68

4.0

2.11

2.21

mmol/l

0.08

276

Systemic disorders of connective tissue in diseases classified elsewhere

3.97

7.65

9.9

7.4

0.76

0.98

mmol/l

0.09

456

1.99

7.63

5.2

3.8

1.09

0.75

mmol/l

0.39

305

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

505

3900

1.31

7.62

4.9

3.6

1.50

1.59

mmol/l

0.22

365

2870

Ulcerative colitis (strict definition, require KELA)

471

3604

1.33

7.62

4.9

3.6

1.46

1.57

mmol/l

0.27

339

2657

Other lesions of median nerve

548

1.89

7.62

3.7

3.3

1.42

2.01

mmol/l

0.76

415

Personal history of medical treatment

209

2.52

7.61

8.7

4.5

1.79

1.86

mmol/l

0.04

156

Ocular pain

258

1796

1.47

7.59

3.2

3.8

1.52

1.70

mmol/l

0.41

182

1333

Cardiomyopathy, Hypertrophic obstructive

318

2.18

7.58

5.5

3.1

1.81

1.38

mmol/l

0.61

231

Defects in the complement system

181

2.72

7.58

5.1

7.2

1.17

1.16

mmol/l

0.01

135

Tuberculosis of other organs, strict, including avohilmo

499

1.93

7.58

4.2

3.8

1.93

2.03

mmol/l

0.10

369

Motorcycle rider injured in other and unspecified transport accidents

174

1117

1.60

7.57

3.8

3.5

1.00

1.37

mmol/l

0.63

125

830

Other and unspecified immunodeficiencies with predominantly antibody defects

281

2.30

7.56

15.3

4.1

1.38

1.62

mmol/l

0.18

204

Neovascular glaucoma

152

949

1.66

7.55

4.9

3.9

1.23

1.88

mmol/l

0.84

100

693

Other keratitis

324

2348

1.40

7.54

4.2

3.4

1.86

1.71

mmol/l

0.28

233

1756

Tuberculosis, IBD comorbidity

238

1636

1.49

7.54

4.2

3.4

2.09

1.96

mmol/l

0.17

182

1181

235

1574

1.56

7.52

21.4

9.4

0.85

0.78

mmol/l

0.13

174

1142

Autonomic disorders

515

1.91

7.50

4.1

4.0

1.52

1.88

mmol/l

0.45

390

Carcinoma in situ of other and unspecified sites

167

1072

1.63

7.49

4.0

3.7

1.29

1.88

mmol/l

1.39

127

776

Congenital malformations of the nervous system

118

697

1.79

7.46

15.5

8.1

1.17

1.09

mmol/l

0.11

507

Panniculitis affecting regions of neck and back

113

653

1.79

7.45

3.2

3.4

2.23

1.88

mmol/l

0.54

481

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

358

4798

0.73

7.45

3.7

4.7

1.53

1.68

mmol/l

0.39

246

3560

Dependent personality disorder

320

2.16

7.45

3.3

3.0

2.41

2.00

mmol/l

0.33

239

Single spontaneous delivery

757

4933

0.80

7.44

2.9

3.5

2.15

1.94

mmol/l

0.84

562

3700

Malignant neoplasm of ureter, including Hilmo

188

2.63

7.43

6.3

4.0

0.63

2.43

mmol/l

1.93

138

Giant cell arteritis

153

962

1.65

7.42

4.1

3.5

1.76

2.20

mmol/l

0.85

116

724

Congenital malformations of pulmonary and tricuspid valves

360

2.26

7.42

17.2

10.6

2.00

0.71

mmol/l

4.07

271

Benign leiomyoma with endometriosis

402

3021

1.35

7.42

3.6

3.3

2.18

2.16

mmol/l

0.04

312

2317

Acute appendicitis

2140

17548

1.14

7.41

3.5

3.4

1.64

1.65

mmol/l

0.05

1567

12808

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

454

3471

1.33

7.41

4.8

3.6

1.44

1.58

mmol/l

0.36

329

2556

Left ventricular outflow tract obstruction, narrow definition

220

1502

1.52

7.40

10.6

6.4

1.98

1.32

mmol/l

2.70

175

1125

Syndrome of inappropriate secretion of antidiuretic hormone

107

3.24

7.39

4.9

3.8

2.27

1.66

mmol/l

0.42

Palmar fascial fibromatosis [Dupuytren]

530

4144

1.30

7.38

4.1

3.7

1.38

1.83

mmol/l

1.59

376

3002

Severe visual impairment, monocular

213

2.48

7.35

6.4

3.7

1.71

1.79

mmol/l

0.04

160

Bullous disorders

201

1345

1.54

7.34

4.0

3.9

1.67

1.93

mmol/l

0.39

139

993

Trichomoniasis

129

2.95

7.34

3.9

3.1

2.11

1.75

mmol/l

0.24

101

Alcoholic gastritis

290

2.24

7.34

5.6

3.8

2.49

1.94

mmol/l

0.59

208

Contact with sharp glass

121

716

1.74

7.33

3.3

3.8

0.93

1.64

mmol/l

1.07

513

Additional codes for the location of defect, injury or illness

193

1280

1.55

7.33

3.6

4.0

1.33

1.74

mmol/l

0.96

134

955

Other and unspecified epidermal thickening

103

585

1.84

7.32

6.0

3.8

1.71

1.86

mmol/l

0.15

430

Carcinoma in situ of skin of trunk

136

836

1.70

7.30

5.7

3.8

1.10

2.15

mmol/l

2.83

105

616

Benign lipomatous neoplasm

905

7506

1.22

7.30

3.3

3.4

1.92

1.84

mmol/l

0.27

676

5585

Right hemicolectomy

205

1380

1.53

7.29

4.3

3.6

1.62

2.00

mmol/l

0.58

150

1016

Adenocarcinoma and Papillary adenocarcinoma of kidney

246

2.37

7.28

5.7

4.0

0.55

2.06

mmol/l

1.96

186

Crowding of teeth, including avohilmo

379

2342

1.37

7.28

11.5

5.8

1.19

0.94

mmol/l

0.95

271

1622

Polyarthritis, unspecified

117

688

1.76

7.28

3.7

3.8

2.67

1.94

mmol/l

1.24

522

Benign neoplasm of urinary organs

167

1076

1.60

7.27

4.7

3.6

1.37

1.99

mmol/l

1.41

123

810

malignant neoplasm of female genital organs, including Hilmo

458

3346

1.32

7.26

3.9

3.2

2.03

2.20

mmol/l

0.34

346

2560

Chondromalacia

528

1.88

7.23

2.7

3.4

1.42

1.69

mmol/l

0.37

396

Varicella [chickenpox], including avohilmo

212

1440

1.52

7.22

5.8

5.1

1.28

1.17

mmol/l

0.19

155

1053

Lesion of radial nerve

125

751

1.72

7.21

4.1

3.2

1.59

1.81

mmol/l

0.19

561

Atrophic disorders of skin

431

3285

1.33

7.20

3.2

3.4

2.00

1.99

mmol/l

0.01

314

2477

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

338

2490

1.39

7.20

3.1

3.6

2.19

1.87

mmol/l

0.76

252

1806

Enduring personality changes

4.10

7.19

3.3

2.8

1.73

1.20

mmol/l

—

Arthropathic psoriasis

325

2379

1.39

7.17

3.6

3.5

2.00

1.78

mmol/l

0.40

234

1796

Other noninflammatory disorders of vulva and perineum

221

1507

1.49

7.17

3.3

3.2

1.93

2.02

mmol/l

0.13

171

1112

Other noninflammatory disorders of cervix uteri

128

773

1.70

7.16

4.5

3.2

1.88

2.45

mmol/l

1.24

102

587

Other congenital malformations of heart

308

2.33

7.16

18.0

9.1

1.53

0.55

mmol/l

2.46

225

Dermatopolymyositis (FG)

253

2.31

7.16

4.5

3.3

1.93

1.82

mmol/l

0.06

190

Radial styloid tenosynovitis [de Quervain]

139

856

1.66

7.16

3.3

2.01

1.74

mmol/l

0.33

103

635

Renal agenesis and other reduction defects of kidney, including avohilmo

182

2.72

7.15

7.6

8.9

0.51

1.30

mmol/l

0.83

132

Viral meningitis, including avohilmo

108

624

1.78

7.13

3.2

3.8

1.65

1.63

mmol/l

0.02

463

Eosinophilia

355

2.10

7.13

6.5

4.6

2.13

1.72

mmol/l

0.56

270

Anankastic personality disorder

104

594

1.80

7.12

2.1

3.1

1.59

1.47

mmol/l

0.17

432

Viral meningitis

102

580

1.81

7.11

2.9

3.2

1.64

1.67

mmol/l

0.03

429

Astigmatism

260

1840

1.45

7.10

9.7

5.5

1.62

1.36

mmol/l

0.52

185

1352

Hypoplasia of dental enamel, prenatal

311

4.79

7.09

58.7

11.2

1.07

0.84

mmol/l

0.33

222

Tuberculosis of other organs

439

1.97

7.09

4.3

3.8

2.01

2.07

mmol/l

0.05

328

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

311

4221

0.72

7.08

3.7

4.8

1.50

1.68

mmol/l

0.42

213

3148

Temporal arteritis

133

818

1.69

7.08

3.8

3.6

1.64

2.17

mmol/l

0.93

101

617

Narcolepsy and cataplexy

3.33

7.08

4.0

3.9

1.73

2.38

mmol/l

0.49

Congenital malformations of great veins

232

2.92

7.08

18.4

12.2

1.81

0.69

mmol/l

2.25

166

Dronedarone medication

539

1.86

7.07

3.7

2.7

1.66

1.43

mmol/l

0.22

385

Other appendicitis

242

1688

1.46

7.07

3.0

3.4

1.92

1.84

mmol/l

0.14

179

1258

Amblyopia ex anopsia

188

1256

1.56

7.06

8.2

6.8

1.33

1.41

mmol/l

0.12

136

935

Small cell lung cancer

100

569

1.83

7.05

3.9

3.4

2.80

2.02

mmol/l

0.82

413

Small cell lung cancer, including Hilmo

100

569

1.83

7.05

3.9

3.4

2.80

2.02

mmol/l

0.82

413

Alzheimer’s disease (Late onset)

637

6499

0.80

7.03

2.8

3.7

2.04

2.13

mmol/l

0.23

450

4776

Respiratory and cardiovascular disorders specific to the perinatal period

246

1583

1.53

7.01

17.8

9.6

1.00

0.73

mmol/l

0.70

183

1154

Hypothermia

413

2.00

7.00

3.5

3.9

1.39

1.91

mmol/l

0.37

311

Other specified disorders of external ear

149

947

1.64

6.98

3.9

3.8

1.33

1.88

mmol/l

1.15

111

707

Systemic sclerosis,strict definition

144

2.76

6.96

5.0

3.6

1.50

1.72

mmol/l

0.16

107

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

3.30

6.95

2.2

1.9

2.60

0.54

mmol/l

0.92

Other disorders of the genitourinary system

372

2796

1.35

6.94

4.0

3.5

1.61

2.10

mmol/l

1.87

292

2141

Postviral fatigue syndrome

110

3.00

6.88

1.8

3.6

1.87

0.97

mmol/l

0.71

Other encephalitis

101

581

1.81

6.88

4.6

4.3

1.78

1.65

mmol/l

0.14

433

Acute myeloid leukaemia

272

2.23

6.83

6.8

4.3

1.06

2.15

mmol/l

1.90

196

Acute myeloid leukaemia, helper endpoint

272

2.23

6.83

6.8

4.3

1.06

2.15

mmol/l

1.90

196

Acute myeloid leukaemia, including Hilmo

272

2.23

6.83

6.8

4.3

1.06

2.15

mmol/l

1.90

196

Other congenital malformations of the digestive system, including avohilmo

271

1942

1.44

6.83

16.5

8.0

1.53

1.16

mmol/l

1.40

210

1432

Hallux rigidus

397

3019

1.34

6.80

2.7

3.4

1.80

2.05

mmol/l

0.64

297

2280

Magnesium deficiency

4.14

6.79

6.2

3.7

2.92

1.82

mmol/l

0.25

Other disorders of eye and adnexa

431

3316

1.32

6.79

4.1

4.2

1.50

1.73

mmol/l

0.75

318

2451

Malignant neoplasm of head and neck, including Hilmo

317

2334

1.39

6.79

3.9

3.6

2.50

1.86

mmol/l

2.11

240

1669

Enterohaemorrhagic Escherichia coli infection

7.23

6.77

4.2

2.2

1.68

2.00

mmol/l

0.17

Other/unspecified enthesopathies of lower limb, excluding foot

196

1324

1.51

6.75

3.4

3.5

1.51

1.80

mmol/l

0.51

144

994

Mucosal proctocolitis

343

2556

1.36

6.74

3.4

1.56

1.68

mmol/l

0.24

246

1920

Atypical virus infections of central nervous system, including avohilmo

171

2.58

6.73

3.6

3.1

1.22

1.97

mmol/l

0.56

121

Dementia in other diseases classified elsewhere

172

1137

1.56

6.72

4.6

3.8

2.07

2.04

mmol/l

0.03

129

836

Colon adenocarcinoma

407

3116

1.33

6.70

3.4

3.5

1.82

2.01

mmol/l

0.42

288

2255

Acquired clawhand, clubhand, clawfoot and clubfoot

3.41

6.69

5.4

3.7

1.24

1.54

mmol/l

0.17

Dermatopolymyositis, unspecified

3.28

6.69

3.5

1.38

1.90

mmol/l

0.19

Osteopathy in diseases classified elsewhere

148

2.73

6.68

7.3

6.3

2.26

2.38

mmol/l

0.06

115

Cerebral aneurysm, nonruptured

253

1800

1.44

6.67

4.4

3.5

1.83

2.00

mmol/l

0.33

198

1369

Pyoderma

398

1.98

6.67

7.9

4.9

2.39

1.76

mmol/l

0.58

297

Idiopathic thrombocytopenic purpura

119

725

1.71

6.63

6.9

5.0

1.25

1.68

mmol/l

0.71

531

Adenocarcinoma and papilloma adenocarcinoma of rectum

321

2379

1.38

6.62

3.0

3.6

2.08

1.90

mmol/l

0.36

242

1722

Complications peculiar to reattachment and amputation

131

2.83

6.61

6.1

3.6

1.62

2.02

mmol/l

0.34

Polycystic ovarian syndrome, broad definition

201

1368

1.49

6.58

2.5

1.10

0.93

mmol/l

0.33

134

891

Struck by thrown, projected or falling objec

170

1124

1.55

6.58

3.2

4.1

1.48

1.52

mmol/l

0.06

129

822

Anorexia

289

2.15

6.58

6.4

4.9

2.41

1.51

mmol/l

0.86

210

Atypical virus infections of central nervous system

167

2.57

6.56

3.7

3.0

1.22

1.96

mmol/l

0.53

118

Colitis, primary sclerosing

283

2.17

6.56

5.3

3.8

1.00

1.55

mmol/l

0.37

212

Glaucoma secondary to other eye disorders

153

992

1.59

6.55

4.9

3.9

1.32

1.85

mmol/l

0.63

101

727

Congenital aortic valve stenosis

165

2.74

6.54

18.1

10.0

2.07

1.12

mmol/l

2.19

117

Giant cell arteritis with polymyalgia rheumatica

133

836

1.65

6.53

3.8

3.7

1.64

2.07

mmol/l

0.71

101

636

Haemolytic-uraemic syndrome

3.78

6.51

23.9

6.5

1.24

1.28

mmol/l

0.02

Lesion of lateral popliteal nerve

154

999

1.59

6.51

3.6

3.4

2.02

1.87

mmol/l

0.22

112

731

Delivery

777

4966

0.82

6.51

3.0

3.5

2.10

1.94

mmol/l

0.60

571

3718

Primary ovarian failure

242

2.23

6.50

4.8

2.8

1.05

1.42

mmol/l

0.39

176

Single ventricle heart

4.27

6.47

16.8

10.2

1.19

1.24

mmol/l

0.03

Renal agenesis and other reduction defects of kidney

166

2.73

6.47

7.9

9.6

0.39

1.20

mmol/l

0.85

120

Other congenital malformations of the digestive system

239

1695

1.46

6.47

18.0

7.5

1.44

1.13

mmol/l

1.00

191

1250

Tuberculosis, wide

245

1746

1.44

6.46

4.2

3.6

2.05

1.95

mmol/l

0.14

188

1265

Carbimazole or st.post thyroidectomy, condition for graves disease

555

4433

1.27

6.45

2.8

3.3

1.97

1.85

mmol/l

0.27

401

3296

Toxic effect of ethanol

119

727

1.69

6.45

5.0

3.5

1.31

1.57

mmol/l

0.31

536

Reactive arthropathies, FINNGEN

193

1314

1.50

6.43

3.7

3.4

1.42

1.83

mmol/l

0.93

141

948

Triptan medication for migraine, single purchase ok

2151

12965

1.13

6.43

2.9

3.4

1.32

1.71

mmol/l

6.56

1555

9527

Migraine, single triptan purchase ok & required. ICD-code if available is included

2151

12965

1.13

6.43

2.9

3.4

1.32

1.71

mmol/l

6.56

1555

9527

Benign neoplasm of meninges

311

2305

1.38

6.43

3.8

3.5

2.16

2.02

mmol/l

0.27

223

1749

Herpesviral [herpes simplex] infections, including avohilmo

679

5544

1.24

6.42

4.3

3.3

1.26

1.69

mmol/l

2.67

498

4030

Chronic myeloid leukaemia, including Hilmo

188

2.47

6.42

4.0

3.6

0.50

1.95

mmol/l

1.39

137

Other and unspecified primary disorders of muscles

183

2.53

6.40

5.6

4.9

1.69

1.22

mmol/l

0.31

139

Benign neoplasm: Pituitary gland, craniopharyngeal duct

164

1084

1.56

6.38

3.2

3.5

1.76

mmol/l

0.01

111

815

Assault by blunt object

245

2.23

6.38

2.7

3.5

2.06

1.26

mmol/l

0.93

177

Bullous pemphigoid

492

1.86

6.37

4.2

3.9

1.84

2.20

mmol/l

0.32

364

Nontoxic multinodular goitre

541

4317

1.27

6.37

3.3

3.4

2.47

2.10

mmol/l

1.51

411

3235

Malignant neoplasm of vulva, including Hilmo

213

2.33

6.36

4.0

3.2

1.63

2.26

mmol/l

0.48

156

Dentofacial anomalies [including malocclusion]

2064

14365

1.13

6.35

4.4

3.5

1.51

1.62

mmol/l

0.82

1501

10495

210

1452

1.54

6.34

23.1

9.9

0.92

0.79

mmol/l

0.26

155

1058

Localized skin eruption due to drugs and medicaments

227

2.30

6.34

3.5

3.7

1.63

1.34

mmol/l

0.24

170

Failure of sterile precautions during surgical operation

3.95

6.34

4.8

2.5

2.45

1.60

mmol/l

0.47

Congenital malformations of gallbladder, bile ducts and liver

355

2.08

6.32

23.6

7.5

1.00

1.40

mmol/l

0.74

260

Other specified disorders of muscle

535

1.80

6.32

4.1

2.12

1.94

mmol/l

0.17

389

L01XX Other antineoplastic agents

201

1390

1.49

6.31

3.9

3.6

1.56

1.97

mmol/l

0.69

139

1037

Disorders of breast

1225

9277

1.17

6.28

2.8

3.2

2.08

1.89

mmol/l

0.94

890

6890

Contact with nonpowered hand tool

138

882

1.61

6.27

3.0

3.7

1.98

1.66

mmol/l

0.45

100

653

Other congenital malformations of nervous system

229

2.30

6.26

11.9

5.4

1.20

1.16

mmol/l

0.03

162

Endometriosis ASRM stages 1,2

376

2870

1.32

6.24

2.9

1.44

1.68

mmol/l

0.83

272

2090

Panniculitis, unspecified

177

2.46

6.22

4.1

3.0

1.46

2.03

mmol/l

0.45

129

Other congenital malformations of urinary system

168

2.63

6.22

28.2

5.4

1.21

mmol/l

0.00

115

Psoriasis (vulgaris), strict definition

110

666

1.71

6.22

3.1

3.4

1.56

1.66

mmol/l

0.09

493

Secondary systemic amyloidosis

3.92

6.21

5.4

2.5

1.26

2.03

mmol/l

0.34

Rheumatoid lung disease

3.17

6.20

5.4

3.9

3.05

2.43

mmol/l

0.48

Ulcerative enterocolitis

584

1.75

6.17

3.8

3.4

0.78

1.76

mmol/l

1.57

432

Malignant neoplasm of renal pelvis, including Hilmo

250

2.22

6.16

6.5

3.7

1.83

2.17

mmol/l

0.19

180

Sequelae of intentional self-harm, assault and events of undetermined intent

112

2.89

6.16

4.9

4.3

2.48

1.12

mmol/l

1.26

Foreign body in alimentary tract

196

1356

1.49

6.15

3.7

4.9

1.23

1.65

mmol/l

0.67

143

995

Cholangitis (primary sclerosing, PSC), with reimbursement 202

454

1.88

6.15

13.2

5.0

0.77

1.70

mmol/l

1.28

333

Impaction of intestines

118

2.83

6.14

3.1

4.2

1.93

1.80

mmol/l

0.05

Rare circulating lymphoid malignancy

131

2.79

6.13

6.0

4.0

2.03

2.45

mmol/l

0.21

Ganglion

525

4190

1.27

6.13

3.1

3.3

1.75

1.77

mmol/l

0.06

399

3068

Arnold-Chiari syndrome

192

2.41

6.12

12.2

5.2

0.83

1.01

mmol/l

0.20

136

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

529

1.81

6.12

15.6

6.8

1.36

1.28

mmol/l

0.09

388

Unspecified dementia

428

2994

1.30

6.11

3.1

3.9

2.14

2.10

mmol/l

0.07

296

2189

Motor disorders

156

1053

1.63

6.10

18.4

9.6

0.36

0.89

mmol/l

1.74

117

770

Hyperprolactinaemia

495

1.81

6.09

3.1

3.2

1.34

1.65

mmol/l

0.40

366

Other localized connective tissue disorders

346

1.99

6.08

4.9

2.9

1.69

2.07

mmol/l

0.34

261

Psoriatic arthropathies, ICD10

297

2205

1.37

6.08

3.2

3.4

1.97

1.80

mmol/l

0.29

216

1667

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

220

1556

1.45

6.06

3.9

4.3

2.10

1.78

mmol/l

0.67

179

1108

Benign neoplasm of other and unspecified female genital organs

114

701

1.67

6.05

3.5

3.4

1.85

1.92

mmol/l

0.06

539

Congenital malformations of aortic and mitral valves

173

1175

1.53

6.05

11.0

5.5

2.11

1.34

mmol/l

2.56

134

860

Benign neoplasm: Skin, unspecified

133

851

1.61

6.04

4.5

3.6

1.41

1.81

mmol/l

0.66

633

Early lumbar disc prolapse, operated

204

1419

1.46

6.03

2.4

2.7

1.07

1.27

mmol/l

0.38

145

1024

Postprocedural musculoskeletal disorders, not elsewhere classified

232

1660

1.43

6.03

4.7

3.7

2.08

2.02

mmol/l

0.08

177

1236

Heterophoria

248

1792

1.41

6.02

6.3

4.4

1.66

1.54

mmol/l

0.20

187

1317

Tumor necrosis factor alpha inhibitors

423

3300

1.30

6.01

3.3

3.7

1.55

mmol/l

0.00

297

2432

Other and unspecified coagulation defects

150

986

1.56

6.00

5.8

3.7

1.40

1.66

mmol/l

0.38

109

732

Selective deficiency of immunoglobulin A [IgA]y

3.16

5.99

6.0

4.7

1.10

1.24

mmol/l

0.06

Other conditions related to polyarteritis nodosa

5.56

5.99

1.9

2.9

1.35

2.04

mmol/l

0.25

Other disorders of the musculoskeletal system and connective tissue

453

3571

1.29

5.99

4.0

3.5

1.89

1.87

mmol/l

0.05

337

2652

Other superficial mycoses

419

1.88

5.98

4.9

3.7

1.84

1.76

mmol/l

0.06

299

Infectious mononucleosis

204

1423

1.46

5.98

3.7

3.2

1.16

1.14

mmol/l

0.04

146

1007

Infectious mononucleosis, including avohilmo

204

1423

1.46

5.98

3.7

3.2

1.16

1.14

mmol/l

0.04

146

1007

Tuberculosis, wide, including avohilmo

245

1771

1.41

5.98

4.2

3.6

2.05

1.97

mmol/l

0.10

188

1280

Necrotizing fasciitis

103

2.99

5.98

5.0

4.2

3.67

1.68

mmol/l

2.21

Adalimumab

266

1945

1.39

5.97

3.2

3.6

1.53

1.52

mmol/l

0.03

179

1464

Maternal care for other conditions predominantly related to pregnancy

376

2811

1.31

5.97

2.5

2.7

1.21

1.30

mmol/l

0.24

243

1991

Other complications of labour and delivery, not elsewhere classified

1301

0.58

5.97

1.5

2.5

0.49

0.86

mmol/l

0.58

834

Other salmonella infections, including avohilmo

125

789

1.63

5.96

5.3

3.6

1.57

1.76

mmol/l

0.25

579

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS